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ABSTRACT
Protein tyrosine phosphatases (PTPs) are a diverse family of signaling molecules
capable of dynamic modes of post-translational regulation. Using a combination of
chemical labeling and enrichment, targeted structural mass spectrometry (MS), and
immunochemistry, we have discovered unique regulatory mechanisms among two
members of the Class I PTP sub-group, VH1-like dual specificity phosphatases (DUSPs).
Human YVH1 (hYVH1 or DUSP12) was found to be reversibly regulated by a variety
of cellular oxidants, resulting in concomitant enzymatic inactivation and zinc ejection
through the formation of disulfide bonds. This was one of the first accounts of PTP
oxidation outside of the active site cleft, and of disulfide exchange reactions among PTPs
to prevent irreversible oxidation of the active site. Furthermore, using gold nanoparticles
and mercury-immobilized metal affinity chromatography, we developed novel methods
for studying PTP thiol-oxidation, which can be readily applied to alternative redoxregulated biomolecules and systems biology applications. Similarly, we have optimized
the development of a library of multifaceted, low pH thiol-labeling and enrichment
reagents for application in quantitative analysis of biological thiols by MS.
Additionally, we have uncovered a mechanism which may participate in regulating
sub-cellular localization of the lipid phosphatase myotubularin related-protein 2
(MTMR2). Specifically, we have evidence that dephosphorylation of MTMR2 Ser58
increases accessibility of key residues within a putative lipid-binding domain, which may
lead to its stabilized localization to substrate-rich endosomes. Here, MTMR2 depletes
phosphatidylinositol 3-phosphate (PI(3)P) substrate molecules, causing mis-localization
of resident PI(3)P-binding proteins, and increased activation of extracellular signalregulated kinases 1 and 2 (ERK1/2). We have further identified ERK1/2 as kinases
capable of phosphorylating MTMR2 Ser58. This resultant ERK1/2 activation may then
lead to phosphorylation of MTMR2, destabilizing endosomal interactions through
competitive shielding of key residues within the lipid-binding domain required for
association, and thus completing a functional negative feedback mechanism to remove
MTMR2 from PI(3)P-rich early endosomes. This may, in part, be critical for achieving
vi

proper homeostatic endosomal signaling and maturation rates, acting to halt or slow
maturation events to allow for increased receptor-signaling responses from these PI(3)Pdepleted endosomes until an appropriate threshold is met, triggering ERK1/2-mediated
attenuation of the stimulus through MTMR2 phosphorylation.
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represents an individual trial of n = 3 independent experiments. ..................................... 60
Figure 2.9 - Proposed model of sustainable activity under conditions of oxidative stress.
Under mild oxidative conditions, zinc is ejected due to thiols in the zinc-coordinating
region serving as reducing agents, allowing the active site cysteine to remain reduced and
catalytically competent. Severe oxidative conditions supersede the reducing power of the
C-terminal thiols. However, the active site cysteine is protected from irreversible thiol
oxidation (e.g. sulfonic acid) by disulfide bond formation with a proximal cysteine
residue. Once reducing conditions are restored, the active site cysteine thiol is recovered
while the C-terminal thiols rapidly re-coordinate zinc. .................................................... 65
Supplementary Figure S2.1 - Mass fingerprint analysis of the zinc domain deletion
variant hYVH1ΔCT1 tryptic peptides. A) Reduced, carbamidomethylated hYVH1ΔCT1
mass fingerprint. Highlighted are the active site and N-terminal vicinal thiol-containing
peptides at m/z 1305.74 and 1021.48 respectively. B) Oxidized, carbamidomethylated
hYVH1ΔCT1 mass fingerprint. Highlighted are the reduced active site and N-terminal
vicinal thiol-containing peptides at m/z 1248.65 and 964.27 respectively.
Carbamidomethylated peaks are largely reduced or absent. Also highlighted is a putative
intra-molecular disulfide peak at m/z 2211.28 of these target peptides. ........................... 67
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Supplementary Figure S2.2 - Differential thiol labeling mass fingerprints of hYVH1
tryptic peptides. A) Reduced, carbamidomethylated
hYVH1 mass fingerprint.
Highlighted is the extreme C-terminal vicinal thiol-containing peptide of the zinccoordinating domain, m/z 1820.93. B) Reduced, N-ethylmaleimidyl hYVH1 mass
fingerprint. Highlighted is the same vicinal thiol-containing peptide, m/z 1956.67. C)
Oxidized, carbamidomethylated hYVH1 mass fingerprint. Highlighted is the absence of
characteristic peak at m/z 1820.93. D) Differential thiol labeled hYVH1 mass fingerprint.
Highlighted is the reappearance of peak m/z 1956.52. ..................................................... 68
Scheme 3.1 - AuNP enrichment method for identifying S-nitrosylation sites in proteins.
Free thiols of S-nitrosylated proteins are alkylated with iodoacetamide (IAM). Proteins
are proteolyzed and AuNPs are introduced to the digest. Any S-NO peptides react with
the AuNPs, releasing NO• to form AuNP-thiolate peptides complexes. The resultant
AuNP-bound peptides are harvested by centifugation and eluted off by thiol exchange
using small molecular weight thiols. Released peptides are analyzed by mass
spectrometry, and target peptide/protein assignment can be done by comparison to in
silico digestion of known protein sequences or bioinformatic database mining. ............. 75
Scheme 3.2 - Simple modification of the AuNP-based enrichment technique
discriminates between sites of S-nitrosylation, S-glutathionylation, and free thiols.
Free thiols of S-nitrosylated and S-glutathionylated proteins are alkylated with
iodoacetamide (IAM). Proteins are de-nitrosylated with ascorbate, differentially
alkylated with N-ethylmaleimide (NEM) and proteolyzed. AuNPs are introduced to the
digest where any S-NO peptides or free thiols, now S-NEM and S-carbamidomethylated
(CAM) peptides, react with the AuNPs, and are enriched. S-glutathionylated peptides do
not bind and thus remain in the supernatant. AuNPs are eluted by thiol exchange and
released peptides are analyzed by mass spectrometry. Target peptide/protein assignment
is confirmed by comparison to in silico digestion of known protein sequences or
bioinformatic database mining. ......................................................................................... 87
Figure 3.1 - AuNPs bind S-NO-PDI causing release of NO•. A) Increasing amounts of
S-NO-PDI in phosphate buffered saline were added 1:1 to a constant amount (~5.3 × 109)
of AuNPs in argon-purged, septa-sealed 2 mL vials. A 500 μL aliquot of the headspace
was then injected into the NOA to quantify NO•. Data on the graph represents the
average of n = 3 independent experiments and error bars represent S.D. B) AuNPs
from sealed vials were collected, harvested by centrifugation, washed, and incubated for
the times indicated with SDS-PAGE sample buffer (+/- 100 mM DTT). The AuNPs were
again collected by centrifugation, and the supernatants were resolved by SDS-PAGE.
Protein was visualized by silver stain. .............................................................................. 80
Figure 3.2 - AuNPs successfully enrich thiol-containing peptides from S-NO-PDI GluC digests. A) Fully reduced PDI was alkylated with IAM, exchanged into 50 mM
ammonium bicarbonate, and proteolyzed by a 10:1 ratio of PDI:Endoproteinase Glu-C.
Peptide mass fingerprints were analyzed by MALDI-TOF MS and compared to in silico
digests as described in 'Experimental Procedures'. B) Fully reduced PDI was Sxx

nitrosylated by S-nitrosoglutathione (GSNO), then alkylated with IAM, proteolyzed, and
analyzed as above. C) Fully reduced PDI was S-nitrosylated, alkylated, and proteolyzed
as above. The digest was added to 1.3 × 1010 AuNPs and incubated for 30 min at 37 °C.
The AuNPs were washed, and AuNP-bound peptides eluted by thiol exchange using 100
mM DTT. Peptide samples were desalted using Vivapure C-18 Microspin columns and
analyzed by MALDI-TOF MS as above........................................................................... 82
Figure 3.3 - Tandem mass spectrometry of AuNP-enriched PDI peptides confirms thiol
peptide association. Tandem mass spectrum (MS/MS) of A) b' domain thiol-containing
peptide at m/z = 951, B) a domain thiol-containing peptide at m/z = 1692, and C) b'
domain thiol-containing peptide at m/z = 2352 were analyzed by post-source decay as
described in 'Experimental Procedures'. ........................................................................... 83
Figure 3.4 - AuNPs successfully enrich thiol-containing peptides from S-NO-hYVH1
tryptic digests. A) Fully reduced hYVH1 was alkylated with IAM, exchanged into 50
mM ammonium bicarbonate, and proteolyzed by a 10:1 ratio of hYVH1:trypsin. Peptide
mass fingerprints were analyzed by MALDI-TOF MS and compared to in silico digests
as described in 'Experimental Procedures'. B) Fully reduced hYVH1 was S-nitrosylated
by S-nitrosoglutathione (GSNO), then alkylated with IAM, proteolyzed, and analyzed as
above. C) Fully reduced hYVH1 was S-nitrosylated, alkylated, and proteolyzed as above.
The digest was added to 1.3 × 1010 AuNPs and incubated for 30 min at 37 °C. The
AuNPs were washed, and AuNP-bound peptides eluted by thiol exchange using 100 mM
DTT. Peptide samples were desalted using Vivapure C-18 Microspin columns and
analyzed by MALDI-TOF MS as above........................................................................... 84
Figure 3.5 - Tandem mass spectrometry of hYVH1 peptides shows presence of Snitrosylation and S-glutathionylation. Tandem mass spectrum (MS/MS) of A) active
site Cys115-containing peptide at m/z = 1248, and B) S-glutathionylated active site
Cys115-containing peptide at m/z = 1553, were analyzed by post-source decay as
described in 'Experimental Procedures'. ........................................................................... 85
Figure 3.6 - AuNPs successfully enrich differentially labeled, thiol-containing peptides
from S-nitrosylated and S-glutathionylated hYVH1 tryptic digests. A) Fully reduced
hYVH1 was S-glutathionylated then alkylated with IAM, and proteolyzed by a 10:1 ratio
of hYVH1:trypsin. Peptide mass fingerprints were analyzed by MALDI-TOF MS and
compared to in silico digests as described in 'Experimental Procedures'. B) Fully reduced
hYVH1 was S-nitrosylated and alkylated with IAM. Sample was mixed with an
undigested sample from A), then de-nitrosylated with ascorbate and alkylated with Nethylmaleimide. Proteins were exchanged into 50 mM ammonium bicarbonate and
processed as above. C) Digests from B) were added to 1.3 × 1010 AuNPs and incubated
for 30 min at 37 °C. The AuNPs were washed, and AuNP-bound peptides eluted by thiol
exchange using 100 mM DTT. Peptide samples were desalted using Vivapure C-18
Microspin columns and analyzed by MALDI-TOF MS as above. ................................... 89
Figure 3.7 - Tandem mass spectrometry of hYVH1 peptides shows presence of Snitrosylation and S-glutathionylation using modified AuNP-enrichment scheme.
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Tandem mass spectrum (MS/MS) of A) active site Cys115-NEM peptide at m/z = 1373,
B) S-glutathionylated Cys11-containing peptide at m/z = 2839, and C) S-glutathionylated
Cys23-containing peptide at m/z = 3291 were analyzed by post-source decay as described
in 'Experimental Procedures'. ........................................................................................... 90
Figure 4.1 - Human YVH1 (DUSP12) is a thiol-rich dual specificity phosphatase.
Schematic displaying domain architecture of hYVH1. The N-terminal phosphatase
domain contains the highly conserved HCX5R(S/T) motif along with three additional Cys
residues. hYVH1 also possesses a unique C-terminal zinc-coordinating domain which
coordinates two moles of zinc putatively through action of seven Cys residues.............. 97
Figure 4.2 - Non-specific oxidation of hYVH1 thiols during proteolytic digestion at
neutral pH. Recombinant hYVH1 and CAM-labeled hYVH1 were subjected to an
overnight trypsin digestion using a 1:25 protein:protease ratio in 50 mM ammonium
bicarbonate pH 8, shaking at 37 °C. The resulting tryptic peptides were analyzed by
MALDI-TOF MS with A) or without B) prior reduction with 25 mM TCEP. ............... 107
Figure 4.3 - Schematic workflows of Hg-IMAC-based methodology. Left) Protein of
interest is exposed to oxidative stress, sample is then acidified to quench the reaction and
reduce the rate of oxidation “preserving” reversibly oxidized thiols (disulfides, Sglutathionylated, cyclic sulfenamides, S-nitrosylated thiols etc.). A rapid proteolytic
digest using acid proteases (i.e. pepsin or Glu C) is then performed whereby peptides are
then passed over Hg-IMAC resin to capture any reduced or S-nitrosylated thiols.
Captured peptides are eluted using DTT and detected by MALDI-TOF MS. Resin flowthrough is split into two fractions, with one fraction left untreated (oxidized thiols) and
the other reduced with TCEP (reversibly oxidized thiols). Both fractions are then passed
over fresh Hg-IMAC resin, resin is eluted, and eluant analyzed using MALDI-TOF MS.
Peptides found in the reduced fraction not found in the non-reduced fraction are putative
reversibly oxidized thiols. Right) Protein is treated as above, however, after acid quench,
any reduced thiols are blocked with 4-DTP at low pH for 1 h. These reduced thiols have
been labeled and can no longer participate in non-specific disulfide formation and can be
differentiated from S-nitrosylated thiols. Moreover, the pH can be raised to 7 - 8
allowing for conventional protein digestion with trypsin and MALDI-TOF MS analysis.
......................................................................................................................................... 110
Figure 4.4 - Characterization of Hg-IMAC selectivity for wild type hYVH1 peptide
thiols. Both CAM-labeled and unlabeled wild type hYVH1 were trypsin digested,
mixed, acidified, and incubated with Hg-IMAC resin for 1 hr using acetonitrile additive.
Supernatant was collected and bound peptides were competitively eluted using DTT. All
samples were analyzed by MALDI-TOF MS. A) Mixed peptides before Hg-IMAC
enrichment. B) Flow-thru supernatant showing near depletion of thiol containing
peptides while IAM labeled peptides remain. C) Peptide eluant from Hg-IMAC
enrichment showing selective thiol-containing peptide enrichment as CAM-labeled
peptides were not detected in the eluant. ........................................................................ 113
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Figure 4.5 - Characterization of Hg-IMAC selectivity for hYVH1 C115S peptide thiols.
Both CAM-labeled and unlabeled hYVH1 C115S were trypsin digested, mixed, acidified,
and incubated with Hg-IMAC resin for 1 hr using acetonitrile additive. Supernatant was
collected and bound peptides were competitively eluted using DTT. All samples were
analyzed by MALDI-TOF MS. A) Mixed peptides before Hg-IMAC enrichment. B)
Flow-thru supernatant showing near depletion of thiol containing peptides while IAM
labeled peptides remain. C) Peptide eluant from Hg-IMAC enrichment showing specific
and selective thiol-containing peptide enrichment. Neither CAM-labeled peptides nor the
C115S peptide were detected in the eluant. .................................................................... 114
Figure 4.6 - Characterization of reversibly oxidized thiols in the DUSP domain of
hYVH1. hYVH1ΔCT1 was exposed to oxidative stress, acidified and rapidly proteolyzed
with Glu C. Peptides were then passed over Hg-IMAC resin to capture any remaining
reduced thiols. The resin flow-through was split into two fractions, with one fraction left
untreated (oxidized thiols) and the other reduced with TCEP (reversibly oxidized thiols).
Both fractions were then passed over fresh Hg-IMAC resin, the resin was eluted, and the
eluants analyzed by MALDI-TOF MS. A) TCEP-reduced, Hg-IMAC eluant of reversibly
oxidized thiol-containing peptides were observed, highlighting putative candidate(s). B)
Non-TCEP-reduced, Hg-IMAC eluant of oxidized thiol-containing peptides were not
observed, ensuring primary Hg-IMAC enrichment went to completion. C) TCEPreduced, Hg-IMAC eluant of reversibly oxidized thiol-containing peptides from A) were
CAM-modified with IAM to confirm enriched peptides contained free thiols as denoted
by m/z shifts of 57. D) CAM-modified peptides from C) were digested by trypsin and reanalyzed to confirm candidate identification through both improvement of ionization
efficiency and target mass identification by tandem MS. ............................................... 116
Figure 4.7 - Identification of putative disulfide exchange within the active site of
hYVH1 using 4-DTP labeling methodology. Both wild type hYVH1 and hYVH1 C115S
were exposed to oxidative stress, acidified and rapidly labeled with 4-DTP. Samples
were neutralized, digested with trypsin, equally partitioned, with one equivalent being
reduced with TCEP, the other untreated. All samples were spotted and analyzed by
MALDI-TOF MS. A) Oxidized, 4-DTP-labeled wild type hYVH1 displays putative
disulfide linkages. B) Oxidized, 4-DTP-labeled, TCEP reduced wild type hYVH1 shows
complete ablation of putative disulfides. C) Oxidized, 4-DTP-labeled hYVH1 C115S
displays only a single putative disulfide linkage, suggesting disulfide exchange occurs
involving this thiol. D) Oxidized, 4-DTP-labeled, TCEP reduced hYVH1 C115S also
shows complete ablation of the lone putative disulfide, further suggesting evidence of
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Supplementary Figure S4.1 - Characterization of Hg-IMAC resin. A) Standard curve
of Cys-HCl free thiol with DTNB showing linear relationship. B) Binding of Cys-HCl by
Hg-IMAC resin as shown by reduction of free thiol with respect to increasing quantities
of slurry, showing a linear relationship with slope denoting a binding capacity of 2.2 μM
thiol/mL of slurry. C) Box plot for seven independently prepared batches of Hg-IMAC
resin (data extrapolated to 1 mL of slurry) showing reproducibility. ............................. 120
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Supplementary Figure S4.2 - Non-specific oxidation of hYVH1 thiols during
proteolytic digestion at neutral pH. Recombinant hYVH1 C115S and CAM-labeled
hYVH1 C115S were subjected to an overnight trypsin digestion using a 1:25
protein:protease ratio in 50 mM ammonium bicarbonate pH 8, shaking at 37 °C. The
resulting tryptic peptides were analyzed by MALDI-TOF MS with A) or without B) prior
reduction with 25 mM TCEP. ......................................................................................... 121
Supplementary Figure S4.3 - Characterization of Hg-IMAC selectivity for wild type
hYVH1 peptide thiols. Both CAM-labeled and unlabeled wild type hYVH1 were trypsin
digested, mixed, acidified, and incubated with Hg-IMAC resin for 1 hr using Tween-20
additive. Supernatant was collected and bound peptides were competitively eluted using
DTT. All samples were analyzed by MALDI-TOF MS. A) Mixed peptides before HgIMAC enrichment. B) Flow-thru supernatant showing near depletion of thiol containing
peptides while IAM labeled peptides remain. C) Peptide eluant from Hg-IMAC
enrichment showing selective thiol-containing peptide enrichment as CAM-labeled
peptides were not detected in the eluant. ........................................................................ 122
Supplementary Figure S4.4 - Characterization of Hg-IMAC selectivity for hYVH1
C115S peptide thiols. Both CAM-labeled and unlabeled hYVH1 C115S were trypsin
digested, mixed, acidified, and incubated with Hg-IMAC resin for 1 hr using Tween-20
additive. Supernatant was collected and bound peptides were competitively eluted using
DTT. All samples were analyzed by MALDI-TOF MS. A) Mixed peptides before HgIMAC enrichment. B) Flow-thru supernatant showing near depletion of thiol containing
peptides while IAM labeled peptides remain. C) Peptide eluant from Hg-IMAC
enrichment showing specific and selective thiol-containing peptide enrichment. Neither
CAM-labeled peptides nor the C115S peptide were detected in the eluant. .................. 123
Supplementary Figure S4.5 - Schematic workflow of 4-DTP labeling efficiency and
specificity. Protein sample is acidified, labeled with 4-DTP and partitioned equally.
Samples are treated with or without TCEP to reduce 4-TP labeling, then neutralized and
CAM-labeled with IAM. Samples are digested with trypsin and analyzed by MALDITOF MS to ensure specificity and completion of 4-DTP labeling under the given
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Supplementary Figure S4.6 - Characterization of 4-DTP labeling efficiency and
specificity for wild type hYVH1 peptide thiols. Wild type hYVH1 was acidified, labeled
with 4-DTP and partitioned equally. Samples were treated with A) or without B) TCEP
to reduce 4-TP labeling, then neutralized and CAM-labeled with IAM. Samples were
digested with trypsin and analyzed by MALDI-TOF MS to ensure specificity and
completion of 4-DTP labeling under the given conditions. A) Despite an extreme excess
of IAM labeling agent, no CAM modified peptides are observed in the absence of TCEP
reduction, whereas in B), multiple CAM modifications are observed............................ 125
Figure 5.1 - Synthetic scheme of isothiocyanate-cyclic activated disulfide reagents
using oxidized glutathione. In the first step of synthesis, one amino group of excess
GSSG reacts with an isothiocyanate derivative (ITC) to form ITC-GSSG. This product is
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purified by RP-HPLC, followed by reduction of the disulfide bond by tris(2carboxyethyl)phosphine (TCEP) generating a free thiol in the glutathione moiety (GSH)
to form ITC-GSH. The free thiol is activated by 4,4'-dithiopyridine (4-DTP) forming
ITC-GS-4-TP whereby the disulfide is subsequently attacked by the thiol of the thiourea
to form the cyclic activated disulfide and release of 4-thiopyridone (4-TP). Adapted from
Nielson et al., Anal. Biochem., (2012) 421:1, 115-120. ................................................. 139
Figure 5.2 - Separation of phenylisothiocyante modified oxidized glutathione
derivatives by anion exchange chromatography. A) Reaction controls from synthetic
schemes according to Nielsen et al. were injected and separated to use as comparative
references. Reaction solvent (Blank), phenylisothiocyanate (PITC) without oxidized
glutathione (GSSG), PITC with GSSG immediately quenched with ethanolamine, and
GSSG without PITC were resolved by anion exchange chromatography. B) Synthetic
reactions of PITC with GSSG were quenched at 10, 40 or 80 min and resolved by anion
exchange chromatography. C) Structure and chemical characteristic of GSSG along with
gradient conditions used in separations. In all cases, absorbance at λ = 254 nm and
conductivity were monitored continuously. Conductivity of linear sodium chloride
(NaCl) gradient shown in red.......................................................................................... 140
Figure 5.3 - Mass spectra of differentially resolved fractions by anion exchange
chromatography. Synthetic reactions quenched at A) t = 10 and B) 80 min were analyzed
by liquid chromatography/mass spectrometry (LC/MS) as described in 'Experimental
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Figure 5.4 - Synthetic scheme of Edman's degradation. Phenylisothiocyanate (PITC)
first reacts with the amino terminus of a protein or peptide under mildly organic alkaline
conditions to form a phenylthiocarbamoyl (PTC) adduct. This is then converted by both
anhydrous and aqueous acids, and heat, to the phenylthiohydantoin (PTH)-amino acid
dervative used in analysis, being accomplished by nucleophilic attack of the carbonyl
carbon within the first peptide bond by a formed thiolate resulting from tautomerization
of the PTC thiourea. Adapted from Edman, P., Acta Chem. Scand., 4 (1950) 34. ........ 143
Figure 5.5 - Suspected route and structure of synthetic by-product formation during
phenylisothiocyanate reaction with oxidized glutathione. A) The unique peptide bond
formed in glutathione (GSH) leaves the free α-carboxyl group of glutamate proximally
located to the thiourea thiolate for nucleophilic attack and loss of an oxygen, as opposed
to attack of the carbonyl and hydrolysis of the amide bond. B) Proposed structure of the
synthetic by-product cyclic PITC-GSSG-PITC at m/z = 849. C) Tandem mass spectrum
(MS/MS) of synthetic by-product at m/z = 849 as analyzed by liquid
chromatography/mass spectrometry (LC/MS) described in 'Experimental Procedures'. 144
Figure 5.6 - Modified synthetic scheme of isothiocyanate-cyclic activated disulfide
reagents using glutathione and 4,4'-dithiopyridine. In the first step of this modified
synthesis, glutathione (GSH) is reacted with 4,4'-dithiopyridine (4-DTP) to form GS-4TP. Next, an isothiocyanate derivative (ITC) is added to react with the free amino group
to form ITC-GS-4TP, with subsequent conversion to form either the desired cyclic
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activated disulfide (ITC-CAD) and 4-thiopyridone (4-TP) or cyclic ITC-GS-4-TP and
water................................................................................................................................ 146
Figure 5.7 - Mass spectral analysis of modified cyclic activated disulfide synthesis
products. A) Reaction products synthesized in water:pyridine:triethylamine at a 1:4 ratio
of activated glutathione (GS-4-TP) to phenylisothiocyanate (PITC) were analyzed by
liquid chromatography/mass spectrometry (LC/MS) as described in 'Experimental
Procedures'. B) Tandem mass spectrum (MS/MS) of synthetic PITC-cyclic activated
disulfide at m/z = 441 as analyzed by liquid chromatography/mass spectrometry (LC/MS)
described in 'Experimental Procedures'. ......................................................................... 148
Figure 5.8 - Tandem mass spectra of modified cyclic activated disulfide starting
materials glutathione and glutathione-4-thiopyridine. A) Glutathione at m/z = 306 and
B) glutathione-4-thiopyridine at m/z = 417 were analyzed by liquid
chromatography/tandem mass spectrometry (LC/MS/MS) as described in 'Experimental
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Figure 5.9 - Precursor ion scanning mass spectra for characterizing cyclic activated
disulfide synthetic reaction products. Fragment ions at A) m/z = 76 and B) m/z = 112
were analyzed by liquid chromatography/precursor ion scanning mass spectrometry
(LC/PIS/MS) as described in 'Experimental Procedures'. .............................................. 150
Figure 5.10 - Timed ion chromatograms of phenylisothiocyanate-cyclic activated
disulfide show sensitivity to reduction and alkylation. Unpurified reaction mixture
containing phenylisothiocyanate cyclic activated disulfide (PITC-CAD) was reacted with
A) water, B) N-ethylmaleimide (NEM), C) tris(2-carboxyethyl)phosphine (TCEP) and D)
TCEP then NEM. Samples were analyzed by liquid chromatography/mass spectrometry
(LC/MS) as described in 'Experimental Procedures', with data representing the timed ion
chromatograms of m/z = 441 to detect the loss of PITC-CAD. ...................................... 152
Figure 5.11 - Timed ion chromatograms of phenylisothiocyanate-cyclic activated
disulfide show a positive reaction upon reduction and alkylation with Nethylmaleimide. Unpurified reaction mixture containing phenylisothiocyanate cyclic
activated disulfide (PITC-CAD) was reacted with A) tris(2-carboxyethyl)phosphine
(TCEP) or B) TCEP then N-ethylmaleimide (NEM). Samples were analyzed by liquid
chromatography/mass spectrometry (LC/MS) as described in 'Experimental Procedures',
with data representing the timed ion chromatograms of m/z = 568 to detect the formation
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Figure 5.12 - Timed ion chromatograms of phenylisothiocyanate-cyclic activated
disulfide show sensitivity to reduced cysteine not alkylated cysteine. Unpurified reaction
mixture containing phenylisothiocyanate cyclic activated disulfide (PITC-CAD) was
reacted with A) cysteine alkylated with N-ethylmaleimide (NEM) or B) cysteine.
Samples were analyzed by liquid chromatography/mass spectrometry (LC/MS) as
described in 'Experimental Procedures', with data representing the timed ion
chromatograms of m/z = 441 to detect the loss of PITC-CAD. ...................................... 154
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Figure 5.13 - Timed ion chromatograms of phenylisothiocyanate-cyclic activated
disulfide show a positive reaction with reduced cysteine not alkylated cysteine.
Unpurified reaction mixture containing phenylisothiocyanate cyclic activated disulfide
(PITC-CAD) was reacted with A) cysteine alkylated with N-ethylmaleimide (NEM) or B)
cysteine. Samples were analyzed by liquid chromatography/mass spectrometry (LC/MS)
as described in 'Experimental Procedures', with data representing the timed ion
chromatograms of m/z = 562 to detect the formation of PITC-CAD-Cys. C) PITC-CADCys at m/z = 562 was analyzed by liquid chromatography/tandem mass spectrometry
(LC/MS/MS) as described in 'Experimental Procedures'. .............................................. 156
Figure 5.14 - Theoretical model of the minimal and optimal reaction characteristics
involved in the formation of CAD-based reagent design. Reaction constraints would
allow 'tuning' of CAD-based reagents through manipulation of the primary sequence of
the peptide (R1, R2, R3 etc.), the ability to impose chemical reactivity past the minimal
spatial limits of ITC thiolate (Y), and through functional derivatization of the ITC reagent
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Figure 6.1 - Characterization of a phospho-Ser58 MTMR2 antibody identifies ERK1/2
phosphorylation of recombinant MTMR2 in vitro. A) Phospho-Ser58 and nonphosphoSer58 peptides were incubated with and without alkaline phosphatase, spotted on
nitrocellulose membrane and probed with an in-house generated α-phospho-Ser58
MTMR2 (α-pSer58) antibody. B) HEK293 cells were transfected with empty vector
(UT), FLAG-MTMR2, and FLAG-MTMR2 phospho-mimetic variants, FLAGimmunoprecipitated (IP: FLAG), treated with and without alkaline phosphatase, and
probed for MTMR2 (IB: α-FLAG) and phospho-Ser58 MTMR2 (IB: α-pSer58). C)
Purified bacterial recombinant MTMR2-His6 was incubated with various MAPKs in vitro
as described in 'Experimental procedures' and phosphorylation of Ser58 MTMR2 was
detected using the α-pSer58 antibody. Total MTMR2 and kinase levels were determined
with their respective antibodies. ..................................................................................... 176
Figure 6.2 - siRNA-mediated depletion of ERK1/2 protein levels reduces MTMR2
Ser58 phosphorylation. A) HEK 293 cells were transfected with control scramble
siRNA or ERK1/2 siRNA, followed by FLAG-MTMR2 or FLAG-MTMR2 S58A and
cultured as described in 'Experimental Procedures'. Cells were stimulated with 5 ng/ml
EGF for 10 minutes, lysed and analyzed by immunoblot analysis. B) Graphs represent
normalized quantitative immunoblot densitometry data of each indicated antibody to their
respective α-actin loading control. Data represents mean and SEM values from at least n
= 3 independent experiments, with ***P<0.001, **P<0.01 or *P<0.05. ..................... 178
Figure 6.3 - Inhibition of ERK1/2 activity decreases MTMR2 Ser58 phosphorylation.
A) HEK293 cells were transiently transfected with empty vector (UT) or with FLAGMTMR2, serum-starved (- serum) for 30 minutes, then treated with the MEK inhibitor
U0126 to inhibit ERK1/2 activation (where indicated). Following stimulation with 5
ng/ml EGF for 5 or 30 minutes at 37°C, cells were lysed, FLAG-immunoprecipitated (IP:
FLAG), then probed for phosphorylation of MTMR2 Ser58 by immunoblot (IB).
xxvii

Immunoblots of all samples for FLAG was used to confirm equal transfections and
loading IP levels. Total ERK1/2 and actin lysate immunoblots served as loading
controls, while pERK1/2 immunoblots displayed U0126 efficacy and ERK1/2 activation
by EGF. B) MTMR2 Ser58 phosphorylation was quantified by densitometry using
ImageJ, normalized to FLAG IP levels and represented as fold change relative to serumstarved control without inhibitor. C) Changes in ERK1/2 phosphorylation (pERK1/2)
thus activation is represented as the relative change in pERK1/2 levels compared to total
ERK1/2 levels. All data represents mean and SD values from at least n = 3 independent
experiments, with ***P<0.001, **P<0.01 or *P<0.05. ................................................ 180
Figure 6.4 - Endogenous MTMR2 Ser58 and ERK1/2 phosphorylation is influenced by
altering serum conditions. A) HEK 293 cells were cultured and processed as described
in 'Experimental Procedures', following either serum (+ 10% (v/v) serum; + serum) or
low serum (+ 0.5% (v/v) serum; - serum) treatment for ~ 12 h. Both lysate and
immunoprecipitates (IP) were subjected to immunoblot (IB) analysis using the indicated
antibodies. B) Graphs represent normalized quantitative densitometry data to the
indicated loading control (y-axis). Data represents mean and SD values from at least n =
3 independent experiments.............................................................................................. 181
Figure 6.5 - Inhibition of the ERK1/2 pathway induces sub-cellular targeting of
MTMR2 to Rab5-positive endosomes. A-C) HeLa cells were transiently transfected with
FLAG-MTMR2 or FLAG-MTMR2 S58A and treated with the MEK inhibitor U0126
(ERK1/2) at 50 µM for 1 hour, SB203580 (p38) at 20 µM for 30 minutes and SP600125
(JNK) at 40 µM for 1 hour as indicated and described in 'Experimental Procedures'.
Cells were analyzed by immunofluorescence for either FLAG-MTMR2 (grayscale or red)
alone or with endogenous Rab5 (green). Merged images display regions of colocalization and are represented in expanded views. Images were collected using 40x oil
objectives; Scale bars: 15 μm. ........................................................................................ 183
Figure 6.6 - Serum starvation induces subcellular targeting of MTMR2 to Rab5positive endosomes. A) HeLa cells were transiently transfected with FLAG-MTMR2 and
analyzed by immunofluorescence microscopy following either serum (+ 10% (v/v)
serum; + serum) or low serum (+ 0.5% (v/v) serum; - serum) treatment as described in
'Experimental Procedures'. Cells were probed for FLAG-MTMR2 (red) and Rab5
(green). B) HeLa cells were treated as above and probed with endogenous MTMR2
(green) and Rab5 (red). Merged images display regions of co-localization and are
represented in expanded views. Images were collected using 40x oil objectives; Scale
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CHAPTER 1 - LITERATURE REVIEW

1.1 Regulation through cellular phosphorylation
Since its discovery in the late 1950's by Krebs and Fischer, phosphorylationdependent regulation has grown to become known as a mechanism involved in nearly all
aspects of cellular life [1-3]. This ubiquitous modification of biomolecules is thought to
influence ~ one-third of the human proteome, being controlled by the catalytic functions
of protein kinases and phosphatases [Fig. 1.1]. The diversity of functional consequences
on targeted substrates is overwhelming; modification through phosphate addition or
removal can result in the increase or decrease of enzymatic biological activity,
stabilization or marking for destruction, facilitation or inhibition of movement between
sub-cellular compartments, even in the formation or disruption of protein–protein
interactions [3]. Coupled to the availability of phosphoryl donors (ie. ATP), reversible
phosphorylation as a regulatory mechanism is a well suited choice as the most general
mode of cellular maintenance utilized in eukaryotes.
Phosphorylation of cellular proteins typically occurs on serine, threonine and tyrosine
(pSer, pThr and pTyr) residues, however, others residues have been reported as targets.
These events are tightly controlled by two protein superfamilies, the protein kinases and
the protein phosphatases, whereby the former catalyze the transfer of a phosphate moiety
onto target substrates from the γ-phosphate of adenosine triphosphate (ATP), whereas the
latter catalyze hydrolysis to regenerate native substrate and inorganic phosphate [Fig.
1.1]. This addition or removal of a phosphate molecule can invoke distinct chemical
properties to a given substrate due to its negative charge distribution at physiological pH,
thus its ability to form hydrogen and/or electrostatic bonds [4]. Since phosphorylationdependent regulation is commonly observed among these families of enzymes
themselves, this further exemplifies the layers of control afforded through such a
mechanism over the orchestration of proper cellular physiology.

Disruption of this

homeostatic control leads to many disease states including cancer, diabetes and
neurodegenerative disorders [5-8].
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Figure 1.1 - Protein phosphorylation
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1.2 The protein phosphatase superfamily
Although an abundance of cellular regulation is exerted through mechanisms mediated
by reversible phosphorylation, the collectively small number of enzymes responsible for
catalysis is astonishing. The protein kinase superfamily houses ~ 500 members, whereas
the protein phosphatases consist of ~ 140 members, suggesting that among these
enzymes, an even greater dynamic of regulation must act to control the fate of some ≥ 10
000 protein substrates [9-12]. The protein phosphatase superfamily is partitioned into
two main sub-familes known as the protein Ser/Thr phosphatases (PS/TPs) and the
protein tyrosine phosphatases (PTPs), not only on the basis of substrate specificity, but
through large differences among three-dimensional structure, association with protein
effectors, regulatory domains and catalytic mechanism [13-16]. The latter is partitioned
even further into four sub-families, the largest of which is known as the class I cysteinebased PTPs [Fig 1.2] [6,10]. This sub-family can be further classified into either the
classical PTPs or the vaccinia H1 (VH1)-like dual-specificity phosphatases (DUSPs)
based on domain architecture and homology between catalytic domains. Dual specificity
phosphatase classification originated from their inherent ability to dephosphorylate both
pTyr and pSer/pThr containing substrates such as those of the mitogen-activated protein
kinase (MAPK) family, however, this catalytic competency and substrate specificity
varies greatly among members in this sub-family.

For instance, the myotubularins

dephosphorylate phosphoinositides (PIPs) [17,18] whereas the atyptical DUSPs have
been shown to target proteins, nucleics and molecules yet to be defined [10,19].
Interestingly, the first DUSP to be cloned was a protein encoded by a region of the open
reading frame within the H fragment of a HindIII digestion of vaccinia virus DNA known
as the H1 region (VH1) [20]. And while this enzyme has defined a major sub-family of
PTPs, the distinct cellular functions of many of its related eukaryotic counterparts are yet
to be defined, designating these enzymes as a members of the atypical sub-group of
DUSPs [10,20].
1.3 Catalytic mechanism of protein tyrosine phosphatases
Despite the low sequence identity among the protein tyrosine phosphatase superfamily
[14], these enzymes share both a highly conserved catalytic mechanism and domain
architecture, in which their activities proceed through a thiol-phosphate intermediate
3

Figure 1.2 - The protein tyrosine phosphatase superfamily. From Julien et al., Nat. Rev.
Cancer, 11:1 (2011) 35-49.

4

Figure 1.3 - A) Protein tyrosine phosphatase catalytic mechanism and B) deviations
among active site clefts. Adapted from Tanner et al., Antioxid. Redox Signal., 15:1
(2011) 77-97 and from Begley et al., Proc. Nat. Acad. Sci., 103:4 (2006) 927-932.
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[Fig. 1.3A] [21-28]. The active site cleft of PTPs possess an invariant signature motif,
HCX5R(S/T), where it is this unique microenvironment that is responsible for reducing
the pKa of the catalytic cysteine thiol to enhance competency during the thiolate-based
dephosphorylation of a diverse array of phosphorylated substrates [10,29-32]. Deviances
in the depth and sequences within the active site cleft, along with the presence of
additional regulatory domains, are all thought to assist in specific substrate targeting
among the sub-groups within the PTP superfamily [Fig. 1.3B] [10,14,27,33,34].
Redundancy within the catalytic mechanism and domain architecture supports the
notion that many of the PTPs exhibit a modular multi-domain arrangement [10]. Thus,
most enzymes in this family, in addition to a catalytic domain, exist as multi-domain
containing entities posing them for the capability of targeted regulation and diverse
functionality [Fig. 1.4]. Although many of these inherent domains are involved in the
regulation of protein-protein or protein-lipid interactions, several others are still poorly
understood in terms of their functional regulation such as catalytically inactive PTP
domains in which critical residues necessary for catalysis have been altered [10]. Some
more unique examples include the novel C-terminal zinc coordinating domain of the
atypical DUSP human orthologue of the yeast VH1-like phosphatase (hYVH1 or
DUSP12) [35], and the N-terminal pleckstrin homology-glucosyltransferases, Rab-like
GTPase activators and myotubularins (PH-GRAM) domain of the lipid phosphatase
myotubularin-related protein 2 (MTMR2) [36,37].
1.4 The dual specificity phosphatase hYVH1
One of the first eukaryotic DUSPs identified was a yeast VH1-like (YVH1)
phosphatase cloned from Saccharomyces cerevisiae whose mRNA levels were
dramatically induced by nitrogen starvation and low temperature [38].

It was later

discovered to have a human orthologue (hYVH1), and has since been classified as an
atypical DUSP based on its poor characterization and lack of MAPK targeting motifs
[10,35]. The hyvh1 gene encodes a ubiquitously expressed, 340 amino acid protein,
which in addition to an N-terminal phosphatase domain, possesses a novel C-terminal
zinc coordinating domain that has been shown to coordinate 2 mols of zinc per mol of
protein [Fig. 1.5] [35]. This cysteine-rich domain is highly conserved among YVH1
6

Figure 1.4 - Modular multi-domain arrangement of protein tyrosine phosphatases.
From Alonso et al., Cell, 117:6 (2004) 699-711.
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Figure 1.5 - Domain architecture of the atypical dual specificity phosphatase hYVH1
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orthologues with this being the only phosphatase known to contain such a domain [35].
Moreover, orthologues are present as single gene copies and display an overall sequence
conservation suggesting that there has been pressure against hyvh1 gene duplication
throughout evolution.
Deletion of the yvh1 gene in yeast disrupts normal growth processes, resulting in slow
growth, a deficiency in spore maturation, and a decrease in glycogen accumulation,
whereas insertion and expression of the hyvh1 gene is capable of restoring a normal yeast
growth phenotype [35,39-41]. Strikingly, although a catalytically defective point mutant
is fully capable of complementing the slow growth phenotype, a hYVH1 variant lacking
the non-catalytic C-terminal zinc-coordinating domain was unable to afford
complementation [40].

It has also been demonstrated that the C-terminal zinc-

coordinating domain of hYVH1 is not essential for intrinsic phosphatase activity in vitro,
however, it is required for interaction with the ATPase domain of heat shock protein 70
(Hsp70) [42]. Similarly, over-expression of wild type hYVH1, but not catalytically dead
or zinc-coordinating domain deletion mutants, prevents cell death induced by Fas
receptor activation, heat shock, and hydrogen peroxide (H2O2), the first known
physiological role for hYVH1 catalytic function [42]. Support of hYVH1 as a prosurvival phosphatase was preceded by a high throughput siRNA screen of HeLa cells
showing that knock-down of hyvh1 was one of the top human phosphatases whose
reduced protein expression led to the induction of apoptosis [43].
Discovering the ability of hYVH1 to protect cells from oxidative stress was rather
paradoxical since most cysteine-based PTPs are inactivated under these conditions
[28,44-48]. It was later determined, however, that cysteine residues within the zinc
coordinating domain serve as a redox buffer, allowing hYVH1 to function under
oxidative conditions known to inactivate PTPs [49]. Oxidation by H2O2 resulted in
reversible and concomitant zinc ejection and enzymatic inactivation, whereby the zinc
ejection correlated with loss of phosphatase activity suggesting a threshold component to
the mechanism.

As the primary oxidative modification of hYVH1 is formation of

disulfide bonds, this mechanism prevents irreversible oxidation of the active site and zinc
coordinating cysteines, allowing for restoration of both catalytic activity and zinc
9

coordination [49]. Since hYVH1 is the only member of the PTP superfamily shown to
possess a zinc coordinating domain, this protective mechanism is likely a defining feature
among YVH1 orthologues.
More recent findings have elegantly established YVH1 as a novel 60S ribosome
biogenesis factor in yeast, and a necessary element for the formation of a fully mature
60S subunit [50-54]. Ribosome profiling revealed that YVH1 co-sediments with the late
pre-60S subunit [52], whereas tandem affinity purification confirmed YVH1 association
with members of this subunit [51,54]. In yvh1 deletion strains, defects in 60S subunit
biogenesis are observed, resulting in increased levels of free 40S subunits, an
accumulation of halfmer polysomes, and impaired nuclear export of late pre-60S particles
[51,52]. Moreover, a distinct role of YVH1 in 60S subunit maturation has emerged as it
has been shown to be an essential 'recycling factor' necessary for regulating the mutually
exclusive association of Mrt4 and the stalk protein P0, with the 60S subunit. These
events are thought to occur in a linear fashion, each being dependent on the former,
whereby Mrt4 is dissociated by YVH1 during cytoplasmic translocation of the pre-60S
subunit, followed by YVH1 dissociation by P0 en route to the formation of a mature 60S
subunit [Fig. 1.6] [51-53]. This process of stalk protein P0 addition is a necessity for
final maturation of 60S ribosomal subunits in the cytoplasm, exemplifying the critical
importance of YVH1 in coordination of distinct trans-acting factors. In all cases, a
YVH1 variant containing the zinc-coordinating domain alone was able to rescue YVH1
deletion strain phenotypes, suggesting that the catalytic domain is not required for the
ribosome biogenesis role(s) of YVH1 [51-53].
Investigations that hYVH1 may possess a similar role in mammalian cells have
discovered that it can also associate with the pre-60S ribosomal subunit endogenously.
This association is not dependent on catalytic activity, however, regardless of catalytic
competency, association is sensitive to treatment with oxidants, with dissociation
occuring in a dose-dependent manner. Intriguingly, regions within both the catalytic and
zinc-coordinating domains were found necessary for pre-60S association, as deletion of
either ablated interaction with this ribosomal subunit [55]. Also, similar to yeast deletion
studies, it was observed that knock-down of hvyh1 in HeLa cells promoted the mis10

Figure 1.6 - Linear mechanism of 60S ribosomal subunit maturation. From Lo et al.,
Mol. Cell, 39:2 (2010) 196-208.
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localization of the ribosome trans-acting factor MRTO4, while knock-down of the
ribosome stalk protein P0 resulted in failed dissociation of hYVH1 from the late-pre60S
subunit and its nuclear exclusion [52,53]. Moreover, P0 knockdown resulted in MRTO4
mis-localization presumably through the inability to promote dissociation of hYVH1
from the pre-60S subunit, thus causing the inability of hYVH1 to promote MRTO4
dissociation for subsequent P0 docking and formation of mature 60S subunits [53]. It
will be interesting to investigate if the redox-sensing function of hYVH1 regulates the
rate of ribosome biogenesis during cellular stress through its direct associative actions
with the late pre-60S ribosomal subunit.
Recent flow cytometry data has revealed that hYVH1 expression levels also regulate
cell cycle progression suggesting that hYVH1 may represent a novel mediator of cell
growth and proliferation during times of cellular stress. Transient overexpression of
hYVH1 caused a significant increase in the G2/M cell population and in polyploidy,
which was accompanied by a decrease in the G0/G1 population [56]. Consistent with
most other findings, the zinc-coordinating domain is necessary and sufficient for hYVH1mediated cell cycle changes, whereas phosphatase activity is dispensible. Moreover,
siRNA-mediated knock-down of hYVH1 protein expression resulted in a dramatic
increase in the G0/G1 population and in cellular senescence.

Interestingly,

phosphorylation studies of hVYH1 suggested a site of modification at Ser335 which
regulates the sub-cellular targeting of hYVH1 and augments the hYVH1 G2/M
phenotype [56]. As this site resides in close proximity to the zinc coordinating domain, it
is thought the observed phenotypes are exerted through this essential domain, further
establishing the crucial role of this novel domain in the physiological functions of
hYVH1.
The importance of these functional roles of hYVH1 is highlighted by the fact that
hyvh1 has been found up-regulated or amplified in a variety of cancers including
neuroblastoma, retinoblastoma, intracranial ependymoma, and chronic myelogenous
leukemia [57-60]. The hyvh1 gene is located on chromosome 1q21-23, a region often
found amplified in a wide variety of neoplasms, and thus it is highly probable that the
hyvh1 gene is overexpressed in other cancers as well [35,61]. It has become increasingly
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clear that better characterizing the role of hYVH1 in regulating ribosome biogenesis, cell
cycle progression, and cell survival, all processes that support tumour growth and
survival, may uncover a direct function in human pathophysiology among these reported
pleiotropic roles for human YVH1.
1.5 The myotubularin lipid phosphatase MTMR2
Myotubularins (MTMs) constitute one of the largest sub-groups among the PTP
superfamily in eukaryotes [10,62,63], and although the majority of PTPs recognize
phosphotyrosine containing proteins as substrates, MTM members dephosphorylate the
lipid second messengers phosphatidylinositol 3-phosphates (PI3P) and PI(3,5)P2 [18,6466]. Through the interaction and recruitment of effector proteins containing appropriate
phosphoinositol (PIP)-binding modules, these phosphoinositols (PIPs) exert key
contributions to membrane targeting, vesicular trafficking, and regulation of signal
transduction pathways.

Therefore, it is thought that PI kinases and phosphatases

antagonize such effector molecules that utilize PI(3)P or PI(3,5)P2 as targeting ligands
and/or allosteric activators [67]. Recent evidence in support of this hypothesis stems
from the ability of MTMR2 to dephosphorylate endosomal PI(3)P resulting in mislocalization of the PI(3)P-binding Fab1p/YOTB/Vac1p/EEA1 (FYVE) domain and the
novel PI(3)P-binding protein receptor-mediated endocytosis-8 (RME-8) [68,69].
It is not surprising that in addition to the catalytic domain, MTMs themselves possess
several regulatory domains suspected to mediate both protein-protein and protein-lipid
interactions [Fig. 1.7]. The three dimensional crystal structure of MTMR2 revealed that
this enzyme possesses an N-terminal PH-like domain, a module known to associate with
PIPs [70-72], within its suspected GRAM domain [37], which has since been coined a
PH-GRAM domain [Fig. 1.8] [34,36].

Additionally, one of the more striking

characteristics of human MTMs is the presence of at least six catalytically dead members,
which have germline substitutions in catalytically essential residues within the PTP active
site motif [Fig. 1.7] [63,73,74]. Even more surprising was the discovery that these
inactive phosphatases form paired associations with active members, serving as adapters
that regulate the localization and activity of their catalytically competent MTM
counterparts [75-79]. It is becoming increasingly clear that along with PIP recognition,
13

Figure 1.7 - Domain architecture of the myotubularin sub-group of dual specificity
phosphatases. From Begley et al., Mol. Cell, 12:6 (2003) 1391-1402.
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Figure 1.8 - Crystal structure of MTMR2 reveals a pleckstrin homology (PH)-like
domain fold in the GRAM sequence homology domain. From Begley et al., Mol. Cell,
12:6 (2003) 1391-1402 and Begley et al., Proc. Nat. Acad. Sci., 103:4 (2006) 927-932.
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multiple alternative interactions function in unison to regulate the targeted membrane
association of PIP-binding proteins [80].

Combining PIP-association with such

mechanisms as oligomerization, co-operative binding, and multiple domains or binding
sites, not only acts to alter the stabilization of interactions, it also affords a far greater
diversity of regulatory control over signal manipulation than that achieved through PIP
levels alone [72,80]. The ability of MTMs to homo-dimerize, combined with the fact that
inactive binding partners may function as naturally occurring substrate trapping mutants
[81], further highlights the possibility that this multivalent, avidity-based, membrane
association known as 'co-incidence detection' may exist among the MTMs [72,75,77,80].
Coming full circle, as first discovered by Krebs and Fischer, phosphorylation is often
a central component in the overall regulation of protein function, including that of
signaling enzymes. Moreover, their inaugural accounts were also the first evidence of
phosphorylation-dependent allosteric regulation of enzymes [1,2]. In the case of lipid
phosphatases and MTMs, upon discovery of its physiological substrate, this was all but
too evident for the functionally similar lipid phosphatase, phosphatase and tensin
homolog (PTEN) [82]. Numerous reports have been published describing the complex
nature of PTEN phosphorylation and how this mechanism critically regulates its activities
[83].

Although it is not yet fully clear, several lines of evidence suggest that

phosphorylation of PTEN results in decreased activity, and the inability to interact with
both PIPs and a binding partner that targets and stabilizes it at the membrane [84,85].
Collectively this has led to a model that phosphorylation of PTEN induces a 'closed
conformation', whereby phosphorylation prevents interaction with PIPs and membrane
stabilizing factors through allosteric blockage of key residues responsible for mediating
these associations [85]. Dephosphorylation of these sites induces an 'open conformation'
that allows PTEN access to membrane compartments, and thus, to act on its lipid
substrate. In a similar, yet unrelated account, the PI(4)P phosphatase synaptojanin has
also been found to be regulated by phosphorylation [86].

In resting neurons,

synaptojanin is thought to be constitutively phosphorylated by cyclin-dependent kinase 5
(CDK5), inhibiting its interaction with the membrane targeting protein endophilin,
resulting in mis-localization and inactivation [87]. In response to the appropriate stimuli,
calcineurin dephosphorylates synaptojanin rendering it fully active and available to be
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recruited to the proper sub-cellular compartment and perform its lipid phosphatase role
[87].
As the lipid substrates for MTMs are also found present on membrane
bilayersincluding endocytic vesicles, the mechanisms that control MTM sub-cellular
targeting and/or phosphoinositol recognition are also predicted to be critically important
for their function. Unlike PTEN and other well characterized lipid phosphatases, the
physiological roles and cellular pathways affected by MTMs are still poorly understood.
However, emerging evidence has implicated a role for phosphorylation-dependent
allosteric regulation in the control of MTMR2 sub-cellular localization, thus access to its
physiological substrates PI(3)P and PI(3,5)P2 [69]. It was observed that phosphorylation
potently sequesters MTMR2 from substrate-rich endosomes, whereas a phosphorylation
deficient variant strongly co-localized with PI(3)P/Rab5-positive endocytic vesicles.
This resulted in depletion of PI(3)P, mis-localization of PI(3)P-binding proteins, and
increased activation of growth factor receptor signaling pathways in response to ligandmediated stimulation, notably in extracellular signal-regulated kinases 1 and 2 (ERK1/2)
activity [68,69]. Since catalytic activity and hetero-dimerization with its inactive partner
MTMR5 were found to be independent of phospho-status, regulation of MTMR2 subcellular localization is thought to occur through an allosteric mechanism [69].
Furthermore, it has been discovered that ERK1/2 are capable of phosphorylating
MTMR2, strongly suggesting that the endosomal targeting of MTMR2 may be regulated
through a phospho-dependent, ERK1/2 negative feedback mechanism [88]. Even more
compelling was the observation that differential MAPK activities were shown to control
the shuttling of MTMR2 between Rab5/PI(3)P-rich and adaptor protein containing a
pleckstrin homology domain, phosphotyrosine binding domain (PTB) and a leucine
zipper motif (APPL1)-containing endosomal subtypes in a phospho-dependent manner
[88]. These results highlight that similar to PTEN and synaptojanin, phosphorylation is
capable of potent allosteric regulation among the diverse cellular activities involving PIPs
through direct influences on lipid phosphatases.
One of the more uncommon attributes of MTMs is that within this sub-group of PTPs,
associations of three MTM family members have been well established among distinct
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human pathological diseases [77].

Even more puzzling is that mutations in genes

encoding highly homologous family members (MTM1 and MTMR2), with similar tissue
expression patterns and a common substrate, results in different diseases. The mtm1 gene
was discovered to be mutated in X-linked myotubular myopathy (XLMTM), a severe
congenital muscular disorder characterized by hypotonia and generalized muscle
weakness in newborn males [77,89]. In contrast, mutations in two other MTM genes,
mtmr2 and mtmr13, have been shown to cause the neurodegenerative disorders CharcotMarie-Tooth (CMT) disease 4B1 and 4B2 respectively [90,91]. Charcot-Marie-Tooth
disease is one of the most prevalent hereditary neuromuscular diseases, afflicting
approximately one in 2500 individuals.

Charcot-Marie-Tooth disease 4B1 is an

autosomal recessive disease comprised of a demyelinating neuropathy characterized by
abnormal Schwann cell proliferation and folding of myelin sheaths in peripheral nerves
[77]. The discovery that genetic mutations in the catalytically inactive MTMR13 can
cause CMT4B2 was intriguing since it is a known associating partner of MTMR2 [92].
This indicates that mutations in genes whose products associate with active MTMs can
result in similar neuromuscular disorders even when wild-type, catalytically active
MTMs are present. Altogether, this suggests that MTMs are both differentially and
highly regulated enzymes in which continued study is necessary to provide critical insight
to links between pathophysiology and cellular activity.
1.6 Mass spectrometry
To draw attention to his recent advancements on Goldstein's discovery of
'kanalstrahlen' (canal rays) or 'positive rays' [93], Thomson published a monograph
entitled "Rays of positive electricity and their application to chemical analyses" [94]. In
it, he claimed "I feel sure that there are many problems in Chemistry which could be
solved with far greater ease by this than by any other method". A bold statement to say
the least, but since the publication of this monograph 100 years ago, analysis by means of
'positive rays' is arguably one of the most utilized modes of analysis among the industrial,
experimental and natural sciences.
Although contributions by many throughout history have enabled the field of mass
spectrometry, many consider Sir John Joseph Thomson (Nobel laureate for discovery of
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the electron) as the founding father of mass spectrometry (MS). His discoveries were,
however, only plausible due to the work of others in the field, a trait honoured in research
science truly to this day. Although widely applicable to volatile and/or thermally stable
chemicals, MS did not fully enter the biological sciences until some 75 years later upon
the development of matrix-desorption and electrospray ionization by Hillenkamp et al.
and Fenn et al. respectively [95,96], and the rest is, well, history.
As pertains to this document, the primary focus will be common MS-based
technologies in the study of biological systems. However, to begin, a brief description of
the nomenclature, pertinent equipment, and analytical read-out(s) will be outlined [97].
Mass spectrometry is simply the mass analysis of charged, gaseous ions (or pseudo-ions),
which is enabled by manipulation of the position of these charged ions in space using
electric and/or magnetic fields. To obtain free ions void of any other matter, analysis
takes place under low pressure (ie. in vacuo). As all elements have naturally occurring
isotopes which vary by mass, mass spectrometry concerns itself with the mass of these
individual isotopes of the elements, not the atomic mass of the elements, as the latter is
the weighted average of the naturally occurring stable isotopes that comprise the
element(s). Thus, the detected mass is not that of the molecular weight, but that of an
isotope of a given charge (ie. m/z, dimensionless) or the mass of an ion's individual
isotope(s) on the atomic scale divided by the number of charges it possesses.

A

molecular ion or precursor ion is formed within the ionization source (ie. a tryptic
peptide) and it is the source of all fragment ions. A fragment ion results from the
decomposition of precursor or molecular ions (ie. an ion formed by breakage of a peptide
bond within the tryptic peptide precursor ion). A peak is a computerized recording of the
mass spectrum, with the peaks representing the ions formed within the mass spectrometer
(ie. ions are not found in mass spectra and peaks are not found in mass spectrometers).
Moreover, peaks have intensities whereas ions have abundances, where in most instances,
mass spectral peaks are plotted as relative intensities of the peak of highest intensity (ie.
ion of most abundance). To note, mass spectral peaks and chromatographic peaks are
different entities, however, common liquid chromatography/mass spectrometry (LC/MS)
applications plot the sum of the ion current over time to produce a total ion
chromatogram (TIC) (ie. the sum of all ion abundances at a given time over time). From
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Figure 1.9 - Schematic image of mass spectrometer components. Adapted from Watson
and Sparkman, (2007) Introduction to Mass Spectrometry, 4th Edition: Instrumentation,
Applications, and Strategies for Data Interpretation.
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this, by selecting for a single m/z, a plot of that specific ion current over time can be
produced (either during or post analysis), which is referred to as an extracted or timed ion
chromatogram (EIC or TIC).
The main features of a mass spectrometer are outlined, along with corresponding
pressure requirements [Figure 1.9]; the sample inlet, the ion source, ion guides (arrows),
mass analyzer, detector and computerized data system. First, it is evident that analyte
must be introduced into the system, and this analyte must become ionized. Two of
themost common procedures among biological MS are matrix-assisted laser desorption
ionization (MALDI) [96,98] and electrospray ionization (ESI) [95], both being
considered 'soft' ionization methods as they do not routinely fragment analytes upon
ionization [Fig. 1.10].

As imagined, these processes are fundamentally different,

however, achieve the same outcome; formation of charged, gaseous analytes. In the
former, analyte is mixed with an organic, ultra-violet (UV) absorbing matrix, in a suitable
solvent that has similar solubility characteristics to that of the analyte, to a final
concentration of ~ 1:5000. This provides sufficient protection from subsequent radiation
damage, prevents ionic interactions within the analyte upon desorption into the gas phase,
and incorporates the analyte into a crystalline matrix critical for the success of MALDI
experiments [98,99]. A pulsed N2 laser at 337 nm then illuminates the spot, whereby the
energy is absorbed by the matrix and transferred through to the analyte en route to
gaseous ionization [Fig. 1.10A]. The exact mechanisms involved in the MALDI process
of analytes remains under investigation, however, many have contributed to studying
such phenomena [100].
In contrast, ESI, as its name implies, involves forcing an analyte, suspended in a
suitable volatile solvent, through an electrically charged, fine tipped capillary resulting in
the 'sprayed' dispersion of solution into fine droplets. To achieve the highest sensitivity,
similar to the necessity for optimal co-crystalization in MALDI, ESI relies on formation
of the 'Taylor cone'. This forms as a result of the electric field applied to the capillary,
producing electrostatic forces which pull the liquid droplets out of the capillary toward
the ground plate [100]. After an ~ 1 mm flight path, this jet of fluid spreads into a plume
visible to the naked eye whereby the droplets rapidly diminish in size due to evaporation
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Figure 1.10 - A) Matrix assisted laser desorption ionization and B) electrospray
ionization sources
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of the volatile solvent in the heated source. This electrostatic force alone is sufficient
enough to promote evaporation of the small volumes analyzed during nano ESI (nESI)
[101], however, the volumes processed by standard mirco ESI sources require the aid of a
desolvation gas which flows over the capillary to increase the concentration of analyte
ions within the droplets [Fig. 1.10B]. The decreasing size in droplets increases repulsive
forces between excess charges within the droplet, ultimately resulting in gaseous
ionization of charged analytes [102,103].
Common mass analyzers include the time of flight (TOF) and the triple quadrupole.
The operating principles of TOF instruments involve measuring the time required for an
ion to travel from the ion source (typically MALDI for TOF instruments) to a detector ~
1 - 2 m away [Fig. 1.11A] [104]. All of the charged, gaseous ions formed in the ion
source receive the same kinetic energy (KE) during acceleration, and as such, those of
different m/z will have correspondingly different velocities when drifting in a field free
region (ie. the drift tube). During this time, ions separate into packets based on their
velocity, which is directly proportional to their mass as shown in Equation 1.
KE = 1/2mv2

(1)

where KE is the kinetic energy or accelerating voltage, m is the mass and v is the
velocity.
Based on this, ions reach the detector in order of increasing m/z. One significant
advantage of TOF mass analyzers is there is theoretically no upper limit of m/z values
that can be measured, a limitation among most other mass analyzers which transmit and
separate ions of different m/z using electric and/or magnetic fields such as triple
quadrupoles. Linear TOFs do lack sufficient resolving power, however, refocusing and
re-accelerating ions at the end of the drift tube using an ion mirror(s) (ie. reflectron) can
circumvent this anomaly and allow for more structural details to be obtained (ie. tandem
MS or MS/MS). As with most MS applications, this increased resolution comes at the
expense of sensitivity. These two features are often traded off during any MS-based
analysis, however persistant development of new hybrid instrumentation, ion optics and
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Figure 1.11 - A) Time of flight and B) triple quadrupole mass analyzers
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software packages continue to minimize the effects solicited by these compounding
issues.
As the name implies, quadrupole instruments are constructed of four (quad)
symmetrically arranged rods (or poles) to which an electric current is applied, and thus
serve as electrodes. Operation of this mass analyzer is based on the motion of ions in
modulating electric fields, whereby the pairs of rods opposite each other are connected to
either the positive or negative terminal of a variable direct current (DC) source. In
combination, variable radio frequency (RF) alternating current (AC) potentials are also
applied to each pair of rods, collectively causing ions to oscillate dimensionally based on
their rate of movement through the quadrupole (accelerating voltage), m/z, and the
frequency and magnitude of the AC signal [105]. Upon proper tuning of the fields, the
ion-tragectory of certain m/z ratios is stabilized during transit through the quadrupole en
route to the detector, while alternatively, any de-stabilized ions collide with the
quadrupole electrodes, becoming neutralized and thus unable to reach the detector [Fig.
1.11B] [106]. Through modulating these fields, quadrupoles can reach nearly 4000 m/z
mass ranges, not nearly that of the TOF, but their scanning speed and ease of tuning for
targeted approaches makes them very powerful in biological MS applications.
Once charged, gaseous ions are formed and separated by mass, fragmentation of
precursors, also known as tandem MS or MS/MS, can yield varying degrees of structural
and chemical information. Although others exist, including metastable fragmentation
(spontaneous decomposition of ions due to internal energy obtained from ionization in
the source; known as post-source decay; PSD), a common approach to induce precursor
ion fragmentation is through collision of ions with a neutral, inert gas.

In this

collisionally activated or induced dissociation (CAD or CID), ions convert some of their
translational or kinetic energy into internal energy upon collision with the selected
gaseous atoms or molecules, thus causing it to decompose [107,108]. Through the
combined influences of proton mobility and relative bond energies within precursor ions,
and the control of gaseous composition and collsion energies, precursor decomposition
can be finely tuned during CID to assist in breakage of targeted chemical bonds, making
this a very useful tool in structural mass spectrometry. For instance, tuning the CID can
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Figure 1.12 - Nomenclature of peptide precursor ion fragmentation
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promote near exclusive peptide bond breakage into fragment ions, however, increasing
the energy and/or altering the gaseous composition can result in more random breakage,
providing either more or less information depending on that which is sought. Pertaining
to the gas-phase fragmentation of peptides, the general model involves charge-directed
bond cleavages via proton mobility [109]. Protonation among the peptide backbone
initiates the charge-directed breakage of amide bonds, resulting in the formation of either
y- or b-type ions, so designated by whether the charge remains on the C-terminal (y ion)
or N-terminal (b ion) fragment after bond cleavage [Fig. 1.12].
Combination of CID 'tuning' with triple quadrupole mass analyzers, among others,
provides the ability to develop targeted MS-based approaches. In its simplest form, a
given precursor can be defined by the compilation of characteristic fragments it
decomposes into at a given CID energy and gaseous composition. As such, a precursor
can then be identified and defined by any fragment masses which are unique to that given
precursor. Tandem MS (fragment ion scans/daughter ion scans) acquires fragment ion
data of a given precursor [Fig. 1.13A], which allows one to tune the MS, and specifically
focus target fragment ions of given precursors among the first and/or last quadrupoles.
Collectively, these analytical approaches are termed precursor ion scans (PIS) and
multiple reaction monitoring (MRM) [Fig. 1.13B,C]. As an analogy, these would be
similar to fixing a fluorescence emission wavelength (λ) while scanning excitation λ's (in
PIS) [Fig. 1.13B], or fixing both the emission and excitation λ's (in MRM) [Fig. 1.13C].
These techniques, referred to as 'targeted proteomics' among biological mass
spectrometrists, are extremely powerful due to their accuracy, sensitivity and throughput.
Moreover, this technology allows for 'finding needles in haystacks' such as cross-linked
or modified peptides within complex mixtures. Detailed fragment ion characteristics
allow for PIS to identify any precursor ion that is composed of, or contains, that specific
fragment simply by fixing the 'emission λ' and scanning the 'excitation λ' [Fig. 1.13B].
Furthermore, combining targeted MS with targeted chemical labeling and enrichment of
proteins, or chemical 'omics', has become a valuable tool in studying post-translational
modifications both qualitatively and quantitatively. As these cellular modifications are
routinely low in abundance, using such sensitive MS-based methods increases their
analytical detection, boasting a clear advantage to their study via integrated MS
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Figure 1.13 - Targeted mass spectrometry using A) daughter/fragment ion scanning,
B) precursor ion scanning or C) multiple reaction monitoring
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approaches. Moreover, coupled to MS, chemical labeling has become a tour de force in
the field of structural biology in the form of hydrogen-deuterium exchange MS. In this
technique, protein is diluted into deuterium oxide, and the base-catalyzed exchange of
amide backbone protons with deuterons takes place. This exchange is acid-quenched, the
protein rapidly digested by an acid protease, and subjected to MS analysis. The relative
deuterium uptake of peptides can be calculated by their corresponding increase in m/z,
and thus, inferences on structural changes or binding interactions can be made based on
alterations in solvent accessibility between control and stimulated states [Fig. 1.8B]
[110].
Based on these criteria, it becomes clear to see that alterations in the mass of
molecules can yield pertinent structural and potentially functional data. One common
example of this among biological mass spectrometry is the addition of a phosphate group
to a protein. Upon MS analysis, a mass shift will be observed for the modified residue
containing-peptide precursor ion as compared to a dephosphorylated control. Moreover,
based on the mass of the precursor, and the fragmentation pattern, not only can the
intrinsic peptide sequence be identified, so can the site of modification and perhaps
inferred function. This capability has been greatly bolstered by the sequencing of the
human genome, which has since taken Thomson's 'positive rays', and mass spectrometry,
into the complex world of systems biology.
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1.7 - OBJECTIVES
The objectives of this thesis are to use targeted structural and biological mass
spectrometry, immunochemistry, and chemical synthesis as discovery tools in studying
the cellular biology of distinct signaling proteins of the protein tyrosine phosphatase
superfamily. Of main focus is the redox- and phospho-dependent regulation of human
YVH1 and myotubularin related protein-2 (MTMR2).
Specifically, we aim to:
1) Study the mechanism(s) of redox regulation of hYVH1 using spectrophotometry
and differential thiol-labeling mass spectrometry
2) Develop novel labeling and enrichment strategies for studying post-translational
modification of protein thiols and thiol-dependent biological processes both
qualitatively and quantitatively using mass spectrometry
3) Design, isolate/purify, characterize, and employ phospho-specific antibodies and
structural mass spectrometry-based methods to study the mechanism(s) of MTMR2
phosphorylation-dependent regulation
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CHAPTER 2 - REDOX REGULATION OF THE DUAL SPECIFICITY
PHOSPHATASE HUMAN YVH1 THROUGH DISULFIDE BOND FORMATION

2.1 - INTRODUCTION
Human YVH1 (hYVH1; also known as DUSP12) is a member of the dual specificity
phosphatase (DUSP) sub-family of protein-tyrosine phosphatases (PTPs) [1,2]. It is
constructed of an N-terminal DUSP catalytic domain and a unique C-terminal zinccoordinating domain [3]. Poor characterization and lack of mitogen-activated protein
kinase targeting motifs further classify this enzyme as an atypical DUSP [1]. Human
YVH1 exists as a lone isoform, with orthologues exhibiting high evolutionary
conservation and similar domain organization, suggesting that this enzyme may
participate in distinct processes fundamental to cellular physiology [3]. Deletion of the
yvh1 gene in yeast disrupts normal growth processes [4], whereas insertion and
expression of the hyvh1 gene is capable of restoring a normal yeast growth phenotype [3].
Moreover, amplification of the dusp12/hyvh1 gene has been reported in multiple
sarcomas, implicating a role for hYVH1 in human pathological diseases [5-7].
Recently, deletion studies from our laboratory have shown that the C-terminal zinccoordinating domain of hYVH1 is not essential for intrinsic phosphatase activity in vitro,
however, it is required for interaction with the ATPase domain of heat shock protein 70
(Hsp70) [8]. Similarly, over-expression of wild type hYVH1, but not catalytically dead
or zinc-coordinating domain deletion mutants, prevents cell death induced by Fas
receptor activation, heat shock, and hydrogen peroxide (H2O2) [8].

Despite these

findings, current information on hYVH1 biochemical, enzymatic and physiological
functions remains limited.
PTPs and DUSPs share similar active site architecture and catalytic mechanism,
characterized by a conserved HCX5R(S/T) motif [9,10]. The unique microenvironment
formed within this catalytic cleft acts to reduce the pKa of an invariant cysteine residue,
enhancing both its nucleophilicity and oxidation susceptibility [11,12].

Thus, the

stimulated or constitutive generation of reactive oxygen species (ROS) can elicit
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oxidative second messenger signaling responses capable of transient and reversible posttranslational inactivation of both PTPs and DUSPs through oxidation of the catalytic
cysteine [13-15].

Oxidative susceptibility and modification varies among PTPs and

DUSPs, a likely consequence of slight variations in active site conformations or mediated
through unique regulatory domains [16-18]. Accumulating evidence suggests that redoxmediated oxidation of PTPs is a dynamic modification that can impose differential
regulation among PTP family members [13,19]. Sulfenic acid, cyclic sulfenamide, and
disulfide bond formation have all been shown to facilitate stable, reversible, active site
modifications among various PTPs and DUSPs [14,20,21].

Furthermore, evidence

suggests that oxidation predominantly and rapidly targets the active site cysteine, whereas
other cysteinyl residues remain in the reduced state [15,21].
This study investigated the relationship between the C-terminal zinc-coordinating
domain and the catalytic domain of hYVH1 during oxidative conditions. We provide
data suggesting that the zinc-coordinating domain is targeted during oxidative stress to
impede oxidation of the active site cysteine. Increased exposure to oxidative conditions
readily induces disulfide bond formation within the zinc-coordinating and catalytic
domains, resulting in concomitant zinc ejection and enzymatic inactivation. Zinc ejection
is readily reversible and required for hYVH1 activity upon returning to reducing
conditions.

Thus, we propose a mechanism for protection of phosphatase activity

through the intrinsic redox-buffering capacity of this unique zinc-coordinating domain.
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2.2 - EXPERIMENTAL PROCEDURES
Cell culture, transfection, and Annexin V assay
HeLa cells (ATCC) were maintained as a monolayer in Dulbecco’s Modified Eagles
Medium Nutrient Mixture F12 HAM (Sigma) supplemented with 10% (v/v) fetal bovine
serum (Gibco by Life Technologies) at 37 °C and 5% CO2. Transient transfection was
carried out at 70% cellular confluency using FuGENE® 6 HD (Roche Applied Science)
according to the manufacturer’s protocol. For H2O2 (ACP Chemicals Inc.) treatments,
cells were exposed to the indicated concentrations for 1 h at 37 °C. Cell viability was
determined using a fluoroscein isothiocyanate-conjugated Annexin V kit (Vybrant
Apoptosis Assay Kit 3; Molecular Probes) according to manufacturer’s instructions and
as described previously [8]. Cells were also treated with Hoechst 33342 dye (Molecular
Probes) and viewed using fluorescence microscopy.

Approximately 500 cells were

counted per experiment using the Northern Eclipse software program, with apoptotic
cells being detected by positive Annexin V staining. The percentage of apoptotic cells in
the total sample population, as determined by Hoechst staining, was calculated. The data
shown is as the average from n = 3 independent experiments.

Recombinant protein expression and purification
Bacterial expression of pGEX-4T1 GST-hYVH1 constructs and protein purification
was as previously described with slight modification [3,8].

Production of the

catalytically inactive variant GST-hYVH1 C115S and the C-terminal zinc-coordinating
domain deletion mutant, GST-hYVH1ΔCT1, were as previously described [3,22].
Recombinant proteins were eluted with 50 mM Tris-HCl, 150 mM NaCl, 2.5 mM CaCl2,
0.1% 2-mercaptoethanol, 80 units of thrombin (Sigma) pH 8, for 4 h at 4 °C from
glutathione-agarose (Sigma) to remove the glutathione S-transferase tag. Purified protein
samples were concentrated and exchanged into metal-free 50 mM Tris-HCl, 50 mM
NaCl, 1 mM dithiothreitol (DTT; Sigma), 0.25 mM phenylmethylsulphonyl fluoride, pH
7.4, using Amicon Ultra-4 centrifugal filters (Millipore) at 4 °C. Metal-free buffers were
prepared by passage through a Chelex-100 column (Sigma) to remove contaminating
metals, with pH being checked and readjusted (if necessary) after each passage. All
44

metal-free buffers were tested for residual contaminants prior to experimental analyses
via complexometric titrations to ensure trace levels were below the experimental
detection limits. Protein concentration was determined against standard bovine serum
albumin as per Bradford assay (Bio-Rad), and samples were aliquoted and stored at -80
°C until use. The purity of all proteins in this study was ~ 80–90%, as judged by SDSPAGE analysis.

Oxidation-induced enzymatic inactivation, thiol loss, and zinc ejection
Phosphatase activity was monitored at 30 °C using the artificial substrate analog 6,8difluoro-4-methylumbelliferyl phosphate (DiFMUP; Invitrogen). Protein samples were
exchanged into preheated (30 °C), metal-free 50 mM Tris-HCl, 50 mM NaCl, pH 7.4
using 0.5 mL Zeba™ Desalt Spin Columns (Pierce Biotechnology) followed by
immediate treatment with H2O2. Concentrated stock solutions of H2O2 were prepared in
non-chelex treated buffer to initiate production of ROS, and were subsequently diluted
into metal-free buffer for use in experimental analyses. At defined time points, aliquots
were mixed with 0.9 mM DiFMUP in 50 mM Tris-hydroxyaminomethane, 50 mM bisTris, 150 mM NaCl, pH 6, similar to previously described methods [20,22]. Samples
were loaded into a 96-well FluroNunc plate (Sigma), and initial velocity data were
recorded (DiFMUP; λex = 358 nm; λem = 450 nm). Data were expressed as percentage
activity of reduced hYVH1 samples in 5 mM DTT.

Specific activity values were

calculated and compared for both fully reduced hYVH1 and hYVH1ΔCT1.

As a

comparative control, phosphatase activity of the archetypical DUSP, vaccinia H1 related
(VHR; Biomol), was monitored under similar conditions. Similarily, at defined time
points of oxidation, samples were incubated with 20 mM DTT for 30 min to quench
oxidation, followed by addition of DiFMUP as above to assess the reversibility of
activity.

Thiol quantitation was accomplished using a modified 5,5'-dithio-bis(2-

nitrobenzoic acid) (DTNB; Sigma) assay similar to one described [23]. Samples, as those
above, were treated for 10 min with defined concentrations of H2O2 and then incubated
for 5 min with ~ 50 units of catalase. Reactions were mixed with 500 μM DTNB in 50
mM Tris-HCl, 50 mM NaCl, pH 7.4, for 30 min and absorbance was monitored (ε = 14
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150 L*mol-1*cm-1 @ λAbs = 412 nm) [24]. Similarly, zinc release was monitored using a
4-(2-pyridylazo)-resorcinol/parachloromercuribenzoic acid (PAR/PCMB; Sigma)-based
assay as described [25]. Aliquots were taken at defined time points (as above) and mixed
with metal-free 100 μM PAR in 40 mM potassium phosphate buffer pH 7.5, and
absorbance was monitored (PAR; ε = 66 000 L*mol-1*cm-1 @ λAbs = 500 nm). Addition
of 50 μM PCMB in 100 μM PAR solution elicited complete zinc release, and the total
absorbance was recorded. Data were expressed as percentage of total zinc (free zinc +
protein bound zinc).

All data represents the average result from at least n = 3

independent experimental analyses.

Probing thiol redox-status using MALDI-TOF mass spectrometry
A differential thiol labeling strategy similar to one previously described [25] was
utilized to assess thiol redox-status in response to oxidation. Full length hYVH1 and
hYVH1ΔCT1 were oxidized with 100-fold molar excess H2O2 for 1.5 h, precipitated with
cold (-20 oC) 10% trichloroacetic acid (wt/vol), and washed three times with cold (-20
o

C) 100% acetone. Pellets were resuspended in denaturing buffer (6 M Urea, 200 mM

Tris-HCl, 10 mM EDTA, pH 8.5) supplemented with 100 mM iodoacetamide (IAM;
Sigma) shaking for 1 h at 25 oC. Each sample was divided and precipitated as above.
Samples were resuspended in denaturing buffer in the presence or absence of 10 mM
DTT shaking for 45 min at 25 oC, followed by the addition of 100 mM N-ethylmaleimide
(NEM; Sigma) shaking for 1 h at 25 oC. Samples were again precipitated as above,
resuspended in 50 mM ammonium bicarbonate, and digested with either sequencinggrade trypsin (Promega) or endoproteinase Glu-C (Roche Applied Science). Aliquots
were collected at various time points, quenched with a final concentration 1% formic
acid, and stored at -20 oC for future matrix-assisted laser desorption ionization-time of
flight mass spectrometry (MALDI-TOF MS) analysis. To further assist identification of
inter-peptide disulfide bond formation, a tryptic digest of oxidized, iodoacetamidelabeled, wild-type hYVH1 was modified using the Ettan chemically assisted
fragmentation (CAF) MALDI sequencing kit (Amersham Biosciences) as per the
manufacturer’s protocol, without lysine modification. The resulting peptides have a
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derivatized sulfonic acid group (136 Da) added to all free amines. In all cases, digests
were spotted 1:1 with 10 mg/mL matrix solution (α-cyano-4-hydroxycinnamic acid in
60% acetonitrile, 1% formic acid; Sigma) on the target plate by the dried-droplet method.
Peptide mass fingerprints and tandem mass spectrometry (MS/MS) using post source
decay (PSD) was performed on selected parent ions as previously described [8] and
compared to in silico fragmentation using the Protein Prospector software
(http://prospector.ucsf.edu/).

Metal-free enzymatic activity, reversibility of zinc binding and sulfenic acid analysis
Protein samples were exchanged into metal-free 50 mM Tris-HCl, 50 mM NaCl, pH
7.4, as above, then treated for 10 min with or without a 2.5-fold molar excess of
PCMB/total thiol content. Samples were exchanged again to remove excess PCMB and
free zinc, incubated with or without 5 mM DTT for ~ 30 min, mixed with 0.9 mM
DiFMUP as above, and analyzed for phosphatase activity. Similarly, full length hYVH1
was treated with PCMB, as above, or with 100-fold molar excess H2O2 for 1.5 h, to elicit
zinc ejection. Samples treated with PCMB were incubated in the presence or absence of
slight excess DTT for ~ 10 min without previous buffer exchange to facilitate reversible
zinc binding. Samples oxidized with H2O2 were incubated in 50 units of catalase, and
then in the presence or absence of slight excess DTT without previous buffer exchange.
Slight excesses of DTT were necessary as it was observed that higher amounts of DTT
effected zinc-PAR interactions, presumably through equilibrium based competitive
binding. All samples were mixed with 100 μM PAR and the absorbance was monitored
as described above. Thiol oxidation state was also monitored using the electrophilic
reagent 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole (NBD-Cl; Sigma) as described [20,26].
Full length hYVH1 was exchanged, oxidized and quenched as above, then incubated with
1 mM NBD-Cl for 1 h. Samples were again exchanged as above and compared to a nonoxidized, NBD-Cl treated control by monitoring the absorbance range across λAbs = 250 –
530 nm. All data represents the average result from at least n = 3 independent
experimental analyses.
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2.3 - RESULTS
hYVH1 mediates protection against hydrogen peroxide induced cell death
Our previous work demonstrated that hYVH1 can associate with Hsp70, and potently
defend cells from insults such as heat shock, Fas receptor activation, and H2O2 [8].
Moreover, a catalytically inactive or a zinc domain deletion variant (hYVH1ΔCT1) failed
to yield protection, indicating that both the phosphatase activity and the zinc coordinating
domain are required for the cell survival function of hYVH1. To test the extent of
hYVH1 cytoprotective ability, we subjected HeLa cells to increasing amounts of H2O2.
Cells expressing hYVH1 were substantially more resistant to H2O2 cytotoxicity at 100
and 250 µM final concentrations as compared to control cells; ~ 27 fold and 7 fold less
cell death respectively [Fig. 2.1]. However, at 500 µM H2O2, hYVH1 failed to protect
cells to any significant extent. These results suggest that hYVH1 can protect cells up to a
threshold level of oxidative stress, above which there may be a mechanism in place to
down-regulate the cell survival ability of hYVH1.

hYVH1 resists oxidative inactivation in vitro
From our previous work it was also determined that hYVH1 catalytic activity exhibits
substantial thermal stability in vitro when directly compared to the prototypical DUSP
VHR. Moreover, we determined that full length hYVH1 had increased sustainability of
catalytic activity under non-reducing and combined heat-shock/non-reducing conditions
when compared to the catalytic domain variant hYVH1ΔCT1 [8]. It is believed that the
nucleophilic cysteine residue within the active site of PTPs and DUSPs is rendered
susceptible to oxidation under non-reducing conditions due to its reduced pKa value.
However, hYVH1 possesses a unique zinc-coordinating domain containing seven Cys
residues with suspected involvement in the coordination of 2 mols of zinc per mol of
protein [3]. We hypothesized that by being an oxidative target itself, this domain may
reduce the susceptibility of redox-induced inactivation at the active site Cys. Again, as a
control, VHR was used, which shares 25% sequence identity with hYVH1 in the DUSP
catalytic domain and has been shown
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Figure 2.1 - hYVH1 protects cells from oxidative stress. HeLa cells were transiently
transfected with empty vector (Control) or hYVH1 and treated with H2O2 (100 µM, 250
µM or 500 µM) for 1 hr at 37°C. A) Cell viability was detected using FITC-conjugated
Annexin V as per manufacturer’s protocol and total cell number was determined using
Hoechst 33342 dye. B) Graphical representation from n = 3 independent experiments
expressing cell death as a percent of total cell number. Error bars represent the S.D.
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sensitive to reversible H2O2-induced inactivation through formation of a stable sulfenic
acid [20]. To assess oxidative resistance, wild type hYVH1, zinc domain deletion mutant
(hYVH1ΔCT1), and VHR were subjected to H2O2 then assayed for phosphatase activity
towards the exogenous substrate DiFMUP. Under reducing conditions, the activity of
VHR was significantly greater than that of both hYVH1 and hYVH1ΔCT1 [Fig. 2.2A].
In comparison, removal of the zinc-coordinating domain did not show significant
deviation in activity when compared with wild type under reducing conditions [Fig.
2.2A]. In stark contrast, exposure to H2O2 at a molar ratio of 1:100 rapidly inactivates
VHR (by ~ 45% after 2.5 min and ~ 60% after 10 min). Meanwhile, hYVH1 displayed
greater resistance to the oxidative conditions, displaying activity loss of ~ 25% after 2.5
min and ~ 35% after 10 min [Fig. 2.2A,B]. The hYVH1ΔCT1 variant experienced
activity loss similar to that of VHR, suggesting that the inherent resistance to inactivation
by hYVH1 is mediated by the zinc-coordinating domain. The addition of excess DTT,
post-oxidation, resulted in nearly complete regeneration (~ 80%) of phosphatase activity
among all enzymes [Fig. 2.2B]. Furthermore, wild type hYVH1 demonstrated similar
resistant behavior when titrated across an increasing molar ratio of H2O2 when compared
with VHR and hYVH1ΔCT1 [Fig. 2.2C]. Collectively, these results demonstrate that the
zinc-coordinating domain provides hYVH1 the capacity to impede redox-induced
inactivation.

Hydrogen peroxide-mediated thiol oxidation leads to zinc release
The above findings suggest that the thiol-rich, C-terminal zinc-coordinating domain
may be involved in resisting oxidative inactivation of hYVH1. To examine the effects of
oxidative conditions on hYVH1 zinc coordination, we performed a PAR/PCMB assay to
monitor zinc release in response to oxidation by H2O2. At ratios of H2O2 similar to those
examined above, zinc was readily released from hYVH1.

Moreover, the loss of

phosphatase activity seemed to parallel the observed rate of zinc ejection at lower
concentrations of H2O2 [Figs. 2.3A-C]. In all cases, spontaneous thiol oxidation and zinc
release was determined to be negligible over the defined experimental times. These
results suggest that zinc ejection and activity loss during increasing levels of oxidative
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Figure 2.2 - Analysis of hYVH1 inactivation by H2O2. A-B) Inactivating effects of H2O2
on DUSP catalytic activity.
A) Initial velocity raw data comparing hYVH1,
hYVH1ΔCT1 and VHR after incubation at 30 °C in a 1:100 molar ratio of H2O2 or 5 mM
DTT for 10 min. B) Designated enzymes (□ hYVH1, ■ hYVH1ΔCT1, ■ VHR) were
incubated as above for the defined time points then monitored for relative changes in
activity. Inactivation and reactivation is expressed as percentage of fully reduced enzyme
without H2O2. C) Similarily, designated enzymes were oxidized at the defined molar
ratios for 20 min then assayed for remaining activity. Data was fit to a one phase
exponential decay equation using GraphPad Prism version 4.00 for Windows, GraphPad
Software, San Diego California USA, www.graphpad.com. All data analyses represent
the mean of at least n = 3 independent determinations. Error bars represent the S.D.
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stress is probably due to thiol oxidation within both the zinc-coordinating and catalytic
domains. Since multiple Cys residues must become oxidized before zinc ejection is
detected, the above trend also suggests that the zinc-coordinating cysteines may be
preferentially oxidized over the active site Cys.
To examine thiol oxidation status more directly, a DTNB-based assay was performed.
The catalytically dead mutant (hYVH1 C115S) was also analyzed to obtain some insight
into the oxidation state of the active site cysteine residue. From primary sequence
analysis, wild type hYVH1 and the hYVH1 C115S mutant contain 11 and 10 cysteine
residues respectively, which were consistent with observed findings of total thiol
content/mol of protein [Fig. 2.3D]. Upon treatment with increasing H2O2 concentrations,
rapid loss of multiple free thiols was observed within 10 minutes as compared to
untreated control. Since oxidation of the active site is reversible, conversion of the
catalytic cysteine to a sulfinic or sulfonic acid is likely not occuring at appreciable levels,
however, if a reversible cyclic sulfenamide or sulfenic acid is formed, we would expect
an equal number of free thiols between wild type hYVH1 and the hYVH1 C115S mutant.
Experimental evidence demonstrated that upon oxidation, wild type hYVH1 harboured
approximately one less free thiol than the hYVH1 C115S mutant, which rather suggested
that the active site cysteine may be participating in reversible intra-molecular disulfide
bond formation during oxidative stress [Fig. 2.3D].

Oxidation of hYVH1 results in intra-molecular disulfide bond formation
The above data suggest that the active site Cys of hYVH1 may be capable of forming
an intra-molecular disulfide bond. This ability would represent a mechanism to avoid
irreversible oxidation during even extreme oxidative stress. Therefore, to further confirm
the DTNB data, disulfide bonding status of both reduced and oxidized hYVH1 was
analyzed using MALDI-TOF MS through the application of differential thiol labeling
methodology

[Fig.

2.4A].

Mass

fingerprints

of

reduced

and

oxidized,

carbamidomethylated (CAM) hYVH1 tryptic digests were obtained and compared for
target peptide identification [Fig. 2.4B]. Reduced, CAM-hYVH1 displayed the
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Figure 2.3 - hYVH1 zinc release, inactivation and thiol depletion by H2O2 exposure.
A-B) Plots of hYVH1 time dependent enzymatic inactivation●)( and zinc re lease (□).
Enzyme was incubated in increasing molar ratios of H2O2 (A, 1:50; B, 1:100) for the
defined time points then analyzed for changes in activity or zinc release as described in
“Experimental Procedures”. C) Similarily, hYVH1 was oxidized at the defined molar
ratios for 20 min then assayed for remaining activity and bound zinc. D) Thiol oxidation
of hYVH1. hYVH1 (□) and hYVH1 C115 S (■) were incubated with increasing molar
ratios of H2O2 (1:0, 1:100, 1:500, and 1:1000) for 10 min then thiol content was analyzed
using a DTNB-based assay as described in “Experimental Procedures”. Data was
normalized to the concentration of enzyme. All data analyses represent the mean of at
least n = 3 independent determinations. Error bars represent the S.D.
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Figure 2.4 - MALDI-TOF MS approach to probe hYVH1 thiol redox status. A)
Schematic diagram of the differential thiol labeling strategy utilized to identify Cys
specific modifications of hYVH1 in response to H2O2-mediated oxidation. B) Table of
target hYVH1 Cys containing tryptic and glutamic peptides.
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characteristic active site peak at m/z 1305.74 along with that of an N-terminal proximal
thiol at m/z 1021.48. No significant amounts of unmodified peptides were observed [Fig.
2.5A]. Oxidized CAM-hYVH1 displayed almost undetectable levels of both of these
target peptides; however, both the active site and proximal thiol peptides appeared in
their reduced form at m/z 1248.65 and 964.47, respectively. Interestingly, a peak at m/z
of 2211.28 appeared, which is ~ 2 Da less than the resultant sum of these target peptides,
suggesting formation of an intra-molecular disulfide bond [Fig. 2.5B]. The remaining
tryptic digest was derivatized using CAF reagent labeling to facilitate unambiguous
identification of this unknown peptide. Using this strategy, an intra-molecular disulfidebonded peptide, upon sulfonation, would be doubly modified, once at each N-termini,
causing a mass shift of 272 Da, which was detected for this peptide [m/z 2483.38; Fig.
2.6A]. Unambiguous identification was accomplished using MS/MS analysis by PSD of
this parent ion, and the formation of an intra-molecular disulfide bond between the active
site cysteine and the N-terminal proximal cysteine was confirmed [Fig. 2.6B].
Similarly, mass fingerprints of reduced CAM- or NEM-hYVH1 Glu-C digests were
obtained and compared for target peptide identification [Fig. 2.4B]. Oxidized CAMhYVH1 was subjected to differential thiol labeling, as described under “Experimental
Procedures”, and mass fingerprints of all Glu-C digests were recorded. Reduced CAM
or NEM digests displayed characteristic peaks, which were assigned to vicinal thiolcontaining peptides of the C-terminal zinc-coordinating domain [Fig. 2.7A,B]. Upon
oxidation, a loss of CAM m/z peaks 2315.26, 2602.66, and 2967.30 is observed, whereas
formation of one NEM peptide at m/z 3101.84 is evident, suggesting that some reduced
thiols exist during oxidation [Fig. 2.7C]. Oxidized, differentially labeled, CAM-hYVH1
resulted in the appearance of target NEM peaks at m/z 2738.61, 3231.65, and 3106.07,
which correspond to the reduced NEM digest [Fig. 2.7B,D]. These observations suggest
that in addition to the ability of the active site Cys to form an intra-molecular disulfide
bond, the zinc-coordinating Cys residues in the C-terminal domain are putatively
involved in a distinct disulfide bonding network. In both cases, higher oxidation states
(sulfinic or sulfonic acids) of the thiolate moieties were not observed, further confirming
predominant formation of disulfide bonds within both domains.
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Figure 2.5 - Mass fingerprint analysis of hYVH1 tryptic peptides. A) Reduced,
carbamidomethylated hYVH1 mass fingerprint. Highlighted are the active site and Nterminal proximal thiol-containing peptides at m/z 1305.74 and 1021.48 respectively. B)
Oxidized, carbamidomethylated hYVH1 mass fingerprint. Highlighted are the reduced
active site and N-terminal proximal thiol-containing peptides at m/z 1248.65 and 964.27
respectively. Carbamidomethylated peaks are largely reduced or absent. Also
highlighted is a putative intramolecular disulfide peak at m/z 2211.28 of these target
peptides.
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Figure 2.6 - Mass fingerprint and MS/MS PSD analysis of CAF labeled hYVH1 tryptic
peptides. A) Oxidized, carbamidomethylated, CAF labeled hYVH1 mass fingerprint.
Highlighted is the doubly CAF labeled putative disulfide peak at m/z 2483.38. B)
MS/MS analysis of the peak at m/z 2483.38. The y ion fragment series corresponds to the
two target peptides AVLVHCHAGVSR and CVAFIGQAR denoting unambiguous
identification of active site disulfide bond formation.
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Figure 2.7 - Differential thiol labeling mass fingerprints of hYVH1 C-terminal
glutamic peptides. A) Reduced, carbamidomethylated hYVH1 mass fingerprint.
Highlighted are three vicinal thiol-containing peptides within the zinc-coordinating
domain, m/z 2315.26, 2602.66, and 2967.30. B) Reduced, N-ethylmaleimidyl hYVH1
mass fingerprint. Highlighted are two of the vicinal thiol-containing peptides, m/z
2738.35, 3102.84, and 3231.43. C) Oxidized, carbamidomethylated hYVH1 mass
fingerprint. Highlighted is the absence of characteristic peaks at m/z 2315.26, 2602.66,
and 2967.30, and the presence of a peak at m/z 3101.84. D) Differential thiol labeled
hYVH1 mass fingerprint. Highlighted is the reappearance of peaks at m/z 2738.61,
3231.65, and 3106.07.
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Zinc coordination is reversible and required for optimal enzymatic activity
Disulfide bond formation within the zinc-coordinating domain would allow this
domain to bind zinc under reducing conditions, and to form disulfide bonds under
oxidative conditions, in a reversible, and thus, regulatory fashion. To assess if the Cterminal domain is capable of potentially governing regulatory events, reversibility of
zinc coordination was tested. Treatment with either the thiol-reactive reagent PCMB or
with H2O2 results in essentially complete zinc ejection in the absence of reducing
reagents. This phenomenon is readily and rapidly reversible to near completion (~ 85%)
upon the addition of reducing agents [Fig. 2.8A].

Interestingly, upon returning to

reducing conditions, re-binding of zinc seems to be a necessity for complete recovery of
catalytic activity. Complete zinc ejection and removal from the system leaves hYVH1
with ~ 40% activity in comparison to when hYVH1 zinc-binding is restored under
reducing conditions [Fig. 2.8B].

Notably, the C-terminal zinc-coordinating domain

deletion variant hYVH1ΔCT1 retains full activity under similar conditions [Fig. 2.8B].
This suggests that once the C-terminal cysteines are re-reduced, zinc coordination is
required to prevent disturbing the phosphatase domain.
Collectively, the above results suggest that oxidation of hYVH1 is a reversible event.
The non-enzymatic, reversible oxidation of thiols can only readily occur at lower thiol
oxidation states, which include disulfide bonds, cyclic sulfenamides and sulfenic acids.
To further confirm disulfide bond formation upon oxidation of hYVH1, NBD-Cl was
used to probe for the presence of sulfenic acid modifications. Upon interaction with a
free thiol, the formed adduct displays a λmax of 420 nm; however, interaction with a
sulfenic acid results in formation of an adduct having a λmax of 347 nm, ultimately
allowing for spectral identification between these species [20,26]. When NBD-Cl was
used to probe hYVH1, no visible evidence of sulfenic acid formation was observed upon
oxidation, confirming that disulfide bond formation is the predominant oxidative
modification of hYVH1 cysteine thiols [Fig. 2.8C]. Taken together, hYVH1 is capable
of reversible oxidation in both catalytic and zinc-coordinating domains, which is
presumably mediated through disulfide bond formation.
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Figure 2.8 - Effects of reversible zinc coordination on enzymatic activity and analysis
of sulfenic acid formation. A) Reversible zinc coordination of hYVH1 under reducing
conditions. Complete zinc ejection via H2O2 (■) or PCMB (■) is rapidly reversible upon
subsequent treatment with slight excess of reducing agent. B) Effects of zinc
coordination on enzymatic activity. Treatment of hYVH1 (□) or hYVH1ΔCT1 (■) with
PCMB reversibly modifies all thiol residues, resulting in zinc ejection. Reduction with
DTT after desalting restored hYVH1ΔCT1 with full activity, while hYVH1 remained
partially inactive. C) Probing oxidized hYVH1 for sulfenic acid modification. Oxidation
of hYVH1 results in loss of free thiols and preferential formation of reversible cystine
bonds, not cysteinyl sulfenic acids. Data analyses (A-B) represent the mean of at least n
= 3 independent determinations. Error bars represent the S.D. Data analysis (C)
represents an individual trial of n = 3 independent experiments.
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2.4 - DISCUSSION AND CONCLUSIONS

This current study has added insight to our initial findings that hYVH1 acts as a cell
survival phosphatase in response to oxidative stress conditions. Moreover, we have
revealed that the zinc-coordinating domain is critical for hYVH1 to resist oxidative
inactivation of its phosphatase activity. Although other phosphatases have shown the
ability to resist oxidation of their active sites by various mechanisms [16-18,21], this is
the first report to demonstrate the involvement of a dynamic zinc-coordinating domain in
facilitating oxidative resistance for a phosphatase.
The prototypical DUSP, VHR, was found to have higher activity than hYVH1 toward
the artificial substrate DiFMUP under reducing conditions. However, in the presence of
H2O2, VHR lost activity readily, whereas hYVH1 still maintained 60% of its original
activity after 20 min of exposure. Inactivation was readily reversible upon treatment with
excess reductant, which is consistent with multiple other studies of PTPs and DUSPs
[11,20]. This result highlights the sensitivity of typical PTPs, such as VHR, to oxidative
conditions and suggests that hYVH1 may be able to maintain activity during times of
oxidative stress when other PTPs are rendered inactive. The cytoprotective nature of
hYVH1-expressing cells also supports this claim [Fig. 2.1]. Why hYVH1 has lower
intrinsic phosphatase activity in vitro under reducing conditions as compared to VHR is
puzzling given that it possesses all of the classical invariant residues known to be critical
for catalytic activity of PTPs and DUSPs [27]. It may be that hYVH1 is highly specific
for its physiological substrate or that it is functionally slow in terms of turnover rate to
better suit being active under cellular stress conditions. We are currently pursuing the
three dimensional structure of hYVH1 by x-ray crystallography and using hydrogendeuterium exchange mass spectrometry to gain more insight into this issue and examine
the structural relationship between the catalytic and the zinc-coordinating domains.
Another intriguing result was the observation that ejection of zinc in response to high
levels of H2O2 correlated with a progressive decrease in phosphatase activity. The zinccoordinating domain of hYVH1 is thought to contain two zinc-associated regions, with
seven of the eight putative coordinating amino acids being Cys residues [3]. These
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potential zinc-coordinating Cys residues may act as a redox buffer, becoming
preferentially oxidized over the active site Cys.

This hypothesis is supported by

comparing the released zinc and remaining activity plots shown in Figure 3, where there
seems to be a correlation between rate of zinc ejection and rate of inactivation. Ejection
of zinc is not detected until the sequential oxidation of multiple Cys residues occurs
resulting in release of free zinc ions, whereas enzymatic inactivation is strictly limited to
the active site cysteine alone. Thus, this finding raises the possibility that the zinccoordinating domain of hYVH1 may serve as a redox sink capable of protecting the
active site Cys up to a certain threshold through preferential oxidation of zinccoordinating cysteines.
To examine the extent of active site Cys oxidation, we measured free thiol content in
response to increasing H2O2. The active site mutant (hYVH1 C115S) was used for a
direct comparison. Control conditions produced the expected result, detecting the 11 Cys
residues that are present in wild type hYVH1, while the hYVH1 C115S mutant was
measured at the expected 10 Cys residues [Fig. 2.3D]. Under increasing oxidative
conditions we were expecting that wild type and the C115S mutant would contain the
same number of reactive free thiols due to oxidation of the active site Cys. Instead, we
reproducibly detected approximately one less free thiol in wild type than in the C115S
mutant. This result raised the possibility that the active site cysteine participated in the
formation of an intra-molecular disulfide bond upon oxidation, resulting in one less
reactive thiol for analysis via DTNB. Since the C115S mutant lacks this capability, an
additional reactive thiol would remain available for detection by DTNB.
Efforts to definitively demonstrate the thiol redox status of multiple cysteine residues
in hYVH1 were conducted using differential thiol labeling and MALDI-TOF MS [Fig.
2.4].

The targeted active site and an N-terminal cysteine-containing peptide were

identified by mass fingerprint analysis of reduced, carbamidomethylated hYVH1 [Fig.
2.5A]. Upon oxidation, both characteristic peaks were lost; however, the presence of
reduced forms of each peptide appeared along with an unknown peak at m/z 2211.28
[Fig. 2.5B]. No higher oxidation states of these Cys residues were observed, further
suggesting disulfide bond formation was the mode of reversible oxidation , not sulfenic
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acid. Notably, the putative disulfide mass of these peptides is 2211.17 Da, very close to
the unknown peptide observed after oxidation. To decipher the identity of the unknown
peptide, the tryptic digest was CAF-labeled to enhance and simplify MS/MS analysis by
PSD. Initial evidence of an inter-peptidyl disulfide bond is denoted by a doubly labeled
moiety, shown at m/z 2483.38 [Fig. 2.6A], with subsequent unambiguous identification
by MS/MS PSD [Fig. 2.6B]. Mass spectrometry analysis of the C-terminal deletion
variant hYVH1ΔCT1 also identified this intra-molecular disulfide bond formation upon
oxidation [Suppl. Fig. S2.1]. These findings strongly support our initial studies that
suggest sustainable activity under oxidative conditions as well as the formation of an
intra-molecular disulfide bond within the active site.

Moreover, presence of these

disulfide-linked peptides in their respective reduced form in the mass fingerprint of
oxidized, CAM-labeled samples further suggest disulfide bond formation due to the
ability of MALDI to partially eradicate disulfide containing moieties. However, the
formation of cyclic sulfenamides in small population can not be ruled out as these
peptides are near identical mass to those of their fully reduced counterparts and thus have
overlapping isotopic envelopes.
To probe the thiol status of the C-terminal zinc-coordinating cysteines, Glu-C peptides
were identified by mass fingerprint analysis. Both CAM and NEM reduced peptides
were identified as reference controls [Fig. 2.7A,B]. Only two characteristic peptides
could be identified in the NEM mass fingerprint [Fig. 2.7B].

After oxidation, all

characteristic peaks denoting zinc-coordinating vicinal thiol pairs were lost; however, a
peak at m/z 3101.84 appeared, possibly denoting the presence of a reduced vicinal thiol
pair after oxidation [Fig. 2.7C]. Differential labeling resulted in the appearance of all
NEM peptides previously identified in the reference mass fingerprint, displaying the
reversibility of the oxidative modification. Furthermore, higher oxidation states of these
peptides were not readily observed, again suggesting that disulfide bonding is the likely
form of modification. A peak broadening at m/z 3102.84 and 3106.07 appeared, which
may be due to peptide isotopic overlap of a singly and doubly modified vicinal thiol pair
at residues 221–244 and 222–244, respectively [Fig. 2.7D and Fig. 2.4B]. Additional
supporting evidence was found when tryptic peptides were analyzed following the
differential thiol labeling where we identified reversible thiol oxidation involving the
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extreme C-terminal vicinal thiol pair [residues 302–316; Fig. 2.4B and Suppl. Fig. S2.2].
Overall, these data further support the working hypothesis that the C-terminal zinccoordinating domain is capable of acting as a redox buffer via oxidation of vicinal thiol
pairs, resulting in disulfide bond formation. Also, the presence of partially and fully
reduced thiol pairs under oxidative conditions supports the idea that this region can
potentially act as a reducing agent in promotion of a catalytically active phosphatase.
The capacity of hYVH1 to form disulfide bonds strongly supports the idea that
enzymatic inactivation and zinc coordination are reversible phenomena. Upon treatment
with micromolar concentrations of reducing agent, zinc-free hYVH1 was capable of
rapid, re-coordination of ~ 85–90% total zinc [Fig. 2.8A]. Interestingly, examining the
activity of zinc-free hYVH1 in the presence of reducing agents resulted in a marked
decrease in activity of hYVH1 (~ 60%), whereas the C-terminal deletion variant
hYVH1ΔCT1 (~ 10%) was unaffected [Fig. 2.8B]. These findings suggest that both
reduced active site and proper zinc-coordination are necessary for full activity in vitro
during re-reduction conditions, highlighting the importance of rapid rebinding of zinc
following recovery from oxidative conditions.

This reversible capacity of zinc

coordination and disulfide bond formation suggests a dynamic regulatory mechanism
under conditions of cellular oxidative stress [Fig. 2.9].
The precise biological role of hYVH1 remains unclear, and currently no substrate has
been identified for this phosphatase. Since the phosphatase activity of hYVH1is required
for its cytoprotective function [8], identification of its phospho-target(s) during oxidative
stress conditions is imperative for acquiring mechanistic understanding of how hYVH1
can protect cells from various insults. Other findings have recently suggested that YVH1
is a novel 60S ribosome biogenesis factor in yeast, and is a necessary element for the
formation of a fully mature 60S subunit [28-31]. We have recently investigated if
hYVH1 may possess a similar role in mammalian cells, and have discovered that it can
associate with the pre-60S ribosomal subunit endogenously. This association is not
dependent on catalytic activity, however, regardless of catalytic competency, the
association is sensitive to treatment with oxidants, dissociating in a dose-dependent
manner. Intriguingly, regions within both the catalytic and zinc-coordinating domains
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Figure 2.9 - Proposed model of sustainable activity under conditions of oxidative stress.
Under mild oxidative conditions, zinc is ejected due to thiols in the zinc-coordinating
region serving as reducing agents, allowing the active site cysteine to remain reduced and
catalytically competent. Severe oxidative conditions supersede the reducing power of the
C-terminal thiols. However, the active site cysteine is protected from irreversible thiol
oxidation (e.g. sulfonic acid) by disulfide bond formation with a proximal cysteine
residue. Once reducing conditions are restored, the active site cysteine thiol is recovered
while the C-terminal thiols rapidly re-coordinate zinc.
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were found necessary for association, as deletion of either ablated interaction with the
ribosomal subunit [22]. Thus, it will be interesting to investigate if the redox-sensing
function of hYVH1 proposed in this study regulates the rate of ribosome biogenesis
during cellular stress through its direct association with the pre-60S ribosomal subunit.
More recently, we have complemented these findings with various substrate trappingmass spectrometry efforts having identified many of the suspected ribosomal subunit
members as well as multiple novel interacting partners involved in RNA processing and
regulation.

Continued MS and hYVH1-mediated ribosome dynamics studies are

currently ongoing to further understand the role of hYVH1 in regulating these processes
of cellular physiology.

Altogether, the discovery of this inherent redox defense

mechanism has provided valuable insights into the protective value of the zinccoordinating domain of hYVH1. This unique regulatory mechanism also sheds further
light on the ability of certain cysteine-based phosphatases to cope with the destructive
consequences of oxidative environments.
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2.5 - SUPPLEMENTARY FIGURES

Supplementary Figure S2.1 - Mass fingerprint analysis of the zinc domain deletion
variant hYVH1ΔCT1 tryptic peptides. A) Reduced, carbamidomethylated hYVH1ΔCT1
mass fingerprint. Highlighted are the active site and N-terminal vicinal thiol-containing
peptides at m/z 1305.74 and 1021.48 respectively. B) Oxidized, carbamidomethylated
hYVH1ΔCT1 mass fingerprint. Highlighted are the reduced active site and N-terminal
vicinal thiol-containing peptides at m/z 1248.65 and 964.27 respectively.
Carbamidomethylated peaks are largely reduced or absent. Also highlighted is a putative
intra-molecular disulfide peak at m/z 2211.28 of these target peptides.
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Supplementary Figure S2.2 - Differential thiol labeling mass fingerprints of hYVH1
tryptic peptides. A) Reduced, carbamidomethylated hYVH1 mass fingerprint.
Highlighted is the extreme C-terminal vicinal thiol-containing peptide of the zinccoordinating domain, m/z 1820.93. B) Reduced, N-ethylmaleimidyl hYVH1 mass
fingerprint. Highlighted is the same vicinal thiol-containing peptide, m/z 1956.67. C)
Oxidized, carbamidomethylated hYVH1 mass fingerprint. Highlighted is the absence of
characteristic peak at m/z 1820.93. D) Differential thiol labeled hYVH1 mass fingerprint.
Highlighted is the reappearance of peak m/z 1956.52.
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CHAPTER 3 - GOLD NANOPARTICLE ENRICHMENT METHOD FOR
IDENTIFYING S-NITROSYLATION AND S-GLUTATHIONYLATION SITES IN
PROTEINS

3.1 - INTRODUCTION
The pioneering work of Stamler et al. [1] showed that NO• can modulate cellular
signaling not only through the guanylate cyclase/cGMP pathway but also by Snitrosylating proteins and small molecular weight thiols. A large volume of subsequent
work has implicated S-nitrosylation (S-NO) of proteins in the regulation, sub-cellular
compartmentalization, and degradation of proteins. Therefore, identification of the Snitrosoproteome is an area of interest in beginning to elucidate reactive nitrogen species(RNS)-mediated signaling pathways in health and disease [2-7].
To date, >1000 plant, animal, and prokaryotic thiol-containing proteins have been
identified as potential S-nitrosylation targets [2]. However, the chemical characteristics
of S-nitrosylated proteins, such as their low S-NO bond energy, photosensitivity,
susceptibility to reduction by ascorbate, thiols, thiol reducing agents, and Cu (I),
complicates their facile isolation and detection. Significant progress in identification of
the S-nitrosoproteome was made by introduction of the “biotin-switch” assay by Jaffrey
et al. [8]. Free protein-thiols are first blocked with an alkylation agent, followed by
reduction of the protein S-nitrosothiols with ascorbate. In the final step, these newly
formed thiols are reacted with thiol specific biotinylating agents, resolved by gel
electrophoresis and detected by Western blot.

Recent improvements to minimize

ascorbate side reactions in the “biotin-switch” assay include the use of S-NO stabilizers
[5] or the replacement of ascorbate with non-disulfide reducing, denitrosylating agents
such as sinapinic acid [9]. Moreover, the “biotin-switch” method has also been used to
directly isolate S-nitrosylated peptides from proteolyzed tissue lysates by capturing the
biotinylated peptides on avidin beads for subsequent identification by liquid
chromatography-tandem mass spectrometry (LC-MS/MS) techniques [10,11].
Saturation-labeling differential gel electrophoresis (DIGE) methods employing
cysteine-specific fluorophores [12-15] have also been developed to identify both the thiol
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proteome and S-nitrosoproteome. The DIGE approach employs a pair of fluorescent
maleimide-conjugated cyanine dyes to specifically label free thiols in multiple protein
samples.

Mixtures of differentially labeled proteins are resolved on the same two-

dimensional electrophoresis gel, and computer-aided analysis of the intensity differences
between fluorophores compares the amount of S-nitrosylated (or thiolated) proteins.
Our aim was to use gold nanoparticles (AuNPs) to identify protein S-nitrosylation sites
by taking advantage of the recently demonstrated property of AuNP reactions with S-NO
proteins to yield NO• and AuNP-protein thiolates [16]. The experimental strategy of this
method is outlined in Scheme 3.1, whereby residual free thiols of S-nitrosylated proteins
are first alkylated with iodoacetamide (IAM). Proteins are next proteolyzed, and AuNPs
are introduced to the digest. Any S-NO peptides are expected to react with the AuNPs,
releasing NO•, and forming AuNP-thiolate peptides complexes. The resultant AuNPbound peptides are then harvested by centifugation and competitively eluted off of the
AuNP surface by thiol exchange using an excess of small molecular weight thiols such as
dithiothreitol (DTT). Released peptides are then analyzed by mass spectrometry, and
target peptide/protein assignment can be done by comparison to in silico digestion of
known protein sequences or bioinformatic database mining. Since alkylated peptides do
retain some thiol character, they are likely to have a higher affinity than other amino acid
residue side chains (i.e., groups with lower Au-affinity (GLA)-peptides) and to some
extent, may be enriched under this scheme. We predict that the sterics of the bulky
residues surrounding disulfide-containing peptides will preclude their interaction with
AuNPs; however, less bulky glutathionylated peptides should interact with AuNPs
yielding gold-thiolates.
Using this AuNP-based enrichment strategy, we have demonstrated that AuNPs are
capable of reversibly binding protein thiols and thioethers causing de-nitrosylation of SNO modified proteins and peptides. Furthermore, this property of AuNPs was found to
provide a simple method for isolation, detection, and enrichment of S-modified peptides
in a single step. Combination with differential thiol labeling and mass spectrometry,
AuNP-based enrichment strategies are capable of unambiguous identification of protein
S-modification sites.
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Scheme 3.1 - AuNP enrichment method for identifying S-nitrosylation sites in proteins.
Free thiols of S-nitrosylated proteins are alkylated with iodoacetamide (IAM). Proteins
are proteolyzed and AuNPs are introduced to the digest. Any S-NO peptides react with
the AuNPs, releasing NO• to form AuNP-thiolate peptides complexes. The resultant
AuNP-bound peptides are harvested by centifugation and eluted off by thiol exchange
using small molecular weight thiols. Released peptides are analyzed by mass
spectrometry, and target peptide/protein assignment can be done by comparison to in
silico digestion of known protein sequences or bioinformatic database mining.
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3.2 - EXPERIMENTAL PROCEDURES
General information
Gold (III) chloride trihydrate, trisodium citrate dihydrate, reduced and oxidized
glutathione, sodium nitrite, iodoacetamide, N-ethylmaleimide, dithiothreitol and formic
acid were purchased from Sigma. All commercial reagents were used without further
purification. Zeba™ Desalt Spin Columns, trifluoroacetic acid, recrystalized α-cyano-4hydroxycinnamic acid, trifluoroacetic acid and ascorbic acid were purchased from
Thermo Scientific. Siliconized micro-centrifuge tubes were purchased from Bio Plas Inc.
and were used for all protein processing steps. Sequencing grade Trypsin was purchased
from Promega, Endoproteinase Glu-C was purchased from Roche Applied Science.
Vivapure C-18 Micro spin columns were purchased from Sartorius Stedim Biotech. High
purity water and acetonitrile were purchased from Honeywell Burdick and Jackson.

Gold nanoparticle (AuNP) synthesis
Gold nanoparticles were synthesized according to the method of Grabar et al [17]. All
glassware was washed and rinsed thoroughly with Milli-Q (18.2 MΩ) high purity water.
In a 1 L double-neck round bottom flask, 197 mg gold (III) chloride trihydrate
(HAuCl4•3H2O) was dissolved in 500 mL of Milli-Q water and refluxed for 1 h in a hotoil bath (~ 100 °C) with vigorous stirring. Following reflux, 571 mg trisodium citrate
dihydrate (Na3C5H5O7•2H2O) was dissolved in 50 mL Milli-Q water and injected rapidly
into the gold chloride solution. A distinct colour change can be seen from yellow to
clear, then to dark burgundy (almost black) signifying the formation of a colloidal
solution. After 10 min, the heat was removed and the solution was allowed to cool to
room temperature. The resulting nanoparticles are 11 ± 1 nm in diameter, exhibit a
maximum absorbance at 521 nm, and are stable for months at 4 °C. The resulting
concentration is ~ 1.3 x 1010 AuNPs/μL.
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S-nitrosoglutathione (GSNO) synthesis
All steps were performed in the dark due to the photosensitivity of the S-NO bond. To
begin, 10.3 mg sodium nitrite (NaNO2) was dissolved in 4 mL of ice-cold 0.5 M HCl,
while 46.1 mg of reduced glutathione (GSH) was dissolved in 1 mL of ice-cold 0.5 M
HCl, then added to the NaNO2 solution. The mixture was incubated in the dark at 4 °C
for 30 min and the pH was adjusted to 7.4 by the addition of dilute NaOH. GSNO
concentration was determined from the absorption maximum of the S-NO bond at 335
nm (ε335nm = 980 L*mol-1*cm-1). The resulting solution was stored as 1 mL aliquots at 80 °C.

Protein nitrosylation and alkylation
Recombinant PDI and hYVH1 were purified as previously described [18,19]. Fully
reduced proteins (2 μM) were nitrosylated by incubation with 1 mM GSNO in 100 mM
sodium phosphate buffer pH 7.4 for 1 h at room temperature. Iodoacetamide (IAM) was
then added to a final concentration of 10 mM and incubated for 2 h at room temperature.
Excess GSNO and IAM were removed by two passes through Zeba™ Desalt Spin
Columns as per the manufacturer’s specifications. At this step, the buffer was exchanged
to 50 mM ammonium bicarbonate (pH ~ 8, unadjusted).

Protein nitrosylation, glutathionylation and differential alkylation
Fully reduced recombinant hYVH1 (30 μM) was nitrosylated or glutathionylated by
incubation with 1 mM GSNO or oxidized glutathione (GSSG) in 25 mM Tris-HCl pH
7.5, 50 mM NaCl in the dark, shaking for 1 h at room temperature. Iodoacetamide was
then added to a final concentration of 20 mM and incubated in the dark, shaking for 1 h at
room temperature. Both samples were desalted as above, except nitrosylated hYVH1
was exchanged into 25 mM Tris-HCl pH 7.5, 50 mM NaCl.

Ascorbate, N-

ethylmaleimide, and copper (II) sulfate were then added to final concentrations of 30
mM, 20 mM, and 300 nM respectively. The sample was incubated in the dark, shaking
for 3 h at room temperature, then desalted as above for subsequent proteolysis.
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Proteolytic digestion
A 10:1 protein:protease (by mass) ratio was maintained for all digests. PDI was
digested for 18 h with Endoproteinase Glu-C shaking at room temperature. hYVH1 was
digested for 12 h with Trypsin shaking at 37 °C. For solution digest spectra, the samples
were quenched by a final concentration of 1% formic acid.

AuNP-peptide binding and elution
AuNPs (500 μL) were pelleted by centrifugation (16 000 x g for 15 min). The
supernatant was discarded and 40 μL of unquenched protein digests were added to the
AuNP pellet and incubated 30 min at 37 °C.

The AuNP-peptide complex was

centrifuged, the supernatant was aspirated and the AuNP-peptide pellet was washed in
200 μL of 10 mM ammonium bicarbonate (pH ~ 7.6, unadjusted) three times. After the
wash-spin steps, the AuNP-bound peptides were then eluted in 20 μL of 100 mM DTT.
Following addition of DTT, the AuNPs were sonicated for 5 min in a water bath to
disperse any AuNP aggregates. This was followed by a 2 h incubation after which the
AuNPs were again pelleted and the supernatant harvested. To ensure the complete
elution of peptides from the AuNP surface, a second addition of 20 μL 100 mM DTT was
incubated with the AuNPs for 8 h with gentle agitation. The AuNPs were centrifuged
and the resulting supernatant was combined with that from the first DTT elution step.
Samples were acidified by the addition of 100 μL 0.1% trifluoroacetic acid, then desalted
and concentrated using Vivapure C-18 Micro spin columns as per the manufacturer’s
protocol. All digests were spotted 1:1 with 10 mg/mL matrix solution (recrystalized αcyano-4-hydroxycinnamic acid in 60% acetonitrile, 0.1% trifluoroacetic acid) on the
target plate by the dried droplet method and analyzed by matrix assisted laser desorption
ionization-time of flight mass spectrometry (MALDI-TOF MS) using an Applied
Biosystems Voyager DE-Pro Mass Spectrometer. Peptide mass fingerprints and tandem
mass spectrometry (MS/MS) using post source decay (PSD) was performed on selected
parent ions as previously described [19] and compared to in silico fragmentation using
the Protein Prospector software (http://prospector.ucsf.edu/).
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3.3 - RESULTS AND DISCUSSION
AuNPs demonstrate a saturable capacity to release NO• from S-NO proteins
Protein disulfide isomerase (PDI) is an ∼ 57 kDa endoplasmic reticulum resident thiol

oxidoreductase which catalyzes isomerization and rearrangement of disulfide bonds to
ensure the proper folding of nascent proteins [20]. PDI is also secreted from cells where
it associates with the cell surface [21,22] and has previously been shown susceptible to Snitrosylation (S-NO) both in vitro and in vivo [18,23]. In order to confirm the ability of
gold nanoparticles (AuNPs) to denitrosylate S-NO proteins, we mixed increasing
amounts of S-NO protein disulfide isomerase (S-NO-PDI) [18] with citrate-capped
AuNPs (10-12 nm) [24] in septa-sealed vials. After 1 min, the headspace was removed
and injected into a Sievers chemiluminescent nitric oxide (NO•) analyzer (NOA) for
quantification of NO• release. These experiments clearly indicate that NO• is released
upon interaction of AuNPs with S-NO-PDI.

Nitric oxide release reaches a plateau

indicating that the AuNP surface becomes saturated with protein above ~ 50 pmol of PDI
[Fig. 3.1A].

Exchange of AuNP-bound proteins by small molecular weight thiols
To further examine both the mode of denitrosylation and the ability of AuNPs to bind
protein thiols, AuNPs from the vials above were isolated, washed, incubated with either
non-reducing (-DTT) or reducing (+DTT) SDS-PAGE sample loading buffer, and
resolved by 10% SDS-PAGE. Resolved proteins were visualized by silver staining, and
comparison of the sample treatments indicated that PDI was only detectable in the DTT
containing samples, thus thiol-bound PDI can be released from AuNPs by thiol exchange.
This further suggests that S-NO-PDI denitrosylation is mediated through the formation of
AuNP-thiolate interactions [Fig. 3.1B].
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Figure 3.1 - AuNPs bind S-NO-PDI causing release of NO•. A) Increasing amounts of
S-NO-PDI in phosphate buffered saline were added 1:1 to a constant amount (~5.3 × 109)
of AuNPs in argon-purged, septa-sealed 2 mL vials. A 500 μL aliquot of the headspace
was then injected into the NOA to quantify NO•. Data on the graph represents the
average of n = 3 independent experiments and error bars represent S.D. B) AuNPs
from sealed vials were collected, harvested by centrifugation, washed, and incubated for
the times indicated with SDS-PAGE sample buffer (+/- 100 mM DTT). The AuNPs were
again collected by centrifugation, and the supernatants were resolved by SDS-PAGE.
Protein was visualized by silver stain.
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AuNPs selectively enrich thiol-peptides from S-nitrosylated proteins enabling the
identification of S-nitrosylation sites
PDI structural domains are arranged in an a-b-b′-a′ topology, where the active site
domains, a and a′, contain the vicinal thiols Cys36XXCys39 and Cys379XXCys382
respectively. In addition, the b and b′ domains each contain an additional free thiol at
positions Cys295 and Cys326 respectively. Previous studies have shown that a′ active
site thiols are susceptible to oxidation such that the native enzyme performs its catalytic
function in a half-oxidized state (i.e., a thiols reduced; a′ thiols oxidized) [18,25].
hYVH1 (or dual specificity phosphatase 12; DUSP12) is a member of the cysteinebased protein tyrosine phosphatase (PTP) superfamily and has been shown to be a cell
survival phosphatase in response to various cellular insults [26,27]. This 37.5 kDa
protein is constructed of an amino terminal catalytic domain containing four free thiols,
Cys11, Cys23, Cys97, and the active site nucleophile Cys115. Unique to this protein is a
carboxyl-terminal domain containing seven Cys residues which participate in the
coordination of 2 mols of zinc [28]. Recent findings show both domains undergo redox
regulation [19], however their susceptibility to S-nitrosylation has not been demonstrated.
Of these, only thiols within the catalytic domain and the vicinal Cys312XCys314 pair are
detectable in tryptic mass fingerprints. Remaining thiols reside in small, un-resolvable
peptide fragments owing to the rich lysine and arginine content within the zinccoordinating domain.
In fully reduced PDI and hYVH1, all detected thiols could be carbamidomethyl
(CAM)-labeled with iodoacetamide (IAM) [Fig. 3.2A and Fig. 3.4A].

When fully

reduced PDI or hYVH1 were S-nitrosylated prior to alkylation, all detected thiols were
partially protected from CAM labeling [Fig. 3.2B and Fig. 3.4B]. Consistent with the
NOA analyses, this strongly suggested the formation of pools of S-nitrosylated thiols in
both PDI and hYVH1, as they resisted alkylation by IAM. The m/z values for these
peptides correspond to those of free thiol peptide masses due to S-NO bond lability
during nitrogen laser desorption ionization at 337 nm in MALDI-MS analyses [Fig. 3.2B
and Fig. 3.4B] [29].
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Figure 3.2 - AuNPs successfully enrich thiol-containing peptides from S-NO-PDI GluC digests. A) Fully reduced PDI was alkylated with IAM, exchanged into 50 mM
ammonium bicarbonate, and proteolyzed by a 10:1 ratio of PDI:Endoproteinase Glu-C.
Peptide mass fingerprints were analyzed by MALDI-TOF MS and compared to in silico
digests as described in 'Experimental Procedures'. B) Fully reduced PDI was Snitrosylated by S-nitrosoglutathione (GSNO), then alkylated with IAM, proteolyzed, and
analyzed as above. C) Fully reduced PDI was S-nitrosylated, alkylated, and proteolyzed
as above. The digest was added to 1.3 × 1010 AuNPs and incubated for 30 min at 37 °C.
The AuNPs were washed, and AuNP-bound peptides eluted by thiol exchange using 100
mM DTT. Peptide samples were desalted using Vivapure C-18 Microspin columns and
analyzed by MALDI-TOF MS as above.
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Figure 3.3 - Tandem mass spectrometry of AuNP-enriched PDI peptides confirms thiol
peptide association. Tandem mass spectrum (MS/MS) of A) b' domain thiol-containing
peptide at m/z = 951, B) a domain thiol-containing peptide at m/z = 1692, and C) b'
domain thiol-containing peptide at m/z = 2352 were analyzed by post-source decay as
described in 'Experimental Procedures'.
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Figure 3.4 - AuNPs successfully enrich thiol-containing peptides from S-NO-hYVH1
tryptic digests. A) Fully reduced hYVH1 was alkylated with IAM, exchanged into 50
mM ammonium bicarbonate, and proteolyzed by a 10:1 ratio of hYVH1:trypsin. Peptide
mass fingerprints were analyzed by MALDI-TOF MS and compared to in silico digests
as described in 'Experimental Procedures'. B) Fully reduced hYVH1 was S-nitrosylated
by S-nitrosoglutathione (GSNO), then alkylated with IAM, proteolyzed, and analyzed as
above. C) Fully reduced hYVH1 was S-nitrosylated, alkylated, and proteolyzed as above.
The digest was added to 1.3 × 1010 AuNPs and incubated for 30 min at 37 °C. The
AuNPs were washed, and AuNP-bound peptides eluted by thiol exchange using 100 mM
DTT. Peptide samples were desalted using Vivapure C-18 Microspin columns and
analyzed by MALDI-TOF MS as above.
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Figure 3.5 - Tandem mass spectrometry of hYVH1 peptides shows presence of Snitrosylation and S-glutathionylation. Tandem mass spectrum (MS/MS) of A) active
site Cys115-containing peptide at m/z = 1248, and B) S-glutathionylated active site
Cys115-containing peptide at m/z = 1553, were analyzed by post-source decay as
described in 'Experimental Procedures'.
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AuNP-pulldowns of the peptide digests effectively enriched for the target thiolcontaining peptides, resulting in overall simplification of the mass fingerprints and
subsequent annotation. Both free thiol and CAM-labeled peptides were observed in PDI
and hYVH1 digests, allowing for detection of both S-nitrosylated and free thiol peptide
pools [Fig. 3.2C and Fig. 3.4C]. Mass fingerprints of PDI revealed that the vicinal thiols
in the a domain (Cys36 and Cys39) and those in the b (Cys295) and b′ (Cys326) domains
are susceptible to S-nitrosylation. The absence of the a′ domain vicinal thiols in the
AuNP-pulldowns [Fig. 3.2C] and their presence in the solution digests [Fig. 3.2B] is in
agreement with previous studies indicating that the vicinal thiols in the a′ active site
domain are quite susceptible to oxidation in comparison to their a domain counterparts
[18,25]. Furthermore, the absence of a′ domain thiols in the AuNP-pulldowns suggests
that, as predicted, AuNPs have limited interaction with disulfide-linked peptides [Scheme
1]. As for hYVH1, most thiol-containing peptides appeared in the reduced state being
indicative of S-nitrosylation, however, CAM-labeled peptides were also observed
suggesting that these too could be differentiated among free and S-NO thiols [Fig. 3.4C].
Surprisingly, GSNO seemed to promote formation of small amounts of Sglutathionylation for the active Cys115 peptide of m/z = 1553 which was confirmed by
tandem MS (MS/MS) [Fig. 3.5B]. Target thiol-containing peptide identities from both
experiments were confirmed by MS/MS [Fig. 3.3 and Fig. 3.5].

AuNPs interact with multiple peptide-thiol species allowing for combined identification
of differentially S-modified residues
The fact that CAM-labeled peptides were pulled down by AuNPs raised the possibility
that thiols and thioethers (i.e. Methionine; Met) retain a higher affinity for gold in
comparison to other functional groups in proteins, even upon chemical modification by
alkylation or thiolation. Therefore, a simple modification of the AuNP-based enrichment
technique

should

permit

discrimination

between

sites

of

S-nitrosylation,

S-

glutathionylation, and free thiols [Scheme 3.2]. To test this, separate batches of hYVH1
were either partially S-nitrosylated or partially S-glutathionylated. The remaining free
thiols were alkylated with IAM, while the S-NO-thiols were denitrosylated with ascorbate
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Scheme 3.2 - Simple modification of the AuNP-based enrichment technique
discriminates between sites of S-nitrosylation, S-glutathionylation, and free thiols.
Free thiols of S-nitrosylated and S-glutathionylated proteins are alkylated with
iodoacetamide (IAM). Proteins are de-nitrosylated with ascorbate, differentially
alkylated with N-ethylmaleimide (NEM) and proteolyzed. AuNPs are introduced to the
digest where any S-NO peptides or free thiols, now S-NEM and S-carbamidomethylated
(CAM) peptides, react with the AuNPs, and are enriched. S-glutathionylated peptides do
not bind and thus remain in the supernatant. AuNPs are eluted by thiol exchange and
released peptides are analyzed by mass spectrometry. Target peptide/protein assignment
is confirmed by comparison to in silico digestion of known protein sequences or
bioinformatic database mining.
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and differentially alkylated with a second thiol reactive agent, N-ethylmaleimide (NEM).
The samples were mixed, proteolyzed, and subjected to AuNP-pulldowns. The peptides
were released by thiol exchange and identified by MS [Fig. 3.6].
The mixed peptide solution indicated the presence of S-glutathionylated, S-CAM, and
S-NEM peptides [Fig. 3.6B].

The reduced peak intensities of the NEM-modified

peptides are indicative of ion suppression in mixed digests. As predicted, the AuNPpulldown significantly enriched for free thiol, alkylated thiol, and Met-containing
peptides [Fig. 3.6C]. This AuNP-enrichment for S-modified peptide thiols indicates that
upon partial S-nitrosylation of hYVH1, Cys11 and Cys115 are S-nitrosylated. On the
other hand, Cys11, Cys23, Cys97, Cys312, Cys314, and the active site Cys115 are
susceptible to S-glutathionylation [Fig. 3.6C, Fig. 3.7 and Fig. 3.5B]. In addition, this
technique was able to enrich for Met-containing peptides, along with decreasing sample
complexity and thus increasing signal to noise ratios.

Future adaption to liquid

chromatography/mass spectrometry will act to further the analytical capabilities of this
AuNP-based method, potentially providing a system to study the S-nitrosoproteome.
In summary, we have for the first time demonstrated that thiols and thioethers retain a
higher affinity for gold in comparison to other functional groups in proteins, even upon
chemical modification by alkylation or thiolation. We have adopted this property of
AuNPs to devise a simple, novel method by which AuNPs can be used to isolate, detect,
and enrich for S-modified peptides in a single step.

When combined with thiol

modification and mass spectrometry, our AuNP-based method can unambiguously
identify sites of protein S-modification, setting the stage for future AuNP-based
applications in studying protein S-nitrosylation and beyond.
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Figure 3.6 - AuNPs successfully enrich differentially labeled, thiol-containing peptides
from S-nitrosylated and S-glutathionylated hYVH1 tryptic digests. A) Fully reduced
hYVH1 was S-glutathionylated then alkylated with IAM, and proteolyzed by a 10:1 ratio
of hYVH1:trypsin. Peptide mass fingerprints were analyzed by MALDI-TOF MS and
compared to in silico digests as described in 'Experimental Procedures'. B) Fully
reduced hYVH1 was S-nitrosylated and alkylated with IAM. Sample was mixed with an
undigested sample from A), then de-nitrosylated with ascorbate and alkylated with Nethylmaleimide. Proteins were exchanged into 50 mM ammonium bicarbonate and
processed as above. C) Digests from B) were added to 1.3 × 1010 AuNPs and incubated
for 30 min at 37 °C. The AuNPs were washed, and AuNP-bound peptides eluted by thiol
exchange using 100 mM DTT. Peptide samples were desalted using Vivapure C-18
Microspin columns and analyzed by MALDI-TOF MS as above.
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Figure 3.7 - Tandem mass spectrometry of hYVH1 peptides shows presence of Snitrosylation and S-glutathionylation using modified AuNP-enrichment scheme.
Tandem mass spectrum (MS/MS) of A) active site Cys115-NEM peptide at m/z = 1373,
B) S-glutathionylated Cys11-containing peptide at m/z = 2839, and C) S-glutathionylated
Cys23-containing peptide at m/z = 3291 were analyzed by post-source decay as described
in 'Experimental Procedures'.
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CHAPTER 4 - INVESTIGATING REDOX REGULATION OF PROTEIN
TYROSINE PHOSPHATASES USING LOW PH THIOL LABELING
AND ENRICHMENT STRATEGIES COUPLED TO MALDI-TOF MASS
SPECTROMETRY

4.1 - INTRODUCTION
Cells utilize a vast array of strategic phosphorylation events to properly respond to
extracellular stimuli.

To achieve this homeostatic phosphorylation, kinases and

phosphatases must be tightly controlled using a variety of temporal and spatial regulatory
mechanisms.

Although often considered the unfavourable by-products of aerobic

respiration, increasing evidence has highlighted the role of cellular oxidants as second
messenger molecules that participate in maintenance of this balanced phosphorylation
[1]. Disruption of this delicate equilibrium can cause or promote numerous human
disease states including cancer, diabetes, and neurodegenerative disorders [2-4].
Reactive oxygen and nitrogen species (ROS/RNS) have been shown to target multiple
members of the protein tyrosine phosphatase (PTP) superfamily, providing a tier of
transient and reversible post-translational regulatory control [5]. PTPs share a highly
conserved active site architecture and catalytic mechanism, in which their catalytic
activities depend on nucleophilic cysteine thiolates [6,7]. Moreover, PTPs possess an
invariant

signature

motif,

HCX5R(S/T),

responsible

for

the

thiolate-based

dephosphorylation of an ever increasing diversity of phosphorylated substrates [8-11].
This tertiary architecture and microenvironment reduces the pKa of the catalytic thiol to
enhance catalytic competency, but also renders these enzymes susceptible to reversible
oxidative inactivation [12-15].

As such, these enzymes pose as molecular ‘redox

switches or sensors’ and can be regulated by discrete, subtle and/or sudden changes in
cellular redox homeostasis [16].
The prevalence, type(s) and effects of oxidative modifications among PTP family
members continues to diversify; a likely consequence of slight variations in active site
conformations or mediation through unique regulatory domains [14,17]. Sulfenic acid,
cyclic sulfenamide, nitrosylation, glutathionylation, sulfhydration and disulfide bond
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formation have all been shown to facilitate stable, reversible, active site modifications
among various PTP family members [13,18-22].

Thus, it was first suggested that

oxidation predominantly and rapidly targets the active site cysteine resulting in
inactivation, whereas other cysteinyl residues remain in the reduced state. More recently,
however, accumulating evidence is beginning to re-define redox regulation of PTPs as a
far more dynamic modification capable of differential regulation. In some cases, redox
sensitive cysteine residues outside of the active site contribute to preserving, or are even a
necessity for, catalytic activity under oxidative conditions [23-25].
Tools for studying PTP redox modifications are continually being developed, allowing
for extraction of pertinent information regarding these regulatory post-translational
modifications [26].

Recently, oxidative modification and conformation sensing

antibodies have been developed as unique tools for studying individual PTP redox events
at both the protein and/or proteomic level [27-30].

However, the economics and

feasibility of such applications requires targeted and previously determined phenotypes
which limits their use in more practical applications such as preliminary screening. Some
of the more routine methods for examining protein thiol redox status rely heavily on
differential labeling, whereby reversibly oxidized protein or peptide thiols are labeled
with some 'reporter tag(s)' for subsequent identification using a variety of analytical
techniques [31]. Efforts from our laboratory have focused mainly on development of
novel labeling and enrichment strategies allowing for quantitative and/or qualitative
identification of protein thiol redox status using mass spectrometry (MS) [23,32,33].
However, as in these and nearly all labeling methods, labeling steps must proceed for
several hours at near neutral pH, in large molar excesses, to ensure optimal and complete
reactivity of thiolates for the specific labeling agents. It is under these conditions that
targeted thiolates are also prone to non-specific oxidation events including those
catalyzed by common buffer contaminants such as molecular oxygen and trace metals (ie.
disulfide bonds, sulfonates etc.) which hampers their accurate analysis and interpretation
[31]. This issue can be partly circumvented by purging or degassing solutions used in
sample handling, and performing cellular lysis under anaerobic conditions as those
described by Meng et al. [34,35]. These precautions are effective in limiting oxidation
by ROS/RNS, but have decreased abilities in preventing disulfide exchange reactions as
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those commonly observed among members of the dual specificity phosphatase (DUSP)
sub-families [18]. Thus, accurate analysis of thiol oxidation, both in vivo and in vitro,
balances between the ability to suppress non-specific thiol exchange/oxidation and the
specificity and reaction rate of labeling reagents used for modification, enrichment and
detection.
Recently, our laboratory has been characterizing the activities of human YVH1
(hYVH1, also known as DUSP12), an atypical dual specificity phosphatase member of
the PTP superfamily [10]. This unique enzyme possesses an N-terminal DUSP catalytic
domain along with a C-terminal, thiol-rich, zinc-coordinating domain [Fig. 4.1] which
has been shown to be indispensible for its biological activities below. YVH1 orthologues
exhibit high evolutionary conservation, similar domain organization, and have recently
been implicated in processes such as ribosome biogenesis, cell survival and cell cycle
regulation [36-42]. Moreover, we previously revealed that oxidation of hYVH1 results in
reversible, concomitant, enzymatic inactivation and zinc release in vitro through
formation of intra-molecular disulfide bonds. This inactivation is more pronounced in
the absence of the zinc-coordinating domain, however, reversibility is independent of this
domains presence suggesting that oxidation preferentially targets this intrinsic redox
buffering region, slowing the rate of oxidative inactivation [23]. We have since observed
that similar to the yeast orthologue, hYVH1 interacts with the mammalian pre-60S
ribosomal subunit, but interestingly, oxidation ablates this association in a dose
dependent manner [42]. Although no bona fide physiological substrate or function have
been elucidated, amplification of the dusp12/hyvh1 gene has been reported in multiple
sarcomas, implicating roles of hYVH1 among human pathophysiology, highlighting the
need for continued study [43-45].
We have begun to develop rapid, specific, sensitive, and reversible low pH thiol
labeling schemes for screening PTP oxidative modification, specifically those involving,
but not limited to, disulfide exchange reactions as those observed by Chen et al. for SHP1 and SHP-2 [18]. From our previous studies on the redox regulation of hYVH1, we
have employed novel labeling and enrichment strategies in combination with mass
spectrometry to develop a platform of simple, rapid, and diverse labeling approaches for
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Figure 4.1 - Human YVH1 (DUSP12) is a thiol-rich dual specificity phosphatase.
Schematic displaying domain architecture of hYVH1. The N-terminal phosphatase
domain contains the highly conserved HCX5R(S/T) motif along with three additional Cys
residues. hYVH1 also possesses a unique C-terminal zinc-coordinating domain which
coordinates two moles of zinc putatively through action of seven Cys residues.
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studying disulfide exchange reactions. Our data suggests that exchange reactions occur
quite readily among vicinal thiols within the catalytic domain of this DUSP similar to
results shown by Chen et al. [18]. We find that the active site cysteine is capable of
participating in multiple disulfide bond reactions in addition to those previously
described, to further provide protection against irreversible oxidation events. Moreover,
we have found evidence of other disulfide pairs, exhibiting the applicability of the
methodology to identifying reversible thiol oxidation. Ultimately, these methods serve to
provide an economical means for preliminary screening of targeted redox-active thiols
within PTP superfamily members in vitro, to in turn, warrant an in depth analysis under
more detailed physiological settings.
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4.2 - EXPERIMENTAL PROCEDURES
Site-directed mutagenesis, recombinant protein purification and characterization of
mutant variants by MS
Target cysteine residues are identified through structural bioinformatics and/or redoxactive thiol enrichment (below), and mutated to serine residues using PCR-based sitedirected mutagenesis.

Mutated constructs are purified by conventional means in a

suitable host organism and characterized by mass spectrometry. Synthesis of pGEX-4T1
GST-hYVH1 mutant constructs was as previously described for hYVH1 C115S and
hYVH1ΔCT1 [23,36,38]. Briefly, PCR-based site-directed mutagenesis was performed
following manufacturers protocol (Stratagene). All mutated plasmid DNA constructs
were confirmed by DNA sequencing (AGCT Corp.).
Recombinant proteins were purified as previously described, being eluted with 50 mM
Tris-HCl, 150 mM NaCl, 2.5 mM CaCl2, 0.1% 2-mercaptoethanol, 80 units of thrombin
(Sigma) pH 8, at 4 °C from glutathione-agarose (Sigma) to remove the glutathione Stransferase tag [23].

Target constructs were brought to 1 mM dithiothreitol (DTT;

Sigma), 5% glycerol (ACP Chemicals Inc.) and 0.5 mM phenylmethylsulfonylfluoride
(PMSF; MP Biomedicals), 0.2 µm sterile filtered, aliquoted at 130 µL and stored at -80
°C until use. All protein concentrations were determined against standard bovine serum
albumin (BSA; Sigma) as per the Bradford assay (Bio-Rad Laboratories Inc.), while
purity of all proteins in this study was approximately 80–90% as judged by SDS-PAGE
analysis.
To characterize individual constructs along with digestion conditions at the protein
level, each construct (~ 20 µg) was carbamidomethylated (CAM) by incubation with 25
mM iodoacetamide (IAM; Sigma) for 60 min, shaking, at room temperature in the dark.
Both CAM-labeled and unlabeled samples of each construct were next exchanged out of
reducing/labeling conditions by precipitation, on ice, with cold (-20 °C) trichloroacetic
acid (TCA; Sigma) at a final concentration of 15%. Pellets were collected after 30 - 60
min by centrifugation at 23 500 x g at 0 - 4 °C, washed 3 times with cold (-20 °C)
acetone, then resuspended in 50 mM ammonium bicarbonate (Fisher Scientific) for
subsequent proteolytic digestion. To each sample, trypsin (Promega) was added to a final
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protease:protein ratio of 1:25, with digestion proceeding for 16 h, shaking at 37 °C.
Digestions were quenched by addition of formic acid (FA; Sigma) to a final
concentration of 0.1%. Labeled and unlabeled samples were combined, mixed, then split
into equal volumes, where one was reduced with tris(2-carboxyethyl)phosphine
hydrochloride (TCEP-HCl; Pierce Biotechnology) shaking at room temperature for 15
min at a final concentration of 25 mM. Samples were spotted 1:1 with α-cyano-4hydroxycinnamic acid (CHCA; Pierce Biotechnology) matrix constituted in 65%
acetonitrile/water (Fisher Scientific) supplemented with 0.1% trifluoroacetic acid (TFA;
Pierce Biotechnology) by the dried-droplet method and analyzed by matrix assisted laser
desorption ionization time of flight mass spectrometry (MALDI-TOF MS). Remaining
peptide samples were diluted to approximately 5 ng/µL in binding buffer (200 mM
phosphate buffer pH 4 with additive; see below) for subsequent loading onto resin as
described below.

Preparation and characterization of Mercury-Immobilized Metal Affinity
Chromatography (Hg-IMAC) resin
The outlined procedures are primarily based on those for BioRad’s discontinued AffiGel 501, an organomercurial derivative of Affi-Gel 10 N-hydroxysuccinimide activated
agarose gel recently adapted by others [46-48]. The following protocol is for preparation
of approximately 4 mL of Hg-IMAC resin. Before use, the chemical compatibility of all
plastics/vessels with the chemicals used throughout this synthesis should be determined.
Also, we strongly advise strict adherence to Good Laboratory Practice (GLP) procedures
and consultation of appropriate Material Safety Data Sheets (MSDS) during and before
synthesizing Hg-IMAC resin.
Affi-Gel 10 resin (Bio-Rad) is warmed to room temperature for ~ 30 min in the dark
to limit hygroscopy, which promotes hydrolysis of the activated succinimidyl ester.
Dissolve 83.76 mg of para-amino-phenylmercuric acetate (Sigma) in 1.2 mL of
anhydrous dimethylformamide (Sigma). Mix via vortex and/or nutation for 20 - 30 min
at room temperature to ensure full dissolution of all organomercurial compound. Agitate
Affi-Gel 10 resin to form a homogeneous suspension, then quickly transfer 4 mL into a
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clean 10 mL glass column with granulated frit, pre-rinsed with anhydrous
dimethylformamide/2-propanol (Fisher Scientific). It is imperative to eliminate residual
water, as water promotes rapid hydrolysis of succinimidyl esters, decreasing labeling
efficiency of subsequent steps, and thus, binding capacity of Hg-IMAC resin. Wash resin
with a minimum of 3 column volumes (12 mL) of anhydrous 2-propanol, then resuspend
resin in 1 column volume of anhydrous 2-propanol, ensuring not to let resin dry. If resin
dries and cracks, wash extensively with 2-propanol with periodic aspiration to remove
trapped air. If the resin has begun to aggregate, restart the synthesis. Add the paraamino-phenylmercuric acetate solution to the resin (60 μmol/mL of gel) and aspirate
carefully as to not introduce air bubbles into the resin. Cover the column with tin foil and
incubate for 4 h with periodic aspiration to mix the resin. This constitutes a four-fold
excess of organomercurial amine to available succinimide esters of the resin. At time,
add 40 µL of ethanolamine (Sigma) to block any unreacted succinimide esters (164
μmol/mL of gel), aspirate and incubate as above for 1 h. Control resin is prepared by
excluding para-amino-phenylmercuric acetate and blocking with excess ethanolamine.
Wash resin with 3 column volumes (12 mL) of dimethylformamide, followed by 12
column volumes (48 mL) of 2-propanol. Store the resin in 2 column volumes (8 mL,
approx. 30% slurry) of 2-propanol in the dark at 4 °C. If require or prefer higher
percentage slurry, centrifuge resin at 2500 x g for 5 - 10 min or allow to settle at 4 °C and
remove the desired volume of 2-propanol. The resin should be used within one month,
however, can be continually tested for efficacy by analysis of binding capacity prior to
use. In our experience, resin maintained binding capabilities over 2+ months, however it
is recommended that binding capacity is checked periodically to ensure reproducibility
and efficacy.
To determine the binding capacity of Hg-IMAC, prepare 1 mg/mL (5.7 mM) stock
standard solution of cysteine hydrochloride (Cys-HCl; Sigma) in water. Dilute ten-fold
in water (570 µM) for use in binding capacity and standard curve analysis. Prepare stock
2 mM solution of 5,5-dithio-bis(2-nitrobenzoic acid) (DTNB; Sigma) in 50 mM sodium
acetate pH 4.5. A 12 point linear standard curve is prepared by mixing Cys-HCl to final
concentrations ranging from 5.7 µM to 114 µM with DTNB at a final concentration of
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200 µM in 100 mM phosphate buffer (ACP Chemicals Inc.) pH 7.4 with a 1 mL final
reaction volume and recording the Abs412nm as per Riddles et al. [49].
Equilibrate and activate various amounts of Hg-IMAC resin slurry (0, 10, 20, 30, 40,
60, 80 µL; see below for equilibration/activation steps) and incubate with 570 µM of
Cys-HCl, mixing by rotation for 45 min. For comparison, perform similar steps using the
control resin. Collect resin by centrifugation at 4000 x g for 6 min, then mix 100 µL of
each supernatant with DTNB at a final concentration of 200 µM in 100 mM phosphate
buffer pH 7.4 with a 1 mL final reaction volume and record the Abs412nm as per Riddles et
al. [49]. Calculate the remaining thiol content and convert to μmol/mL of slurry. In our
experience, the binding capacity of Hg-IMAC resin is reproducibly around 2.3 +/- 0.2
μmol/mL of slurry [Suppl. Fig. S4.1] when performed in a 1:1 phosphate buffered saline
(PBS; Thermo Scientific):water buffer pH 3.5 (adjusted with 85% phosphoric acid; ACP
Chemicals Inc.) supplemented with a final concentration of 10% acetonitrile, and is
consistent with other values in the literature [47]. Also, binding capacity studies have
been performed over a range of pH's, buffers, and solvents, showing no significant
deviations from the reported value above.

Selective enrichment of cysteine containing peptides using Hg-IMAC resin
Hg-IMAC resin slurry (at 100 µL/reaction) was activated by transferring to a 1.5 mL
conical microcentrifuge tube, harvesting by centrifugation at 4000 x g for 1 min at room
temperature, washing 2 x with equilibriation buffer (PBS), 2 x with activation buffer (100
mM ammonium chloride), then 2 - 3 x with binding buffer (200 - 400 mM phosphate
buffer pH 4 with additive; see below). Protein digests as described above (500 µL at 5
ng/µL) were loaded onto the resin and incubated at room temperature, nutating in the
dark for 60 min. Resin was collected by centrifugation at 4000 x g for 1 min, and
supernatant removed for storage. Resin was washed 3 x with wash buffer (10 mM
phosphate buffer pH 4), with bound peptides eluted 2 x with 50 µL 100 - 200 mM DTT
shaking 30 min at room temperature.

Both samples were concentrated by rotary

evaporation at 30 °C to approximately 20 - 40 µL, spotted 1:1 with CHCA matrix as
above, and analyzed by MALDI-TOF MS. If necessary, samples were diluted 1:1 with
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0.1% TFA/water and desalted/concentrated using ZipTip® C18 pipette tips (Millipore
Corp.) as per manufacturers protocol. Samples were again spotted 1:1 with CHCA
matrix and analyzed by MALDI-TOF MS as above.
To note, reduction of surface tension in aqueous buffers during Hg-IMAC activation
and peptide enrichment can be accomplished by adding final concentration of 10%
acetonitrile or 0.001% Tween-20 as additives to all buffers. Tween-20 reproducibly
provided slightly better enrichment, however, must be removed prior to any MS analysis
(either MALDI or liquid chromatography; LC/MS). Failure to remove residual Tween20 results in potent suppression of peptide ions and can be a detrimental contaminate in
LC/MS instrumentation, resulting in tedious decontamination procedures.

Thus, we

suggest to use Tween-20 only when interested in the Hg-IMAC eluant sample, as excess
can be rinsed away during resin washing. If the supernatant is of interest analytically
and/or LC/MS is being employed, we advise to substitute Tween-20 (Bio-Rad
Laboratories Inc.) for acetonitrile.

Screening reversible thiol oxidation with Hg-IMAC enrichment and 4,4-dithiopyridine
labeling coupled to MS
Molar ratio(s) of protein:H2O2 and incubation time(s) are empirically determined
based on a variety of characteristics such as number of suspected redox active thiols,
physiological concentration ratios, and detection limits. A simple activity, DTNB or 4,4dithiopyridine (4-DTP) assay which titrates the redox reversibility will strongly aid in
defining the starting molar ratios to be explored, however, a simple titration may also be
applied directly to the Hg-IMAC scheme instead [13,49,50]. Take care not to dilute
working protein reaction volume too drastically by the addition of H2O2, routinely
calculate the addition of 20 µL concentrated H2O2 to achieve the desired final molar ratio.
Since most reaction volumes are quite small, all pH values are checked on equivalent
reaction mixes containing appropriate scaled up volumes (not concentrations) of each
pertinent component. For small volumes of true reaction mixes, pH was occasionally
monitored by spotting ~ 2 µL on pH paper to ensure reaction conditions are as expected.
All pH values for buffers were obtained using an Orion 410Aplus pH meter equipped
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with an Orion glass Ag/AgCl Sure-Flow Electrode, under 3-point calibration using
standard buffer solutions (Fisher Scientific Buffer solutions pH 1.00 and 4.00; ACP
Chemicals Inc. Buffer solutions pH 7.00 and 10.00).
Reduced protein was rapidly thawed to 0 °C and placed on ice. Samples were
exchanged into reaction buffer (20 mM Tris-HCl pH 7.3, 25 mM NaCl or equivalent)
using Zeba™ Desalt Spin Columns (Pierce Biotechnology) as per manufacturers
protocol.

During column preparation for exchange, stock solutions of H2O2 (ACP

Chemicals Inc.) were prepared in reaction buffer. Once exchanged, the desired volume
of protein was quickly transferred to a suitable microcentrifuge tube, followed by the
addition of the appropriate volume of stock H2O2 to achieve the necessary molar ratio.
The sample was gently mixed and incubated shaking at room (or desired) temperature for
defined time(s). Following incubation, the reaction was quenched by addition of 1 M
phosphate buffer (phosphate:reaction, 1:4, v:v) to 200 mM final concentration pH ~4.
Here, samples were divided into one of two schemes [Fig. 4.3], where initially a
candidate list of redox-active and inactive protein thiols is formed for the subsequent
targeted site-directed mutagenesis scheme. The devised schemes to identify candidate
redox-regulated protein thiols are based on the merging of previously described methods
with key modifications [23,47,50].
Science,

immobilized

pepsin;

First, an acid protease (GluC; Roche Applied

Pierce

Biotechnology,

or

equivalent)

at

1:10

protease:protein ratio was added to initiate digestion, and sample was incubated at 25 °C
shaking for ≤ 1 h.

During digestion, the appropriate amount Hg-IMAC resin was

equilibrated and activated as described above. After digestion, digests were added to
activated resin, and incubated as described. During the 1 h incubation, a second batch of
Hg-IMAC resin was equilibrated and activated as described above. After 1 h, resin was
collected by centrifugation, supernatant removed and partitioned equally into separate
microcentrifuge tubes. One equivalent was reduced with 4 mM TCEP for approximately
10 - 20 min at 25 °C, while the second equivalent was diluted with an equal volume of
water. After reduction, the peptide samples were diluted 1:1 with 200 mM phosphate
binding buffer pH 4 containing the desired additive (10% acetonitrile or 0.001% Tween20). Each of the peptide pools were loaded onto the second activated Hg-IMAC resin
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batches and incubated as described. During incubation, the primary Hg-IMAC resin
containing redox-inactive and reduced thiols was washed and eluted as described. Once
time was met for secondary Hg-IMAC incubations, resins were washed and eluted as
described, with all samples analyzed as previously described above.
Based on the targeted thiols identified, we made an appropriate Cys to Ser point
mutant to solidify our data sets. We analyzed wild-type and C115S hYVH1 for presence
of disulfide pairs among the active site cysteine and N-terminal thiols within the catalytic
domain. After quenching by addition of 1 M phosphate buffer (phosphate:reaction, 1:4,
v:v) to 200 mM final concentration pH ~ 4, 4-DTP (Acros Organics) was added at a 1:10
reagent:protein ratio to initiate labeling, and incubated at 25 °C shaking for 20 - 40 min.
Labeling efficacy of 4-DTP was confirmed by subsequent addition of IAM in the absence
and presence of TCEP [Suppl. Fig. S4.5 and Suppl. Fig. S4.6]. At time, the pH was
neutralized through buffer exchange of protein sample into 50 mM ammonium
bicarbonate using Zeba™ Desalt Spin Columns as per manufacturers protocol. Trypsin
was added at approximately 1:20 protease:protein ratio to initiate digestion, and samples
were incubated at 37 °C shaking. Digests were spotted, as above, every 30 min to
maximize signal:noise ratio and avoid ion suppression effects. Similarly, aliquots were
taken at each time point and reduced with TCEP to further locate disulfide bonding pairs
prior to spotting. All samples were analyzed by MALDI-TOF MS as described above.
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4.3 - RESULTS AND DISCUSSION

Examination of protein thiol redox status continually battles between suppression of
non-specific thiol exchange/oxidation and efficacy of labeling conditions used in the
modification, enrichment and detection steps.

The wide variety of potential redox

modifications, most of which are labile and reversible, greatly confounds all aspects of
their accurate analysis [31]. Members of the PTP superfamily show great dynamic range
among the redox reactions in which they can undergo, with examples representing most
all of the common cellular redox modifications [14].

This phenomenon acts to

complicate studies regarding PTP redox regulation, but also to highlight the necessity for
continual development of methods for expanding current knowledge regarding these
extremely important contributors to signal transduction. However, an economical means
for preliminary screening of targeted redox-active thiols within PTP superfamily
members in vitro would enable more functional studies regarding the specific regulation
afforded through Cys-based oxidation and of those cellular pathways potentially involved
in their reversible regulation.
Coupling thiol labeling/enrichment with 'bottom up' mass spectrometric techniques
has expanded the analytic abilities for studying the vast array of regulatory redox protein
modifications at the proteomic level [28,48,51,52].

Moreover, recent reviews have

suggested that the levels of protein Cys oxidation are ~ 10% under normal cellular
conditions, while in response to oxidants, those levels are capable of reaching > 40% of
total cellular protein Cys residues, illustrating the redox proteome as a prevalent aspect of
cellular physiology [53]. But as previously mentioned, probing redox status of peptide
thiols readily falls victim to formation of non-specific oxidation artifacts during both
labeling and digestion steps, mainly due to the inherent reaction conditions (large molar
excesses, pH ~ 8, extended times) [31]. Common labeling agents (IAM etc.) offer very
little affordability in monitoring reaction efficiency, and as such, put potential limitations
on data acquisition post digestion. These limitations are exemplified upon observing data
from conventional tryptic protein digests obtained using classical conditions without
previously labeling protein thiols [Fig. 4.2 and Suppl. Fig. S4.2]. Here, hYVH1 digests,
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Figure 4.2 - Non-specific oxidation of hYVH1 thiols during proteolytic digestion at
neutral pH. Recombinant hYVH1 and CAM-labeled hYVH1 were subjected to an
overnight trypsin digestion using a 1:25 protein:protease ratio in 50 mM ammonium
bicarbonate pH 8, shaking at 37 °C. The resulting tryptic peptides were analyzed by
MALDI-TOF MS with A) or without B) prior reduction with 25 mM TCEP.
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spiked with carbamidomethylated (CAM) digests for relative comparison, were analyzed
in the presence and absence of TCEP after overnight digestion. One can clearly note that
addition of a reductant post digest results in a drastic increase in reduced thiol peptide
peaks relative to their CAM-labeled counterpart, highlighting the propensity of nonspecific oxidation occurring during typical tryptic digestion. Thus, if labeling efficiency
is limited/unknown, or a label-free analysis is sought, potential limitations are apparent
between most existing thiol-labeling MS-based approaches.
To circumvent these potential limitations among current MS-based approaches used in
studying protein thiol redox regulation, we have devised a scheme using commercially
available and well characterized thiol labeling reagents [Fig. 4.3]. Our current platform
assesses three main aspects of the traditional work-flow; time, pH and label
characteristics. First, decreasing time during all steps will act to limit potential nonspecific oxidation as well as increase throughput, thus posing this as a method for rapid
screening of candidate, reversibly oxidized/regulated protein thiols. Next, decreasing the
pH (≤ 4) will further limit oxidative artifacts as thiols (-SH) are far less reactive than their
deprotonated counterparts, thiolates (-S-) [54]. Moreover, in combination with digestion,
these moieties will become even less prone to artifactual oxidation, as protein thiol pKa
values are largely governed by tertiary microenvironments, which are lost during
proteolytic digestion. This would be the case for the highly conserved active site cysteine
residues characteristic of PTP superfamily members, making this method directly
applicable to the study of such events. Also, in examples such as PTP1B where a stable
cyclic sulfenamide is formed, acidification may also disfavour non-specific reactions of
these spatially proximal reactants (ie. active site cysteine with neighbouring amide
nitrogen). Acidification promotes formation of the less-reactive catalytic thiol (-SH),
while also hovering the hydrogen exchange minima of amide hydrogens among the
peptide backbone (pH ~ 2.5) [55].

These events suggest that reaction kinetics of

sulfenamide formation would be greatly reduced as both reactants would predominantly
exist as stably protonated species, thus disfavouring reactivity based on their chemical
state. Lastly, coupling these phenomena to labeling and/or enrichment strategies has
further strengthened the proposed scheme for analysis of redox regulated thiols.
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Figure 4.3 - Schematic workflows of Hg-IMAC-based methodology. Left) Protein of
interest is exposed to oxidative stress, sample is then acidified to quench the reaction and
reduce the rate of oxidation “preserving” reversibly oxidized thiols (disulfides, Sglutathionylated, cyclic sulfenamides, S-nitrosylated thiols etc.). A rapid proteolytic
digest using acid proteases (i.e. pepsin or Glu C) is then performed whereby peptides are
then passed over Hg-IMAC resin to capture any reduced or S-nitrosylated thiols.
Captured peptides are eluted using DTT and detected by MALDI-TOF MS. Resin flowthrough is split into two fractions, with one fraction left untreated (oxidized thiols) and
the other reduced with TCEP (reversibly oxidized thiols). Both fractions are then passed
over fresh Hg-IMAC resin, resin is eluted, and eluant analyzed using MALDI-TOF MS.
Peptides found in the reduced fraction not found in the non-reduced fraction are putative
reversibly oxidized thiols. Right) Protein is treated as above, however, after acid quench,
any reduced thiols are blocked with 4-DTP at low pH for 1 h. These reduced thiols have
been labeled and can no longer participate in non-specific disulfide formation and can be
differentiated from S-nitrosylated thiols. Moreover, the pH can be raised to 7 - 8
allowing for conventional protein digestion with trypsin and MALDI-TOF MS analysis.
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Organomercurials have long since been known to have an extremely high affinity for
thiols, reacting both rapidly and stoichiometrically, even displacing thiol-bonded nitric
oxide through preferred formation of a stable mercaptide. This reactivity has a pH
maximum of approximately pH 5, exhibiting the practical applicability of these chemicals
towards both low pH labeling and/or enrichment [56].

Immobilization of such

compounds has also allowed for the selective enrichment of target thiol-containing
peptides, such as the recent application used in study of the S-nitroso-proteome [46,48].
This ability to enrich for targets acts to decrease spectral complexity, while increasing
signal:noise ratio, thus sensitivity and accuracy, to ease subsequent analysis.

Since

immobilized organomercurials are capable of displacing nitric oxide from S-nitrosylated
biomolecules, a second reagent capable of rapid, stoichiometric and low pH labeling of
thiols can be exploited to differentiate this sub-population from alternative redox-based
thiol modifications. Such a candidate is 4,4-dithiopyridine (4-DTP), and although the
above features are highly uncommon for most every thiol labeling agent, they are even
further complimented by the ability of 4-DTP to react with free thiols quantitatively,
forming 4-thiopyridone (4-TP), a strongly absorbing chromophore (ε = 21 400 L*mol1

*cm-1 @ λ = 324 nm) which allows for labeling efficiency to be monitored

spectrophotometrically [50]. Furthermore, unlike other thiol-based labeling agents such
as DTNB, as the name implies, the resultant product 4-TP contains a redox-inert thione
(thio-ketone) moiety. This reaction product is thus unable to participate in additional
disulfide exchange reactions, further exemplifying this reagent as a useful primary thiol
blocking agent in studying redox regulation of protein thiols.
Although multiple work-flows can be built on this platform, we have chosen to
highlight one such scheme, which enables analysis of both redox-inactive and redoxactive protein thiols in a single experimental run, and infer relative kinetics/quantities of
each. As a proof of concept, both wild-type hYVH1 and hYVH1 C115S (catalytic Cys to
Ser mutation) digests were spiked with CAM-labeled counterparts, reduced with TCEP,
and loaded onto Mercury-Immobilized Metal Affinity Chromatography (Hg-IMAC) resin
at pH ~ 3.5 [Fig. 4.4 and Fig. 4.5]. Selective enrichment of thiol-containing peptides
was observed; alkylated, CAM-labeled peptides, as well as non-thiol, methionine
containing peptides, remained in the flow through supernatant [Fig. 4.4B and Fig. 4.5B].
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Moreover, mutation of the active site cysteine resulted in loss of this corresponding
peptide in the eluant, suggesting that intrinsic peptide composition has no effect on HgIMAC selectivity and peptide enrichment [Fig. 4.4C and Fig. 4.5C]. Furthermore, since
it is possible to elute thiol-containing peptides using performic acid through formation of
sulfoxides (SOxH) [47], taken together, this data suggests that Hg-IMAC is capable of
selective enrichment of strictly thiol-containing peptides at low pH in the presence of the
reducing agent TCEP. To note, this enrichment method is also highly diverse, allowing
for individual tailoring of experimental procedures. For example, binding is quite rapid,
approaching completion in approx. 30 min, however this rate can be 'tuned' by altering
the amount of resin and/or the amount of protein/peptide loaded. Moreover, efficient
binding is observed over a large dynamic buffer and pH range. For example, 10%
acetonitrile, Tween-20 and guanidium hydrochloride additives displayed no substantial
effects on peptide binding or enrichment over pH values ranging from approx. pH 3 - 7,
highlighting the wide practical applicability of this methodology to a variety of
experimental conditions and hypotheses [Suppl. Fig. S4.3 and Suppl. Fig. S4.4].
Based on the above findings, we have been successful in extending this workflow to
studying redox-regulated thiols within the catalytic domain of hYVH1 [Fig. 4.3; Left].
Briefly, reduced hYVH1ΔCT1 was rapidly exchanged into neutral buffer and
immediately stimulated with H2O2. Oxidation was next quenched by the addition of a
large molar excess of phosphate buffer pH 3.5 to effectively drop the reaction pH to
approx. pH 4. This step serves a dual purpose as it is widely known that phosphate
buffers act to competitively inhibit members of the PTP superfamily, as phosphate ions
can readily occupy the active site [13].

This provides added analytic advantages,

preventing non-specific oxidation of the catalytic cysteine residue during subsequent
sample processing through a direct competition with H2O2. Concomitant addition of an
acid protease (GluC, pepsin or equivalent) initiates digestion, which is followed by an
initial Hg-IMAC enrichment step. The flow through supernatant of this first enrichment
is equally partitioned and treated with or without TCEP, then subjected to a second HgIMAC enrichment, while the initial resin is washed and eluted for subsequent
determination of reduced, redox-inactive thiols. Secondary Hg-IMAC enrichments are
next washed and eluted for analysis of reversibly oxidized, redox-active thiols.
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Figure 4.4 - Characterization of Hg-IMAC selectivity for wild type hYVH1 peptide
thiols. Both CAM-labeled and unlabeled wild type hYVH1 were trypsin digested,
mixed, acidified, and incubated with Hg-IMAC resin for 1 hr using acetonitrile additive.
Supernatant was collected and bound peptides were competitively eluted using DTT. All
samples were analyzed by MALDI-TOF MS. A) Mixed peptides before Hg-IMAC
enrichment. B) Flow-thru supernatant showing near depletion of thiol containing
peptides while IAM labeled peptides remain. C) Peptide eluant from Hg-IMAC
enrichment showing selective thiol-containing peptide enrichment as CAM-labeled
peptides were not detected in the eluant.
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Figure 4.5 - Characterization of Hg-IMAC selectivity for hYVH1 C115S peptide thiols.
Both CAM-labeled and unlabeled hYVH1 C115S were trypsin digested, mixed, acidified,
and incubated with Hg-IMAC resin for 1 hr using acetonitrile additive. Supernatant was
collected and bound peptides were competitively eluted using DTT. All samples were
analyzed by MALDI-TOF MS. A) Mixed peptides before Hg-IMAC enrichment. B)
Flow-thru supernatant showing near depletion of thiol containing peptides while IAM
labeled peptides remain. C) Peptide eluant from Hg-IMAC enrichment showing specific
and selective thiol-containing peptide enrichment. Neither CAM-labeled peptides nor the
C115S peptide were detected in the eluant.
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Of interest to our study were these redox-active thiols or reversibly oxidized thiols of
hYVH1's catalytic domain. It was observed that indeed, hYVH1 possesses other thiols
within the catalytic domain that undergo reversible oxidation upon exposure to H2O2,
which were attributed to the two most N-terminal thiols [Fig. 4.6A]. Moreover, in the
absence of TCEP, no peptides were observed, confirming that the initial Hg-IMAC
enrichment went to completion, removing all redox-inactive, reduced thiols [Fig. 4.6B].
To further confirm certainty of peptide/thiol candidates, reversibly oxidized peptides
from the TCEP reduced Hg-IMAC enrichment experiment were carbamidomethylated
using IAM.

This modification caused all peptides to shift by multiples of m/z 57

characteristic of CAM modification, confirming that all enriched peptides did indeed
possess intrinsic cysteine thiols [Fig. 4.6C]. This also displays that Hg-IMAC does not
interact with disulfide-linked peptides, to again, show thiol-dependent specificity.
As glutamic acid terminated peptides do not ionize as efficiently as those of tryptic
descent, a secondary digest of these CAM-modified, glutamic peptides was performed to
increase ionization efficiency as well as ease target peptide identification [Fig. 4.6D].
Upon tryptic digestion, it clearly identifies that indeed, other catalytic domain thiols of
hYVH1 participate in reversible thiol modifications, suggesting that the redox regulation
of this DUSP may not be limited to the previously described regulation, but instead adapt
a disulfide exchange mechanism similar to that observed for SHP-1 and SHP-2 [18]. To
note, as with any MS-based approach, a potentially strong limitation exists within the
described method of analysis with respect to ion suppressive effects. One can partially
alleviate these influences by further separation of eluted peptides prior to MS analysis by
reversed-phase high performance liquid chromatography or equivalent separations
chemistry to enhance individual peptide resolution. In foresight, this entire workflow has
been constructed for adaption to high-throughput LC/MS-based platforms which would
further extend the analytic capabilities instrumentally, while also combating the potential
limitations described above.
To begin elucidation of this potential mechanism governing the redox regulation of
hYVH1, we have adapted a novel labeling strategy involving 4-DTP as a primary thiol
blocking agent as described above. The efficacy of this reagent as a primary thiol
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Figure 4.6 - Characterization of reversibly oxidized thiols in the DUSP domain of
hYVH1. hYVH1ΔCT1 was exposed to oxidative stress, acidified and rapidly proteolyzed
with Glu C. Peptides were then passed over Hg-IMAC resin to capture any remaining
reduced thiols. The resin flow-through was split into two fractions, with one fraction left
untreated (oxidized thiols) and the other reduced with TCEP (reversibly oxidized thiols).
Both fractions were then passed over fresh Hg-IMAC resin, the resin was eluted, and the
eluants analyzed by MALDI-TOF MS. A) TCEP-reduced, Hg-IMAC eluant of reversibly
oxidized thiol-containing peptides were observed, highlighting putative candidate(s). B)
Non-TCEP-reduced, Hg-IMAC eluant of oxidized thiol-containing peptides were not
observed, ensuring primary Hg-IMAC enrichment went to completion. C) TCEPreduced, Hg-IMAC eluant of reversibly oxidized thiol-containing peptides from A) were
CAM-modified with IAM to confirm enriched peptides contained free thiols as denoted
by m/z shifts of 57. D) CAM-modified peptides from C) were digested by trypsin and reanalyzed to confirm candidate identification through both improvement of ionization
efficiency and target mass identification by tandem MS.
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blocking agent is highlighted by its ability to block subsequent CAM labeling, a
condition that can be, as expected, ablated by TCEP reduction prior to CAM labeling
[Suppl. Fig. S4.5 and Suppl. Fig. S4.6]. Although a variety of reversible modifications
can be stimulated by H2O2, we suspected that the likely candidate was disulfide bonding
based on our, and Chen et al., previous findings [18,23]. Following our alternative
scheme [Fig. 4.3; Right] we were able to calculate putative disulfide masses for potential
tryptic dipeptides between the active site cysteine (Cys115) and N-terminal cysteine
residues (Cys11 and Cys23). Upon analysis, we observe sound evidence for the formation
of a disulfide bond between the active site and an N-terminal thiol (Cys115-S-S-Cys23
disulfide linkage) [Fig. 4.7A]. This species was ablated by addition of TCEP, and
moreover, mutation of the catalytic cysteine to serine (C115S) also resulted in loss of this
species, suggesting that a disulfide linkage is forming between these residues [Fig.
4.7B,C]. Surprisingly, we also observed a suspected linkage between Cys23 and the
vicinal thiol Cys11 (Cys11-S-S-Cys23 disulfide linkage) which was also ablated by
treatment with TCEP [Fig. 4.7A-D]. Overall, these findings have begun to provide
evidence for a disulfide exchange mechanism which prevents irreversible thiol oxidation
in a manner similar to that of SHP-1 and SHP-2 for the atypical DUSP, hYVH1. Current
site-directed mutagenesis efforts creating serine point mutants for individual cysteines
within the catalytic domain of hYVH1 are underway to begin detailed characterization of
the ordered steps within this disulfide exchange mechanism.
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Figure 4.7 - Identification of putative disulfide exchange within the active site of
hYVH1 using 4-DTP labeling methodology. Both wild type hYVH1 and hYVH1 C115S
were exposed to oxidative stress, acidified and rapidly labeled with 4-DTP. Samples
were neutralized, digested with trypsin, equally partitioned, with one equivalent being
reduced with TCEP, the other untreated. All samples were spotted and analyzed by
MALDI-TOF MS. A) Oxidized, 4-DTP-labeled wild type hYVH1 displays putative
disulfide linkages. B) Oxidized, 4-DTP-labeled, TCEP reduced wild type hYVH1 shows
complete ablation of putative disulfides. C) Oxidized, 4-DTP-labeled hYVH1 C115S
displays only a single putative disulfide linkage, suggesting disulfide exchange occurs
involving this thiol. D) Oxidized, 4-DTP-labeled, TCEP reduced hYVH1 C115S also
shows complete ablation of the lone putative disulfide, further suggesting evidence of
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4.4 - CONCLUSIONS

Using a combination of low pH thiol labeling and enrichment strategies, we have
simplified the experimental workflow during sample preparation of redox-regulated
protein thiols. As a proof-of-concept, we have examined the redox-regulation of hYVH1
and elucidated a potential disulfide exchange mechanism.

Such an added layer of

regulation may contribute to the ability of hYVH1 to cope with cellular insults such as
oxidative stress [23,38]. Moreover, we are currently applying this strategy to large-scale
redox proteomic experiments of both mammalian and Daphnia pulex origins for
investigation of global cellular redox regulation of PTP family members.

Through

coupling to mass spectrometry, we have integrated new additions to current thiol
labeling/enrichment schemes used in detection of redox sensitive protein thiols including
those which regulate the activities of PTPs.
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4.5 - SUPPLEMENTARY FIGURES

Supplementary Figure S4.1 - Characterization of Hg-IMAC resin. A) Standard curve
of Cys-HCl free thiol with DTNB showing linear relationship. B) Binding of Cys-HCl
by Hg-IMAC resin as shown by reduction of free thiol with respect to increasing
quantities of slurry, showing a linear relationship with slope denoting a binding capacity
of 2.2 μM thiol/mL of slurry. C) Box plot for seven independently prepared batches of
Hg-IMAC resin (data extrapolated to 1 mL of slurry) showing reproducibility.
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Supplementary Figure S4.2 - Non-specific oxidation of hYVH1 thiols during
proteolytic digestion at neutral pH. Recombinant hYVH1 C115S and CAM-labeled
hYVH1 C115S were subjected to an overnight trypsin digestion using a 1:25
protein:protease ratio in 50 mM ammonium bicarbonate pH 8, shaking at 37 °C. The
resulting tryptic peptides were analyzed by MALDI-TOF MS with A) or without B) prior
reduction with 25 mM TCEP.
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Supplementary Figure S4.3 - Characterization of Hg-IMAC selectivity for wild type
hYVH1 peptide thiols. Both CAM-labeled and unlabeled wild type hYVH1 were trypsin
digested, mixed, acidified, and incubated with Hg-IMAC resin for 1 hr using Tween-20
additive. Supernatant was collected and bound peptides were competitively eluted using
DTT. All samples were analyzed by MALDI-TOF MS. A) Mixed peptides before HgIMAC enrichment. B) Flow-thru supernatant showing near depletion of thiol containing
peptides while IAM labeled peptides remain. C) Peptide eluant from Hg-IMAC
enrichment showing selective thiol-containing peptide enrichment as CAM-labeled
peptides were not detected in the eluant.
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Supplementary Figure S4.4 - Characterization of Hg-IMAC selectivity for hYVH1
C115S peptide thiols. Both CAM-labeled and unlabeled hYVH1 C115S were trypsin
digested, mixed, acidified, and incubated with Hg-IMAC resin for 1 hr using Tween-20
additive. Supernatant was collected and bound peptides were competitively eluted using
DTT. All samples were analyzed by MALDI-TOF MS. A) Mixed peptides before HgIMAC enrichment. B) Flow-thru supernatant showing near depletion of thiol containing
peptides while IAM labeled peptides remain. C) Peptide eluant from Hg-IMAC
enrichment showing specific and selective thiol-containing peptide enrichment. Neither
CAM-labeled peptides nor the C115S peptide were detected in the eluant.
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Supplementary Figure S4.5 - Schematic workflow of 4-DTP labeling efficiency and
specificity. Protein sample is acidified, labeled with 4-DTP and partitioned equally.
Samples are treated with or without TCEP to reduce 4-TP labeling, then neutralized and
CAM-labeled with IAM. Samples are digested with trypsin and analyzed by MALDITOF MS to ensure specificity and completion of 4-DTP labeling under the given
conditions.
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Supplementary Figure S4.6 - Characterization of 4-DTP labeling efficiency and
specificity for wild type hYVH1 peptide thiols. Wild type hYVH1 was acidified, labeled
with 4-DTP and partitioned equally. Samples were treated with A) or without B) TCEP
to reduce 4-TP labeling, then neutralized and CAM-labeled with IAM. Samples were
digested with trypsin and analyzed by MALDI-TOF MS to ensure specificity and
completion of 4-DTP labeling under the given conditions. A) Despite an extreme excess
of IAM labeling agent, no CAM modified peptides are observed in the absence of TCEP
reduction, whereas in B), multiple CAM modifications are observed.
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CHAPTER 5 - MIXED DISULFIDE-BASED LABELING AGENTS FOR THE
DETECTION, ENRICHMENT AND QUANTIFICATION OF BIOLOGICAL
THIOLS

5.1 - INTRODUCTION
Biological thiols play a critical role in normal cell physiology, not only in
maintenance of redox homeostasis of the cellular milieu, but in protein structure,
modification/regulation and catalysis. Increasing evidence is beginning to uncover that
the protein families affected through thiol-mediated regulation are becoming as diverse as
the wide variety of potential thiol modifications themselves [1-6]. To this end, continued
method development is necessary to refine those current studies, but also to drive the
discovery of new ones.
Most studies aimed at studying thiol modification use indirect, reversible or
differential thiol labeling [7]. These methods have been quite powerful in defining the
redox proteome, however, as a stand-alone method of analysis, these approaches tend to
be limited in their abilities to decipher between the many types of thiol oxidation,
reporting only reversibly oxidized thiols. These applications further suffer from sample
handling issues that often leave target thiols prone to non-specific reactions limiting both
their sensitivity and accuracy [7]. Efforts have been made to circumvent formation of
these artifacts, but complete removal has been challenging to achieve [8,9].
Recent efforts to study thiol modifications have employed chemical 'omics'
approaches using a variety of reagents with diverse properties such as cell permeability,
rapid low pH labeling, and/or tailored reactivity [10].

Recent examples have been

successfully applied to the study of S-glutathionylation, S-nitrosylation and sulfenylation,
whereby synthetic labeling agents impose unique reactive properties or functional groups
on thiol-containing targets for subsequent enrichment and/or analysis [1,11]. In the case
of the protein tyrosine phosphatase (PTP) superfamily, which have been shown to be
susceptible to oxidation through their active site cysteine, use of substrate mimicking
labeling agents can isolate non-oxidized, active enzymes, providing specific thioltargeting through chemical reactivity which has tertiary structural constraints [12].
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Collectively, the advantage of directed labeling and/or enrichment of targeted moieties is
the drastic improvement in sensitivity and in accurate characterization of low
stoichiometric thiol modifications.
It is considered that cysteine thiols possess a highly variable pKa depending on their
immediate microenvironment. Most thiols targeted by oxidation exhibit a lower pKa (~ 3
- 6) than that of free cyteine (~ 8). This feature makes them prone to reactivity not only
in a physiological context, but during classical labeling and sample preparation steps,
ultimately decreasing the accuracy of the intended analytical read-out [7,13]. However,
the ability to exploit these pH-dependent chemical characteristics has been hindered by
the availability of labeling agents capable of reacting with a thiol at pH values low
enough to prevent non-specific oxidation [14,15]. We recently examined the ability of
organomercurials to label thiols at low pH and found that not only could these reagents
react and enrich for thiols at pH ≤ 4, they could do so in the presence of reductant. Thus
we described a method for the rapid labeling and enrichment of peptide thiols at low pH
using mercury-immobilized metal affinity chromatography (Hg-IMAC) methods [16].
Others have suggested the use of trichloroacetic acid in the lysis of cells to quench
oxidation and disulfide exchange during handling steps, which could be implemented
quite readily to this scheme, highlighting the future applicability of this method to those
in the field of redox signaling [7,17].
Keeping on the same theme, recent synthesis of a novel reagent capable of reversible
thiol labeling at low pH has been described. Built on a glutathione (GSH)-based back
bone, Nielson et al. describe the use of an isothiocyanate (ITC)-based cyclic activated
disulfide (ITC-CAD) compound which is able to react with thiols both specifically and
rapidly at low pH [18]. Furthermore, through use of fluoroscein-isothiocyanate (FITC),
they were able to impart fluorescent properties onto this molecule (FCAD) for the
sensitive quantification protein thiols through a variety of means. Based on this platform,
we have sought to produce a library of ITC-CAD-based, rapid low pH thiol labeling
agents which possess versatile analytical properties. We have successfully produced and
characterized a phenylisothiocyanate-CAD reagent which possesses similar chemical
properties to that of FCAD described by Nielson et al. [18].
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Moreover, we have

optimized the synthetic scheme, reducing time and cost, while increasing throughput and
characterization, and also have begun to define both the minimal and optimal reaction
characteristics involved in formation of CAD-based reagent design. Through changes to
the synthetic scheme, we have uncovered the potential use of a low pH thiol labeling
agent as a MS-based reporter ion capable of targeted MS approaches. Taken together, we
have fortified and diversified the CAD-based reagent platform, discovering new
molecular properties which may allow for future 'tuning' of such reagents chemical
reactivity.
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5.2 - EXPERIMENTAL PROCEDURES
Synthesis of isothiocyanate-cyclic activated disulfide (ITC-CAD) labeling agents
Preparation of CAD reagents was largely based on methods previously described [18].
Key modifications to the synthetic scheme and overall approach were adapted herein due
to the formation of appreciable amounts of reaction by-products which reduced
experimental yields, the poor adaption to scaling up the synthesis, and the resultant poor
cost efficiency using the cited method above.
Stock solutions of reduced glutathione (GSH; Sigma) and tris(2-carboxyethyl)
phosphine hydrochloride (TCEP-HCl; Thermo Scientific) were prepared gravimetrically
in Burdick and JacksonBrand® High Purity Solvent HPLC Grade water (BJ H2O).
Standardized concentrations of GSH free thiol (-SH) and of TCEP were determined using
recrystalized 5,5-dithio-bis(2-nitrobenzoic acid) (DTNB; Sigma) as per Riddles et al. (ε =
14 150 L*mol-1*cm-1 @ λAbs = 412nm) [19,20]. Stock solutions of 4,4-dithiopyridine (4DTP; Acros Organics) were prepared gravimetrically in BJ H2O, and solubilized by the
addition of 12 M HCl in small increments to an approximate final concentration between
20 and 30 mM [15]. Concentration of stock 4-DTP solutions were determined using
standardized GSH or TCEP solutions (described above) as per Riener et al. (ε = 21 400
L*mol-1*cm-1 @ λAbs = 324nm) using semi-micro acrylic cuvettes with 93 - 97% light
transmission between λ = 313 - 334 nm (Sarstedt) [15]. Stoichiometry of the GSH:4DTP reaction was found to be 1:1 as determined by titration of GSH against 4-DTP, with
reaction completion occurring within 10 min, consistent with previous findings[15].
Based on this data, in 50 mM sodium acetate pH 4.1, 1 mM GSH was reacted with 1.1
mM 4-DTP shaking at room temperature for 30 - 60 min to ensure complete reaction. As
a starting derivative, phenylisothiocyanate (PITC; Sigma) was used based on its intrinsic
absorption characteristics (λAbs = 254nm). Two stock solutions of 20.75 mM PITC were
prepared, by dilution, in different solvent mixtures, either 1:1 BJ H2O:pyridine (Sigma)
or 2:3:1 BJ H2O:pyridine:triethylamine (TEA; Sigma). Solvent pH was estimated with
pH paper and determined to by approximately 8.5 and 10 respectively. Serial dilutions of
each stock into their respective solvent were performed to produce a range of PITC
concentrations (1, 2, 3, 4, and 5 mM), with each being mixed 1:1 with the above GSH:4135

DTP mixture to result in molar ratios of 1:1 to 1:5 respectively. Each reaction was
performed in duplicate shaking at room temperature allowing for incubation of either 30
or 60 min. At time, reactions were quenched with a final concentration of 10 mM
ethanolamine (Sigma) for 30 min at room temperature shaking. Each reaction was
transferred to siliconized microcentrifuge tubes containing an equal volume of toluene,
mixed by vortex, centrifugally pulsed to collect the solution, then rotary evaporated for
30 min at 30 °C to remove the volatile toluene:pyridine azeotrope formed. This step is
repeated one time until all of the organic layer is gone, leaving a volume equivalent to
either the 1 part H2O or 2 parts H2O and 1 part TEA respectively, denoting that most of
the pyridine has been removed. Samples were characterized and analyzed on a Waters
nanoACQUITY ultra-performance liquid chromatography® (UPLC) system interfaced
into a Micromass Quattro-micro® electrospray ionization triple-quadrupole mass
spectrometer (ESI MS) fitted with a Waters nanoESI source as described below.

Analysis of PITC-CAD synthesis and thiol labeling ability
To characterize target PITC-CAD containing samples for both disulfide presence and
thiol labeling ability, samples were tested for thiol-dependent reactions. Stock solutions
of N-ethylmaleimide (NEM; Sigma) and L-cysteine (Cys; Sigma) were prepared
gravimetrically in BJ H2O, while standardized concentrations of Cys free thiol were
determined using a DTNB assay as described above. Solutions of 1.1 mM Cys were
prepared in 100 mM sodium acetate pH 4 or in 25 mM Tris-HCl pH 8 supplemented
with 10 mM N-ethylmaleimide. The latter was incubated at room temperature for 1 h in
the dark to block free thiols. Stock samples containing PITC-CAD were diluted 1:5 into
either buffer solution, 5 mM NEM, 5 mM TCEP, 5 mM TCEP then 5mM NEM, 100 µM
Cys-NEM or 100 µM Cys, incubated for 60 min at room temperature shaking in the dark,
then analyzed by LC/MS as described.
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Analysis and characterization of PITC-CAD reaction products by nanoLCMS/MS
Samples of synthetic PITC-CAD reactions were diluted 1:10 into 0.1% trifluoroacetic
acid (TFA; Thermo Scientific) in BJ H2O, transferred to total recovery, pre-slit
PTFE/silicone septa sealed, LectraBond capped, 12x32 mm glass screw neck vials
(Waters Corp.) and placed into the autosampler plate at room temperature.

The

nanoACQUITY UPLC® was equilibrated with 98% mobile phase A consisting of 0.1%
formic acid (FA; Thermo Scientific) in Optima® LC/MS grade water (Optima H2O;
Fisher Scientific) and 2% mobile phase B consisting of 0.1% FA in Optima® LC/MS
grade acetonitrile (Optima ACN; Fisher Scientific). Samples were injected onto a 180
µm x 20 mm x 5 µm Symmetry® C18 reverse phase nanoACQUITY UPLC trapping
column for 3 min at a flow rate of 5 µL/min under equilibration conditions. Samples
were then resolved on a 100 µm x 100 mm x 1.7 µm BEH®130 C18 reverse phase
nanoACQUITY UPLC analytical column over a 35 min linear gradient of 2 - 55% mobile
phase B at 300 nL/min. Timed-ion chromatograms and mass spectra were acquired on a
Waters Quattro-micro® nanoESI triple-quadrupole MS. Instrument settings varied based
on MS tune requirements for each mode of analysis with tune settings of the quadrupoles
being set for wide-range applicability across a diversity of biomolecules. For targeted
approaches, tune settings were determined empirically by continuous direct-injection of
molecule(s) of interest using the microESI source interfaced onto the above triplequadrupole MS. This practice is necessary to maximize sensitivity of the MS for the
target precursor and/or transition ion(s) during all MS applications. Settings for reverse
phase ultra performance liquid chromatography, MS scan, daughter scan, precursor ion
scanning and multiple reaction monitoring can be found in appendices [Appendix A].
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5.3 - RESULTS AND DISCUSSION

Research on biological thiols continues to reveal their expanding and diverse roles in
cellular homeostasis and physiology. Thus, there remains the need to develop improved
analytical tools for studying their functional state within the cellular milieu under both
normal and conditional states. Based on the preliminary efforts and ideas outlined by
Nielsen et al., we sought to initiate the synthesis of a CAD-based library of rapid, low pH
thiol labeling agents possessing multifaceted analytical properties, with our main focus
being MS-based detection [18]. In our first attempts, we adapted the current CAD
synthetic schemes, however found that the time and amount of processing, along with the
inherent chemistries within, promoted formation of appreciable amounts of reaction byproducts which reduced experimental yields of PITC-CAD. While this scheme produced
single isothiocyanate (ITC) modifications of GSSG, we sought the dually modified form
to double the yield of reaction product upon TCEP reduction [Fig. 5.1]. Moreover, to
purify differentially labeled species, we exploited their UV absorbance property along
with suspected differences among their protonated charge states.

Thus use of ion

exchange chromatography (IEC) as opposed to the original C18 RP-HPLC mode,
resulted in much larger injection and loading/binding capacities, which also offered ease
of scaling-up the synthesis in multiple downstream applications.
From our accounts, using this slightly modified approach, reaction of PITC with
GSSG yielded mixed populations of products over time. As hypothesized, these species
could be isolated and resolved by IEC; single amino-terminal modification was the
predominate product after 10 min reaction time and eluted first (~ 23 min), wheras dual
modification predominated after approximately 40 - 80 min under the given conditions,
eluting at higher salt concentration (~ 52 min) as expected [Fig. 5.2 and Fig. 5.3]. Upon
MS analysis, we observed the presence of additional molecules among each fraction in
addition to the singly or dually modified species, suggesting that appreciable amounts of
non-targeted side reactions may have occurred. Intriguingly, in the singly modified
fraction, the predominant contaminant was a measured 16 m/z less than the mass of the
PITC-modified GSSG (m/z = 746), whereas in the dually modified fraction, the
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Figure 5.1 - Synthetic scheme of isothiocyanate-cyclic activated disulfide reagents
using oxidized glutathione. In the first step of synthesis, one amino group of excess
GSSG reacts with an isothiocyanate derivative (ITC) to form ITC-GSSG. This product is
purified by RP-HPLC, followed by reduction of the disulfide bond by tris(2carboxyethyl)phosphine (TCEP) generating a free thiol in the glutathione moiety (GSH)
to form ITC-GSH. The free thiol is activated by 4,4'-dithiopyridine (4-DTP) forming
ITC-GS-4-TP whereby the disulfide is subsequently attacked by the thiol of the thiourea
to form the cyclic activated disulfide and release of 4-thiopyridone (4-TP). Adapted from
Nielson et al., Anal. Biochem., (2012) 421:1, 115-120.
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Figure 5.2 - Separation of phenylisothiocyante modified oxidized glutathione
derivatives by anion exchange chromatography. A) Reaction controls from synthetic
schemes according to Nielsen et al. were injected and separated to use as comparative
references. Reaction solvent (Blank), phenylisothiocyanate (PITC) without oxidized
glutathione (GSSG), PITC with GSSG immediately quenched with ethanolamine, and
GSSG without PITC were resolved by anion exchange chromatography. B) Synthetic
reactions of PITC with GSSG were quenched at 10, 40 or 80 min and resolved by anion
exchange chromatography. C) Structure and chemical characteristic of GSSG along with
gradient conditions used in separations. In all cases, absorbance at λ = 254 nm and
conductivity were monitored continuously. Conductivity of linear sodium chloride
(NaCl) gradient shown in red.
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Figure 5.3 - Mass spectra of differentially resolved fractions by anion exchange
chromatography. Synthetic reactions quenched at A) t = 10 and B) 80 min were
analyzed by liquid chromatography/mass spectrometry (LC/MS) as described in
'Experimental Procedures'.
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predominant contaminant was 32 m/z less than the target m/z = 881 [Fig. 5.3].
Upon further inspection, it was not surprising to find that these observed by-products
are quite reminiscent of products formed during the first step in the Edman degradation
reaction [21]. In this scheme, PITC first reacts with the amino terminus of a protein or
peptide under mildly organic alkaline conditions to form a phenylthiocarbamoyl (PTC)
adduct, which is then converted by both anhydrous and aqueous acids, and heat, to the
phenylthiohydantoin (PTH)-amino acid derivative used in analysis [Fig. 5.4]. En route
to formation of the PTH derivative, nucleophilic attack of the carbonyl carbon within the
first peptide bond is mediated by a formed thiolate resulting from tautomerization of the
PTC thiourea. Based on this, we suspect that due to the unique peptide bond formed in
GSH between the Cδ carboxylate of glutamate and the α-amino group of cysteine, the free
α-carboxyl group of glutamate is the target for nucleophilic attack and loss of an oxygen
(m/z = 16) in the form of water [Fig. 5.5A,B]. This is further supported by the evidence
of the y1 and y2 fragment ions at m/z = 76 and m/z = 177 of these reaction by-products,
which correspond to the intact α-amino acid glycine and dipeptide cysteine-glycine (CG)
respectively, as well as the fragment ion at m/z = 423 which is suspected to be a result of
breakage about the disulfide forming cyclic PITC-GSH [Fig. 5.5C]. Moreover, if a
similar reaction to that of Edman's degradation was occurring, one would expect the
unique GSH peptide bond would have to hydrolyze, resulting in decomposition of GSSG
which was not detected by LC/MS analysis under the given conditions [Fig. 5.3 and Fig.
5.5].
After the pioneering work by Edman, others had success in gaining sensitivity through
the use of fluoroscein-isothiocyanate (FITC) as their labeling agent in protein sequencing,
which in combination with data presented above, suggests that to some degree, Nielson et
al. likely saw similar yields of reaction by-products [18,22,23]. From these collective
conclusions and datasets, we governed a new synthetic scheme, which would act to
minimize not only potential side reactions, but also processing time and costs, while
maximizing purification yields of target CAD reagents. In reassessment of the original
synthetic scheme for CAD-based reagents, GSSG is modified with an ITC derivative
(ITC-GSSG), purified by analytical RP-HPLC, reduced with TCEP (ITC-GSH), then
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Figure 5.4 - Synthetic scheme of Edman's degradation. Phenylisothiocyanate (PITC)
first reacts with the amino terminus of a protein or peptide under mildly organic alkaline
conditions to form a phenylthiocarbamoyl (PTC) adduct. This is then converted by both
anhydrous and aqueous acids, and heat, to the phenylthiohydantoin (PTH)-amino acid
dervative used in analysis, being accomplished by nucleophilic attack of the carbonyl
carbon within the first peptide bond by a formed thiolate resulting from tautomerization
of the PTC thiourea. Adapted from Edman, P., Acta Chem. Scand., 4 (1950) 34.
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Figure 5.5 - Suspected route and structure of synthetic by-product formation during
phenylisothiocyanate reaction with oxidized glutathione. A) The unique peptide bond
formed in glutathione (GSH) leaves the free α-carboxyl group of glutamate proximally
located to the thiourea thiolate for nucleophilic attack and loss of an oxygen, as opposed
to attack of the carbonyl and hydrolysis of the amide bond. B) Proposed structure of the
synthetic by-product cyclic PITC-GSSG-PITC at m/z = 849. C) Tandem mass spectrum
(MS/MS) of synthetic by-product at m/z = 849 as analyzed by liquid
chromatography/mass spectrometry (LC/MS) described in 'Experimental Procedures'.
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reacted with 4-DTP to form a mixed disulfide between ITC-GSH and 4-thiopyridine (4TP, and thus ITC-GS-4-TP) [Fig. 5.1]. At this point, similar to the Edman degradation
reaction, it is thought that tautomerization of the ITC thiourea results in formation of a
thiolate capable of nucleophilic attack of the activated mixed disulfide, releasing this
efficient 4-TP leaving group, to spontaneously form the ITC-CAD reagent [Fig. 5.1].
Isothiocyanates can react not only with free amines, but also with sulfhydryls and
therefore, use of GSSG affords protection to reactive thiols from ITC-modifications by
means of a disulfide bond between two equivalents of GSH. Since the ITC-GSSG is later
reduced to ITC-GSH for subsequent reaction with 4-DTP, we presumed that the primary
reaction of GSH with 4-DTP would offer the same protection during a subsequent ITCmodification. Moreover, using this as starting material would presumably have multiple
benefits both synthetically and analytically. First, the stoichiometry of the reaction
between GSH and 4-DTP can be monitored by spectrophotometry, has been found to
occur rapidly in a 1:1 ratio at low pH, can be readily scaled-up to > 20 mM
concentrations and produces mixed disulfides with efficient leaving groups for
cyclization as well as chemically inert thio-ketone (thione) products [15]. In addition,
this inert product is incapable of further reaction during subsequent thiol or amine
modification steps, removing the requirement of a purification step prior to final product
formation. Secondly, this would also avoid GSSG and TCEP serving as reactants during
the synthesis, significantly reducing costs of both small and large scale applications.
Lastly, it is suspected that the PTC-adduct-like reaction by-products observed were a
result of kinetic reaction limitations involving the thiourea-based nucleophilic attack of
the activated ITC-GS-4-TP mixed disulfides [Fig. 5.1]. The length of processing time to
isolate and achieve this activated ITC-GSH-4-TP species would likely kinetically favour
attack of the neighbouring α-carboxyl group of glutamate in both ITC-GSSG or ITCGSH, resulting in irreversible consumption of the ITC thiolate, and thus, drastic reduction
of ITC-CAD yields. We hypothesize that use of the thiol-protected, pre-activated starting
material, GS-4-TP, would promote a kinetic battle between reaction of the nucleophilic
ITC thiolate and either the activated mixed disulfide or the α-carboxyl group of glutamate
[Fig. 5.6].
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Figure 5.6 - Modified synthetic scheme of isothiocyanate-cyclic activated disulfide
reagents using glutathione and 4,4'-dithiopyridine. In the first step of this modified
synthesis, glutathione (GSH) is reacted with 4,4'-dithiopyridine (4-DTP) to form GS-4TP. Next, an isothiocyanate derivative (ITC) is added to react with the free amino group
to form ITC-GS-4TP, with subsequent conversion to form either the desired cyclic
activated disulfide (ITC-CAD) and 4-thiopyridone (4-TP) or cyclic ITC-GS-4-TP and
water.

146

This modified CAD synthetic scheme, achieved rapid≤ (1.5 h) and relatively pure
synthesis of PITC-CAD (m/z = 441) in a two step process [Fig. 5.6 and Fig. 5.7].
Moreover, although some reactants and by-products were still observed, a far greater
proportion of target PITC-CAD reagent was generated [Fig. 5.7].

To begin

characterizing the reaction, we performed MS/MS analysis on some of the reactants and
products throughout the synthesis. The initial step involves reaction of GSH (m/z = 306)
with 4-DTP to form GS-4-TP (m/z = 417), where MS/MS analysis can differentiate
among these moieties based not only on their differing precursor ion masses, but also by
their uniquely characteristic fragment ion masses. Glutathione exists as a tripeptide with
the C-terminal dipeptide CG having the potential to serve as a multifaceted reporter ion
system as described above. Fragmentation of GSH results in a prominent y1 ion of m/z =
76 which corresponds to glycine denoting that the species analyzed is constructed of a
GSH molecule, while a detectable y2 ion of m/z = 177 corresponds to a CG dipeptide
denoting that the species contains a reduced thiol [Fig. 5.8A]. Interestingly, the GS-4-TP
sample gave a distinct fragment ion at m/z = 112 which was not observed for GSH. This
daughter ion is likely the result of fragmentation of the 4-TP (111 Da) disulfide bond, and
thus characteristic of 4-TP containing species [Fig. 5.8B]. Also observed were additional
fragment ions corresponding to the neutral loss/gain of sulfur as well as by an ion at m/z
= 288 denoting y2 + 4-TP, further suggesting that the GS-4-TP Cys was participating in a
disulfide bond [Fig. 5.8B].
Based on the observed fragment ion series [Fig. 5.6], the presence or absence of the
m/z 112 fragment ion should be useful to differentiate between the formation of an intact
ITC-CAD reagent versus an off-target reaction by-product. To confirm the use of these
fragments as characteristic reporter ions for analysis, we performed precursor ion
scanning (PIS) MS using either m/z = 76 or m/z = 112 as the target ion and found that the
former identified all GSH containing species, including PITC-CAD [Fig. 5.9A], whereas
the latter only identified 4-TP containing species in which PITC-CAD was not identified
[Fig. 5.9B]. Moreover, PIS MS of m/z = 112 was an order of magnitude more sensitive
than that of m/z = 76 under the given conditions, suggesting that 4-TP labeling may be a
suitable reporter ion for use in many diverse applications aimed at analysis of biological
thiols [Fig. 5.9]. Taken together, we feel that this simplified reaction scheme has
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Figure 5.7 - Mass spectral analysis of modified cyclic activated disulfide synthesis
products. A) Reaction products synthesized in water:pyridine:triethylamine at a 1:4 ratio
of activated glutathione (GS-4-TP) to phenylisothiocyanate (PITC) were analyzed by
liquid chromatography/mass spectrometry (LC/MS) as described in 'Experimental
Procedures'. B) Tandem mass spectrum (MS/MS) of synthetic PITC-cyclic activated
disulfide at m/z = 441 as analyzed by liquid chromatography/mass spectrometry (LC/MS)
described in 'Experimental Procedures'.
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Figure 5.8 - Tandem mass spectra of modified cyclic activated disulfide starting
materials glutathione and glutathione-4-thiopyridine. A) Glutathione at m/z = 306 and
B) glutathione-4-thiopyridine at m/z = 417 were analyzed by liquid
chromatography/tandem mass spectrometry (LC/MS/MS) as described in 'Experimental
Procedures'.
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Figure 5.9 - Precursor ion scanning mass spectra for characterizing cyclic activated
disulfide synthetic reaction products. Fragment ions at A) m/z = 76 and B) m/z = 112
were analyzed by liquid chromatography/precursor ion scanning mass spectrometry
(LC/PIS/MS) as described in 'Experimental Procedures'.
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improved the overall efficiency of CAD-based reagent production, providing a working
platform for continued development of a functionalized library of tailored reagents for a
variety of thiol-directed conjugation applications.
To utilize the CAD-based reagents as biological thiol labeling tools, they must possess
an intrinsic disulfide bond and also react with exogenous thiol-containing moieties
rapidly at low pH. Initially, to examine these properties, we took our unpurified reaction
mixture and treated it with either N-ethylmaleimide (NEM), TCEP, or TCEP followed by
NEM, and compared them to untreated reaction mixture. It was observed that treatment
with NEM alone had little effect on the target PITC-CAD precursor ion of m/z = 441 as
denoted by relatively no change in the timed ion chromatogram (TIC) selecting only m/z
441 +/-1 Da [Fig. 5.10A,B]. However, treatment with TCEP or TCEP and NEM resulted
in a drastic loss of signal, suggesting that TCEP reduction dissociated the PITC-CAD
disulfide bond, thus forming the linearized version which is an estimated +2 Da heavier
and misses the TIC mass window, while TCEP reduction followed by NEM treatment
formed the alkylated version of m/z = 568 [Fig. 5.10 C,D]. To confirm this hypothesis,
we monitored the TIC of m/z = 568 of PITC-CAD-NEM and it was observed that under
TCEP alone, no ions of this mass were readily detected [Fig. 5.11A]. However, in the
samples subsequently treatment with NEM, the formation of a dominant species at m/z =
568 was observed, confirming that PITC-CAD possesses an intrinsic, reactive disulfide
bond moiety and that synthesis was successful [Fig. 5.11B].

To note, dual NEM

modification was not observed to an appreciable amount, suggesting that tautomerization
prefers the thiourea form under these conditions.
Based on this data, a similar approach was utilized to determine if PITC-CAD was
capable of reacting with low molecular weight thiols such as L-cysteine (Cys). Again,
we took our unpurified mixture and reacted it with Cys-NEM or with Cys and analyzed
the products by LC/MS. We observed that reaction with Cys-NEM had very little effect
on PITC-CAD as the TIC of m/z = 441 did not significantly alter in comparison to that of
the starting material alone [Fig. 5.12A and Fig. 5.10A], and that the TIC of m/z = 562, a
PITC-CAD-Cys species was also not detected [Fig. 5.13A]. By contrast, reaction with
Cys resulted in a decrease in the m/z = 441 TIC [Fig. 5.12B] and an increase in the m/z =
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Figure 5.10 - Timed ion chromatograms of phenylisothiocyanate-cyclic activated
disulfide show sensitivity to reduction and alkylation. Unpurified reaction mixture
containing phenylisothiocyanate cyclic activated disulfide (PITC-CAD) was reacted with
A) water, B) N-ethylmaleimide (NEM), C) tris(2-carboxyethyl)phosphine (TCEP) and D)
TCEP then NEM. Samples were analyzed by liquid chromatography/mass spectrometry
(LC/MS) as described in 'Experimental Procedures', with data representing the timed ion
chromatograms of m/z = 441 to detect the loss of PITC-CAD.
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Figure 5.11 - Timed ion chromatograms of phenylisothiocyanate-cyclic activated
disulfide show a positive reaction upon reduction and alkylation with Nethylmaleimide. Unpurified reaction mixture containing phenylisothiocyanate cyclic
activated disulfide (PITC-CAD) was reacted with A) tris(2-carboxyethyl)phosphine
(TCEP) or B) TCEP then N-ethylmaleimide (NEM). Samples were analyzed by liquid
chromatography/mass spectrometry (LC/MS) as described in 'Experimental Procedures',
with data representing the timed ion chromatograms of m/z = 568 to detect the formation
of PITC-CAD-NEM.
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Figure 5.12 - Timed ion chromatograms of phenylisothiocyanate-cyclic activated
disulfide show sensitivity to reduced cysteine not alkylated cysteine. Unpurified reaction
mixture containing phenylisothiocyanate cyclic activated disulfide (PITC-CAD) was
reacted with A) cysteine alkylated with N-ethylmaleimide (NEM) or B) cysteine.
Samples were analyzed by liquid chromatography/mass spectrometry (LC/MS) as
described in 'Experimental Procedures', with data representing the timed ion
chromatograms of m/z = 441 to detect the loss of PITC-CAD.
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562 TIC [Fig. 5.13B], as would be expected for a positive reaction between PITC-CAD
and Cys. Upon MS/MS analysis, it was confirmed that an intact PITC-CAD-Cys species
was formed, being linked through a disulfide bond, exemplifying the ability of PITCCAD to react rapidly at low pH with thiol containing biomolecules [Fig. 5.13C].
Furthermore, from the MS/MS data, formation of a y2 + Cys ion at m/z = 298 suggests
that it is the Cys thiol from GSH forming the mixed disulfide with free Cys, not that of
the ITC thiourea, which also suggests that it is the GSH Cys that NEM is modifying in
the characterizations discussed above [Fig. 5.13C and Fig. 5.11B]. These observations
suggested that, similar to the prototypical FCAD described by Nielsen et al., PITC-CAD
was also effective in rapidly labeling thiols at low pH. Moreover, the ability of these
reagents to form reversible disulfide linkages also highlights their versatility for a wide
variety of thiol-based applications.
From these observations, we have begun to define both the minimal and optimal
reaction characteristics involved in formation of CAD-based reagent design. Although
the inaugural scheme involved use of GSH derivatives as a starting material building
block, our data suggests that the unique peptide bond formed by glutamate hampers the
effective yield of target CAD-reagents. Using a generic peptide moiety may afford less
off target reactions, as the neighbouring α-carboxylate will no longer be adjacent to the
thiourea for attack, but found opposite to the ITC reactive N-terminus, at the peptides
extreme C-terminus. With this, the longer the peptide chain, the farther the C-terminal
carboxylate will be from the reactive thiolate granted no intrinsic glutamic or aspartic
acid (Glu or Asp) residues are located within the primary sequence. Simple synthesis of
peptides increasing in size will define the spatial limits of reactivity, and provide insight
to the minimally optimal size of peptide for such reactivity, after which Glu and Asp
residues could be added with no potential side reaction susceptibility.

Similarly,

sequential placement of a Cys residue throughout a series of synthetic peptides would
allow for definition of the spatial reactivity limits of the ITC thiourea thiolate in forming
the cyclic disulfide. Knowledge of such reaction constraints would allow 'tuning' of
CAD-based reagents through manipulation of the primary sequence of the peptide, the
ability to impose chemical reactivity past the minimal spatial limits of ITC thiolate, and
through functional derivatization of the ITC reagent [Fig. 5.14].
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Figure 5.13 - Timed ion chromatograms of phenylisothiocyanate-cyclic activated
disulfide show a positive reaction with reduced cysteine not alkylated cysteine.
Unpurified reaction mixture containing phenylisothiocyanate cyclic activated disulfide
(PITC-CAD) was reacted with A) cysteine alkylated with N-ethylmaleimide (NEM) or B)
cysteine. Samples were analyzed by liquid chromatography/mass spectrometry (LC/MS)
as described in 'Experimental Procedures', with data representing the timed ion
chromatograms of m/z = 562 to detect the formation of PITC-CAD-Cys. C) PITC-CADCys at m/z = 562 was analyzed by liquid chromatography/tandem mass spectrometry
(LC/MS/MS) as described in 'Experimental Procedures'.
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Figure 5.14 - Theoretical model of the minimal and optimal reaction characteristics
involved in the formation of CAD-based reagent design. Reaction constraints would
allow 'tuning' of CAD-based reagents through manipulation of the primary sequence of
the peptide (R1, R2, R3 etc.), the ability to impose chemical reactivity past the minimal
spatial limits of ITC thiolate (Y), and through functional derivatization of the ITC reagent
(X).
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Future work will involve purifying PITC-CAD and other CAD-based reagents with
varying X group [Fig. 5.14] sterics using IEC as described above. As the pKa of the
pyridine tertiary amine is ~ 5.01, approximately 60 - 70% of it would be protonated at pH
5 [15], and thus, separating target CAD (-2 @ pH 5) from reaction by-products such as
cyclic-ITC-GS-4-TP (~ -0.5 @ pH 5) should be attainable. Furthermore, based on the
striking resemblance of a thiol-bound CAD reagent to GSH, we have begun to use αGSH antibodies in non-reducing immunoblotting as a complimentary screening method
during CAD reagent design, and also to test the potential of these reagents for use in
alternative analytical readouts. Ultimately, once reaction characterization is complete,
we aim to make isotopic versions of CAD library reagents for relative, and potentially
absolute, quantification of reactive thiols by MS. In another application, we have begun
to attempt immobilization of CAD reagents to isothiocyanate-activated polystyrene resin.
Immobilized versions of CAD reagents would allow for reactive thiol enrichment and
reductive elution, and since polystyrene has better resin swelling capacity in organic
solvents such as acetonitrile, this application should readily interface into MS-based
modes of analysis.
One unexpected finding was the ability of 4-TP labeled molecules to readily
decompose during MS/MS to form a fragment ion of m/z = 112 [Fig. 5.8].

This

suggested that any 4-TP labeled thiols within a complex mixture could be identified by
targeted MS modes such as PIS MS using this m/z = 112 reporter ion [Fig. 5.9]. We feel
that this feature will be very powerful to study biologically relevant thiols in vivo, due to
the ability to attain orders of magnitude higher sensitivity using targeted approaches. As
described above and by others, this molecule has an abundance of unique properties
which make it a very suitable redox-active thiol labeling agent, such as low pH labeling
capabilities and inert thione products to name a few [15,16]. Currently the 'gold standard'
of monitoring cellular redox homeostasis involves use of this molecule, and can achieve
approximately 5 pmol sensitivity through monitoring 4-TP absorbance [14,17].
However, stand-alone, this can not discriminate among many thiol containing moieties
within a complex mixture. Replacement of spectrophotometry with targeted quantitative
MS will likely improve sensitivity, and offer the ability to identify and monitor many
distinct thiol modifications in a given LC/MS run. Nonetheless, our results to date
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suggest that this scheme will afford the increased sensitivity, and throughput described,
perhaps adding another 'tunable' tool for studying the growing field of cellular thiol redox
regulation.
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CHAPTER 6 - PHOSPHORYLATION-DEPENDENT ENDOSOMAL
TARGETING OF THE PI(3)P PHOSPHATASE MTMR2 IS MEDIATED BY AN
ERK1/2 NEGATIVE FEEDBACK MECHANISM AND IS REGULATED
THROUGH INDIRECT INFLUENCES ON THE PH-GRAM DOMAIN

6.1 - INTRODUCTION
Although the majority of protein tyrosine phosphatases (PTPs) target phosphotyrosinecontaining proteins as substrates, the active myotubularin (MTM) family members
instead dephosphorylate lipid second messengers phosphoinositides (PI(3)P and
PI(3,5)P2) [1-4].

These phosphatidylinositol phosphates mainly reside in endocytic

structures, having key roles in membrane targeting, vesicular trafficking, and regulation
of signal transduction pathways through recruitment and interactions with distinct
signaling proteins containing appropriate phosphoinositide-binding module(s) [5-7]. The
importance in regulating phosphorylation of phosphoinositides (PIPs) is highlighted by
the discovery that loss of function mutations in three mtmr genes have been associated
with distinct neuromuscular disorders [8-10].

For example, the gene encoding

myotubularin-related 2 (MTMR2) is mutated in Charcot–Marie-Tooth (CMT) disease 4B,
an autosomal recessive demyelinating disorder, characterized by abnormally folded
myelin sheaths, inadequate nerve signaling to muscles, and eventual muscle weakness
and atrophy [8].
Despite the identification of cellular substrates, elucidation of the three-dimensional
crystal structure [11,12], and the well established pathophysiological consequences
resulting from loss of MTMR2 function, how MTMR2 actively participates in vesicular
trafficking remains poorly understood.

Discovering roles for MTMR2 among these

events has been further confounded due to the observations that under typical cell culture
conditions this enzyme is not widely localized to substrate-rich endosomal structures
containing PI(3)P and PI(3,5)P2 even though it possesses a domain thought to be capable
of associating with PIPs [11-18].

Recent evidence from our laboratory has begun

deciphering this anomaly, in which we have identified a prominent phosphorylation site
at Ser58 that dramatically regulates MTMR2 endosomal localization, and thus access to
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its lipid substrates [14].

Using phosphomimetic mutagenesis, we observed that a

phosphorylation deficient variant (MTMR2 S58A) strongly co-localizes with substraterich, Rab5-positive endocytic vesicles, resulting in depletion of PI(3)P, mis-localization
of PI(3)P binding proteins [19], and an increase in growth factor receptor signaling
pathways, most notably activation of the extracellular signal-regulated kinases 1 and 2
(ERK1/2) [14]. Furthermore, our mass spectrometry analysis suggested that MTMR2
Ser58 phospho-levels may be constitutively high under normal cellular growth
conditions, offering an explanation as to the lack of discernable co-localization with
substrate-rich vesicles under these conditions. Moreover, since catalytic activity and
hetero-dimerization with its inactive partner, MTMR5, were found to be independent of
the phospho-status of Ser58, reversible phosphorylation may regulate the endosomal
targeting of MTMR2, and thus its physiological catalytic activity through an allosteric
mechanism. This has provided valuable insight to the regulated control of cellular PIP
levels through direct influences on the spatial and temporal control of PI(3)P
phosphatases. However, the exact mechanism of MTMR2 phosphorylation-dependent
localization, identification of the responsible kinase(s), and the resultant effects on
distinct membrane targeting, vesicular trafficking, and regulation of signal transduction
pathways remains to be elucidated.
Although phosphoinositides are commonly regarded as membrane association cues
targeting peripheral proteins to cellular membranous surfaces, it is becoming increasingly
clear that additional interactions function in unison with PIP recognition to regulate
membrane association of PIP-binding proteins [20].

As PIP-binding domains are

notoriously low-affinity modules that commonly utilize basic residues for directed
association with target PIPs [5,6,18], the combination of PIP-binding with that of a
secondary signal (i.e. oligomerization, co-operative binding, multiple domains or binding
sites etc.) not only stabilizes interactions, it also affords a far greater diversity of
regulatory control over signal manipulation than that achieved through PIP levels alone
[18,20]. Many mechanisms of this multivalent avidity-based membrane association exist,
being commonly referred to as co-incidence detection [18,20].

One such pertinent

example is that of Rab5 and Early Endosomal Antigen 1 (EEA1). The Rab5 GTPase is a
master coordinator of early endosome maturation events including homotypic early
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endosome fusion as well as heterotypic early to late endosome fusion [21,22]. Rab5
collaborates with numerous peripheral PIP-binding proteins to facilitate fusion of
endosome membranes, including Rab5 effectors whose targeting requires association
with endosomal PI(3)P [23-26].

The critical endosomal effectors Rabenosyn-5 and

EEA1 are essential tethering factors during fusion which require association with Rab5
and PI(3)P simultaneously to stably localize at early endosomes, exhibiting a direct role
for endosomal PI(3)P levels in governing proper vesicular trafficking outcomes [24-26].
Taken together, this low affinity, multivalent mode of regulation defines a highly plastic
system, exhibiting dynamic instability which allows for rapid re-modeling in response to
fluctuations in the level of PIPs and/or secondary signals [20]. In combination with the
influences of PI kinases and phosphatases, this can readily translate into pronounced
effects on the membrane associations and functions of PIP-binding proteins, to ultimately
give rise to greater spatial and temporal regulation of phosphoinositide-mediated cellular
processes.
An excellent example of cellular integration amongst these tiers of layered co-incident
regulation involves the recent evidence that endosomes rich in the adaptor protein
containing a pleckstrin homology domain, phosphotyrosine binding domain (PTB) and a
leucine zipper motif (APPL1) represent a critical stage during attenuation of receptor
signaling and initiation of early endosome maturation. APPL1 is another Rab5 effector
complex, which directly binds Rab5, but also to the lipid bilayer through both membrane
and PIP-binding domains, as well as to the cytosolic tail of plasma membrane receptors
through a PTB domain [27-31]. It has been demonstrated that when PI(3)P is depleted
using the PI(3)K inhibitor wortmannin, Rab5/EEA1-positive early endosomes are
converted to Rab5/APPL1-positive early endosomes. Interestingly, the Rab5/APPL1
endosomes displayed a delay in endosomal maturation and an enhanced endosomal
growth factor signaling capability [32]. In addition to functioning as a Rab5 effector and
as a regulator of endosomal signaling, APPL1 serves as a stage marker for proximal early
endosomes [33]. The shedding of APPL1 as vesicles move centrally coincides with
increased levels of PI(3)P, recruitment of EEA1, and subsequent maturation into the
canonical PI(3)P/Rab5-positive endosomes [32,34]. Since APPL1 vesicles are known to
play a functional role in the assembly of signaling complexes for mitogen activated
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protein kinase (MAPK) and protein kinase B (Akt) pathways [29,35,36], increased levels
of PI(3)P act as a molecular switch to turn off growth factor endosomal signaling through
the simultaneous loss of APPL1 on these endosomes [32]. Taken together, regulation of
endosomal PI(3)P levels represents a fundamental aspect in achieving proper homeostasis
of vesicular trafficking and receptor signaling through the orchestration of a vast array of
effector molecules possessing dynamic PIP binding domains.
Here, using in vitro kinase assays, cellular MAPK inhibitors, siRNA and an in-house
generated phosphospecific-Ser58 antibody, we now provide evidence that ERK1/2 are
kinases capable of phosphorylating MTMR2 at position Ser58.
hydrogen-deuterium

exchange

mass

spectrometry,

Furthermore, using

co-immunoprecipitation

and

immunofluorescence we have identified candidate residues within the putative PIPbinding

domain

of

MTMR2

potentially

involved

in

regulating

endosomal

localization/association through transient and competitive interactions between both
phospho-Ser58 and membrane components. This strongly suggests that the endosomal
targeting of MTMR2 may be regulated through a phospho-dependent, ERK1/2 negative
feedback mechanism, which is mediated structurally through indirect influences on the
PIP-binding domain of MTMR2. Moreover, we have identified that Ser58 is the master
regulator of endosomal localization, whereas another phosphorylation event at Ser631
regulates shuttling of MTMR2 between Rab5/PI(3)P-rich and APPL1 endosomal
subtypes in a MAPK-dependent manner [37]. Taken together, our results highlight
multiple tiers of functional regulation among cellular activities involving PIPs through
direct influences of the receptor-mediated MAPK signaling pathway on PI phosphatases.
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6.2 - EXPERIMENTAL PROCEDURES
Plasmids, cell culture and transfections
The synthesis of pCDNA3.1-NF and pET21a vectors containing wild type and mutant
FLAG-MTMR2 or MTMR2-His6 constructs have been previously described [2,14].
Generation of mutant variants were performed using PCR based site-directed
mutagenesis. The forward and reverse primers for the generation of mutant variants are
as

follows;

K137A

forward,

GATAAATAGAGTAGAAGCAATTGGTGGTGCTTCTAG-3',
CTAGAAGCACCACCAATTGCTTCTACTCTATTTATC-3';

reverse
R172A

CCTGAGGGGCGGACAGCAAGATCCATATTTGAG-3',
CTCAAATATGGATCTTGCTGTCCGCCCCTCAGG-3';

R173A
E199Stop

CCCATTTTCAGGGAATACTTATTTGTATTCAAAAGC-3'.
constructs

S58A/K137A/R172A/C417S,

generated

include

forward,
reverse

GCTTTTGAATACAAATAAGTATTCCCTGAAAATGGG-3',
FLAG-MTMR2

forward,

reverse

GAGGGGCGGACAAGAGCATCCATATTTGAGAATC-3',
GATTCTCAAATATGGATGCTCTTGTCCGCCCCTC-3';

5'-

reverse

5'5'5'5'5'5'-

The pCDNA3.1-NF

K137A/R172A,

S58A/K137A/R173A/C417S,

forward,

5'-

K137A/R173A,
S58A/E199Stop,

S58E/E199Stop, and were verified by DNA sequencing (ACGT Corp. and Bio Basic
Inc.). The human cell culture lines HEK293 (ATCC) and HeLa (ATCC) were cultured as
a monolayer and maintained at 37 °C with 5% CO2 in Dulbecco’s modified Eagle’s
medium (DMEM; Sigma) containing 10% (v/v) fetal bovine serum (Gibco), 2 mM Lglutamine (Sigma), supplemented with antibiotics (100 units/ml of penicillin, 100 µg/ml
of streptomycin; Sigma). For transient transfection, cells were seeded into antibiotic-free
medium 24 h prior to transfection, then transfected using FuGENE® HD (Roche Applied
Sciences) at a FuGENE:DNA ratio of 3:1 as per manufacturer's protocol. HEK293 cells
were selected for reproducible transfection efficiency in immunoprecipitation
experiments, while HeLa cells were utilized for immunofluorescence microscopy studies
to better resolve endosomal compartments.
generous gift from Harald Stenmark [38].
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The pEFGP-2xFYVE construct was a

Cell lysis, immunoprecipitation, immunoblotting and immunofluorescence
At time of lysis, cells were washed 1x with ice-cold HyClone® phosphate buffered
saline (PBS; Thermo Scientific) then collected using a rubber scraper and lysed in icecold lysis buffer (50 mM Tris-HCl, pH 7.4, 1% Triton X-100, 150 mM NaCl, 0.1% SDS,
1 mM EDTA, 2.5 mM NaF, 2.5 mM β-glycerophosphate, 1 mM PMSF, 10 µg/mL
aprotinin) by pipetting. Lysates were cleared by centrifugation at 15 000 x g for 15 min
at 0 °C and protein concentration determined by Bradford assay (Bio-Rad). Lysates were
prepared for SDS-PAGE and immunoblot (IB) analysis by the addition of 6x SDS-PAGE
loading dye (final concentration of 1x) and boiling at 95 °C for 5 min. Proteins were
resolved by 10% SDS-PAGE followed by transfer to polyvinylidene flouride membrane
for immunoblot analysis. Immunoblots were routinely processed using Tris-buffered
saline supplemented with Tween-20 (25 mM Tris-HCl pH 7.4, 137 mM NaCl, 2.5 mM
KCl, 0.1% Tween 20; TBST) containing BSA for probing with phospho-antibodies or
skim milk for all other antibodies. Prior to probing targets, membranes were blocked in
either 5% BSA or skim milk, respectively. All primary antibody incubations were done
overnight at 4 °C, while all secondary antibody incubations were done for 1 h at room
temperature, both done under gentle platform rocking. For immunoprecipitation (IP),
equal amounts of lysate, as per Bradfords assay, were loaded on the respective antibodyconjugated agarose support as described below. For immunofluorescence analysis (IFA),
HeLa cells were pre-treated, fixed, permeabilized, immuno-stained and imaged as
previously described [14] and as described below. Prior to probing targets, cells were
blocked with 5% BSA/TBST, while all primary antibody incubations were done in 1%
BSA/TBST for 1 h at room temperature under gentle rotation. All secondary antibody
incubations were done in 1% BSA/TBST for 1 h at room temperature, in the dark, under
gentle rotation.

Production of MTMR2 Ser58 phospho-specific antibody
The target peptide epitope was synthesized (NEO BioScience), resuspended in
conjugation buffer (100 mM NaPO4, 150 mM NaCl, 5 mM EDTA, pH 7.3), reduced with
immobilized TCEP (Pierce Biotechnology) and conjugated to maleimide-activated
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Keyhole Limpet Hemocyanin (Pierce Biotechnology) through an engineered thiol
terminal.

The formulated carrier was then used for immunization of Gallus gallus

(Amicus Biotech Inc.).

Purified polyclonal chicken IgY was isolated by the water

dilution method [39], where chicken anti-pSer58 MTMR2 IgY antibodies were isolated
sequentially by subtractive affinity chromatography against non-phophosphorylated and
phosphorylated peptide epitopes immobilized on iodoacetamide-activated agarose (Pierce
Biotechnology) conjugated similarly to that described above. Antibody specificity was
tested against both MTMR2 peptide and protein epitopes by standard dot and
immunoblot procedures. Briefly, peptides or FLAG-MTMR2 immunoprecipitates (as
described below) were resuspended in 50 mM Tris-HCl pH 9.3, 1 mM MgCl2, 0.1 mM
ZnCl2 and treated with or without 2.5 U of calf intestinal alkaline phosphatase (Promega)
for 4–6 hours at 25 °C shaking, then spotted on nitrocellulose (peptide dot blot analysis)
or prepared for immunoblotting. Alkaline phosphatase activity was monitored using
matrix-assisted laser desorption ionization mass spectrometry as previously described
[Appendix B] [40]. Membranes were probed with chicken anti-pSer58 MTMR2 IgY at
1:1000 (0.7 µg/µl stock) in 2.5% BSA TBST, washed, then probed with donkey antichicken IgY-HRP conjugate at 1:3000 (Gallus Immunotech) in 2% BSA/TBST for
subsequent chemiliuminescent imaging. Detailed characterization of antibody synthesis,
isolation, purification and characterization can be found in the appendices [Appendix
B,D].

In vitro kinase assay
In vitro kinase assays were performed using 5 µg of bacterial recombinant MTMR2His6 proteins purified as described previously [41]. In this study, the activated kinases
ERK1, ERK2, p38a, JNK1 (Signal Chem) were tested with all assays being carried out in
reaction buffer (25 mM HEPES, pH 7.2, 12.5 mM β-glycerol phosphate, 25 mM MgCl2,
5 mM EGTA, 2 mM EDTA, 0.25 mM DTT) containing 200 µM ATP and 100 ng of the
specified kinase. Reactions were incubated shaking at 30 °C for 30 minutes, terminated
with 2x SDS-PAGE loading dye and prepared for immunoblotting as described above.
Protein substrate (20 ng) was probed with chicken anti-pSer58 MTMR2 IgY (as above),
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rabbit anti-MAPK (Sigma) at 1:10,000 in 1% skim milk/TBST, rabbit anti-p38 (Cell
Signaling) at 1:1000 in 5% BSA/TBST, rabbit anti-JNK1 (Santa Cruz Biotechnology) at
1:1000 in 2.5% BSA/TBST and mouse anti-MTMR2 (Santa Cruz Biotechnology) at
1:1000 in 1% skim milk/TBST. Membranes were then probed with donkey anti-chicken
IgY-HRP conjugate (as above), goat anti-rabbit IgG-HRP conjugate (Bio-Rad) or goat
anti-mouse IgG-HRP conjugate (Promega), both at 1:5000 in 2.5% skim milk/TBST for
subsequent chemiluminescent imaging.

Cell treatment with kinase inhibitors
HEK293 or HeLa cells were transfected with FLAG-MTMR2 as described above and
treated with a JNK inhibitor (SP600125; LC laboratories) at 40 µM for 1 hour, a p38
inhibitor (SB203580; LC laboratories) at 20 µM for 30 minutes or a MEK inhibitor to
inhibit ERK1/2 activation (U0126; LC laboratories) at 50 µM for 1 hour.

For

phosphorylation studies, cells were first serum starved for 30 minutes followed by preincubation with U0126, then subsequently stimulated with EGF (5 ng/ml) for 5 or 30
minutes.

Cells were lysed as described above and samples purified by FLAG-

immunoprecipitation for 3 h rotating at 4 °C using anti-FLAG agarose (Sigma). Resin
was washed 3x with IP wash buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 0.1% SDS,
0.1% Triton X-100), eluted with 4x loading dye, resolved by SDS-PAGE and subjected
to immunoblot analysis. Immunoblots were probed with chicken anti-pSer58 MTMR2
IgY (as above), PathScan® Multiplex Western Cocktail I (Cell Signaling) at 1:200 in 5%
BSA/TBST, rabbit anti-MAPK IgG (as above), mouse anti-FLAG IgG (Sigma) at 1:3000,
and rabbit anti-actin IgG (Sigma) at 1:1000, all in 2.5% skim milk/TBST. Secondary
antibodies included donkey anti-chicken IgY-HRP conjugate, goat anti-mouse IgG-HRP
conjugate or goat anti-rabbit IgG-HRP conjugate, with membranes being probed as
described above.

Data was quantified by densitometry from n = 3 independent

experiments using ImageJ, and normalized to FLAG-IP levels. For immunofluorescence
studies, cells were prepared as described above and probed with mouse anti-FLAG IgG
(Sigma) at 1:500, rabbit anti-Rab5 IgG (Santa Cruz) at 1:80, rabbit anti-Rab7 IgG
(Sigma) at 1:100 and rabbit anti-APPL1 IgG (Santa Cruz) at 1:80, as described above.
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Secondary antibodies for visualization included goat anti-mouse IgG-Alexa Fluor 568
conjugate (Molecular probes) at 1:500 and goat anti-rabbit IgG-FITC conjugate (Vector
Laboratories) at 1:500 as described above. Images were acquired with a Zeiss Axiovert
200M inverted fluorescent microscope with FITC/TRITC/DAPI filter cubes and a LD
Plan-APONeofluar 636 0.75 or EC Plan-Neofluar 406 1.3 oil objectives equipped with
103061300 monochrome CCD camera (Axiovision MRM). Captured pictures from both
microscopes were processed with Northern Eclipse software 6.0 (Empix, Mississauga,
ON) with contrast/brightness and exposure image corrections performed using program
processing application software in addition to Adobe Photoshop 7.0.

siRNA treatment and serum starvation
HEK293 or HeLa cells were seeded into antibiotic-free medium 24 hours prior to
transfection with either 35 nM SignalSilence® control siRNA or SignalSilence® p44/42
MAPK (ERK1/2) siRNA (Cell Signaling Technology) using Lipofectamine®
RNAiMAX transfection reagent (Invitrogen) as per manufacturers protocol. Cells were
also left untransfected with siRNA as a comparative control for probing of Ser58
phosphorylation in response to ERK1/2 knockdown. After 30 hours, both siRNA treated
and untreated cells were transfected with either FLAG-MTMR2 or FLAG-MTMR2 S58A
and incubated for another 30–36 hours.

Cells were moved into low (0.5%) serum

containing medium for another 6–10 hours, followed by a short serum starvation and 10
minute EGF stimulation as described below. Cells were also left untransfected for
probing of endogenous MTMR localization and Ser58 phosphorylation in response to
serum starvation.

Cells were then prepared for immunofluorescence microscopy as

described below, or washed, lysed and prepared for immunoprecipitation and/or
immunoblot analysis as described above. For endogenous immunoprecipitation, equal
amounts of lysate were added to mouse anti-MTMR2 IgG (Santa Cruz Biotechnology)
immobilized on protein-A agarose (Thermo Pierce;Invitrogen).

Precipitation was

allowed to go for approx. 6–8 h, nutating at 4 °C. Resin was washed and prepared for
immunoblot analysis similar to that described above for FLAG-immunoprecipitates.
Quantitative immunoblotting of both siRNA and serum starvation experiments was
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performed using chicken anti-pSer58 MTMR2 IgY at 1:200 in 2.5% BSA/TBST, mouse
anti-MTMR2 IgG at 1:1000 in 2.5% skim milk/TBST, mouse anti-FLAG IgG (as above),
rabbit anti-phospho-p44/p42 MAPK IgG at 1:200 (pThr20pTyr204 ERK1/2; Cell
Signaling) in 2.5% BSA/TBST, rabbit anti-MAPK (as above), and rabbit anti-actin IgG
(as above). Secondary antibodies included donkey anti-chicken IgY-HRP conjugate, goat
anti-mouse IgG-HRP conjugate or goat anti-rabbit IgG-HRP conjugate, with membranes
being probed as described above. Acquired chemiluminescent images from at least n = 3
independent experiments were quantified through densitometry using ImageJ (NIH,
http://imagej.nih.gov/ij). Resulting data was normalized to its respective actin loading
control and subjected to either a one-way ANOVA with Tukey’s post test or a two-tailed,
unpaired t-test statistical analysis both with 95% confidence intervals for relative
comparison of related proteins (ie. ERK1/2 versus pERK1/2 and FLAG-MTMR2 versus
FLAG-MTMR2 pSer58) using GraphPad Prism version 4.0 for Windows, GraphPad
Software, San Diego, California, USA, www.graphpad.com. Relative comparison among
all experimental and control samples was performed, with significance differences among
data sets being denoted by at least *P < 0.05. Data are represented as the mean value +/s.e.m. Immunofluorescence of siRNA experiments were performed with rabbit antiphospho-p44/p42 MAPK IgG (pThr20pTyr204 ERK1/2; Cell Signaling Technologies) at
1:50 and mouse anti-FLAG IgG (as above), using goat anti-rabbit IgG-Alexa Fluor 568
conjugate (Molecular Probes, Invitrogen) and horse anti-mouse IgG-Fluoroscein
conjugate (Vector Laboratories) secondary antibodies at 1:500 as described above.
Immunofluorescence of endogenous experiments were performed with rabbit antiMTMR2 IgG (a generous gift from Gregory S. Taylor; University of Nebraska) at 1:50
and mouse anti-Rab5 IgG (BD BioSciences) at 1:50, using goat anti-rabbit IgG-FITC
conjugate and goat anti-mouse IgG-Alexa Fluor 568 conjugate as described above.
Microscopy image analysis and acquisition is as described below.
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Hydrogen-deuterium exchange mass spectrometry
Methods of analysis and data interpretation herein were devised based on the merger
of multiple previously described techniques and reviews to obtain optimal accuracy
throughout sample handling and data acquisition [12,42-50].

Bacterial recombinant

MTMR2-His6 and MTMR2 S58E-His6 were purified as previously described [41]. Equal
amounts of protein were desalted using Zeba™ Desalting spin columns (Pierce
Biotechnology), as per manufacturer's instructions, into 20 mM Tris-HCl pH 7.4, 50 mM
NaCl, 1 mM DTT, 20% glycerol. To initiate deuterium exchange, protein was diluted 1:9
in similar buffer (20 mM Tris-HCl pD 7.0, 50 mM NaCl) constituted in deuterium oxide
(D2O; Sigma). Buffer pD was adjusted with NaOD (Sigma) and measured with a glass
electrode as described by Glasoe et al [51]. Buffer pH values were measured against
three-point calibration curves using the appropriate pH standard solutions (pH 1, 4, 7, and
10; Fisher Scientific). All subsequent steps were performed in a walk-in cold room
(approx. 4 °C) where all plasticware was pre-chilled for at least 12 h, and all
samples/solutions pre-chilled and kept in a circulating ice bath at 0 °C. At defined times,
exchange was quenched by 1:1 dilution with quench buffer (500 mM NaPO4 pH 2.25,
1.71 M Gdn-HCl), rapidly digested using immobilized pepsin (Pierce Biotechnology)
previously activated by washing 2x with quench buffer.

Sample digests were

immediately bound to ZipTip® C18 reverse-phase pipette tips (Millipore) for
concentration and desalting, eluted in 65% acetonitrile/water containing 0.1%
trifluoroacetic acid, and spotted 1:1 with α-hydroxycinnamic acid matrix (Pierce
Biotechnology), constituted in elution buffer, by the dried-droplet method. Just prior to
spotting, a room-temperature stainless steel target plate was placed under a gentle stream
of pre-chilled (4 °C) N2(g) to rapidly chill the metal spots. Pre-chilling target plates (0 - 4
°C) for extended time periods causes condensation to form on plates within MALDI
sources during data acquisition, and has been shown to adversely affect back-exchange
during analysis, thus resulting in both instrumental and experimental concerns [45].
Spots were rapidly dried under the gentle stream of pre-chilled N2(g) and samples were
immediately analyzed on an Applied Biosystems delayed extraction (DE PRO) matrix
assisted laser desorption ionization-time of flight mass spectrometer (MALDI-TOF MS)
in both linear and reflector acquisition modes. Eight spectra were collected from each
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sample (ie. each time point) and this acquired data was calibrated against Sequazyme™
peptide mass standards kit (Applied Biosystems) over an average isotopic m/z range of
905.05 - 5734.59. Extracted average isotopic m/z values from each individual spectra
were graphically represented as collective average values and fit to a one-site binding
curve using graphpad prism (details above).

Primary sequence elucidation was

determined by exact mass matching and/or tandem MS using post-source decay as
previously described [40,52]. Peptide masses of putative pepsin digestion products were
identified with the aid of an in-house generated mathematical matrix capable of
calculating every possible peptide mass upon hydrolysis at every combination of peptide
bond(s). Further described details can be found in the appendices [Appendix C]. Further
confirmation of peptide ID was obtained using nanoLC/MS/MS on an ion trap MS, with
a collective sequence coverage of ~65% under the given data analysis conditions.

Epitope availability immunoprecipitation
HEK293 cells were transfected for 24 h with FLAG-MTMR2, FLAG-MTMR2 S58A,
FLAG-MTMR2 K137A/R172A or FLAG-MTMR2 K137A/R173A as described above.
At time, cells were lysed, lysates cleared, prepared for immunoblotting (as described
above), and both FLAG (as above) and pSer58 MTMR2 immunoprecipitation. For
pSer58 MTMR2 immunoprecipitation, 1.5 µg of chicken anti-pSer58 MTMR2 IgY was
added to equal amounts of transfected lysates and precipitation was allowed to go for 6 h,
nutating at 4 °C. To isolate the antibody complexes, lysates were then added to donkey
anti-chicken IgY-agarose (Gallus Immunotech) for 3 h, nutating at 4 °C. Resin was
washed and prepared for immunoblot analysis similar to that described above for FLAGimmunoprecipitates.

Quantitative immunoblotting was performed as above, using

chicken anti-pSer58 MTMR2 IgY, mouse anti-FLAG IgG, and rabbit anti-actin IgG,
while secondary antibodies included donkey anti-chicken IgY-HRP conjugate, goat antimouse IgG-HRP conjugate, and goat anti-rabbit IgG-HRP conjugate.

Acquired

chemiluminescent images from at least n = 3 independent experiments were quantified
through densitometry using ImageJ (NIH, http://imagej.nih.gov/ij).
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Data represents

normalized values of the relative comparison among all experimental and control samples
being represented as the mean value +/- s.e.m.

Immunofluorescence analysis
HeLa cells were transfected for 24 h with FLAG-MTMR2, FLAG-MTMR2 S58A, or
FLAG-MTMR2 S58A/K137A/R172A with pEFGP-2xFYVE as described above. Cells
were prepared for immunofluorescence as described above, being probed with mouse
anti-FLAG IgG. Secondary antibody used for visualization included goat anti-mouse
IgG-Alexa Fluor 568 conjugate. Images were obtained using a Leica DMI 6000 inverted
fluorescent microscope equipped with FITC/TRITC/DAPI filter cubes and HCX PL APO
40x/1.25-0.75 oil immersion objective with a Leica DFC 425 camera. Post acquisition,
brightness-contrast adjustments were made in Adobe Photoshop and were applied equally
to all panels of a figure.
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6.3 - RESULTS
ERK1/2 phosphorylates MTMR2 at position Ser58 in vitro
Phosphorylation of Ser58 strongly correlates to sequestration of MTMR2 away from
its physiological endosomal substrate PI(3)P, however, has little influence on catalytic
competency or binding with MTMR5 [14]. The ability to monitor phosphorylation levels
of MTMR2 Ser58 would then reflect both the pseudo-inactive state of MTMR2 towards
this endosomal PI(3)P, and also provide an indirect measure of the targeted endosomal
PI(3)P levels.

Furthermore, evidence of the responsible kinase(s) would be key

information to understanding the mechanisms that underlie this critical regulatory event.
To this end, we designed and generated a polyclonal phospho-specific antibody, and
using immunoblot analyses, characterized its phospho-specificity towards MTMR2
Ser58. The antibody readily detects both phospho-Ser58 peptide and wild type MTMR2,
whereas treatment with alkaline phosphatase completely ablates the signal similar to that
of Ser58 peptide or MTMR2 S58A, emphasizing phosphate-dependent recognition [Fig.
6.1A,B]. Interestingly, the phospho-specific antibody also detected MTMR2 S58E [Fig.
6.1B] supporting our previous results that this phosphomimetic mutant of MTMR2 may
functionally behave like Ser58-phosphorylated MTMR2 [14].
From primary sequence analysis, Ser58 resides immediately N-terminal to an adjacent
proline residue. This, the minimal requirement for proline directed kinase recognition,
suggested that phosphorylation of MTMR2 may be mediated through these enzymes,
including those members of the mitogen activated protein kinase (MAPK) family. As
phosphorylation deficient MTMR2 localizes to endosomes, depletes PI(3)P, and
enhances ERK1/2 activation [14], we hypothesized that activated ERK1/2 may, in turn,
regulate MTMR2 in a negative feedback mechanism through phosphorylating Ser58 to
induce MTMR2 release from endosomes attenuating this signal activation. To test this
hypothesis, in vitro kinase assays, using our Ser58 phospho-specific antibody, were
performed to examine the ability of MTMR2 to be phosphorylated by distinct MAPK
family members.

Purified bacterial recombinant MTMR2 was assayed using

commercially available MAPKs, the proteins were separated by SDS-PAGE, and
phosphorylation of MTMR2 Ser58 was examined by immunoblot analysis using our
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Figure 6.1 - Characterization of a phospho-Ser58 MTMR2 antibody identifies ERK1/2
phosphorylation of recombinant MTMR2 in vitro. A) Phospho-Ser58 and nonphosphoSer58 peptides were incubated with and without alkaline phosphatase, spotted on
nitrocellulose membrane and probed with an in-house generated α-phospho-Ser58
MTMR2 (α-pSer58) antibody. B) HEK293 cells were transfected with empty vector
(UT), FLAG-MTMR2, and FLAG-MTMR2 phospho-mimetic variants, FLAGimmunoprecipitated (IP: FLAG), treated with and without alkaline phosphatase, and
probed for MTMR2 (IB: α-FLAG) and phospho-Ser58 MTMR2 (IB: α-pSer58). C)
Purified bacterial recombinant MTMR2-His6 was incubated with various MAPKs in vitro
as described in 'Experimental procedures' and phosphorylation of Ser58 MTMR2 was
detected using the α-pSer58 antibody. Total MTMR2 and kinase levels were determined
with their respective antibodies.
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phospho-Ser58 antibody. It was determined that both ERK1 and ERK2 could effectively
phosphorylate MTMR2 at Ser58, but in contrast, neither recombinant JNK1 nor p38α
were able to detectably phosphorylate MTMR2 Ser58 in vitro under the given conditions
[Fig. 6.1C], providing the first evidence that ERK1/2 may represent the MTMR2 Ser58
kinases.

Both knockdown and inhibition of ERK1/2 reduces MTMR2 Ser58 phosphorylation
The in vitro kinase assays demonstrated direct phosphorylation of MTMR2 Ser58 by
ERK1/2. To complement these studies, we examined the phosphorylation status of Ser58
in cells whose expression levels of ERK1/2 had been reduced using small interfering
RNA (siRNA) and/or whose ERK1/2 phosphorylation had been attenuated. In response
to various stimuli such as growth factors in serum (e.g. epidermal growth factor (EGF)),
ERK1/2 becomes activated by phosphorylation (pERK1/2), which in turns leads to
phosphorylation of downstream target substrates [53]. Conversely, serum starvation has
been shown to attenuate MAPK activation in a variety cell types, providing a means for
tuning MAPK signaling pathways, and thus, their target substrates [54-56].
Recent evidence has suggested that the steady-state pERK1/2 levels remain largely
unaltered upon perturbations in total ERK1/2 protein levels [57].

Since our initial

interpretations were largely confounded by this phenomenon, we devised conditions to
extend the dynamic range of analysis in response to this robustness of MAPK signaling
afforded through sustained pERK1/2 activity. HEK293 cells transfected with ERK1/2
siRNA were grown under low serum conditions for 6 hours followed by a 10 minute EGF
stimulation prior to cell lysis. These initial conditions effectively reduced both total
ERK1/2 and active pERK1/2 protein levels in the cells [Fig. 6.2A,C], and thus following
stimulation, enabled us to examine the direct correlation of these protein levels (both
ERK1/2 and pERK1/2) on MTMR2 Ser58 phosphorylation [Fig. 6.2A,B]. This scheme
significantly decreased ERK1/2, pERK1/2 and phosphorylation levels of MTMR2 Ser58
as compared to control (~50% reduction) [Fig. 6.2].
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Figure 6.2 - siRNA-mediated depletion of ERK1/2 protein levels reduces MTMR2
Ser58 phosphorylation. A) HEK 293 cells were transfected with control scramble
siRNA or ERK1/2 siRNA, followed by FLAG-MTMR2 or FLAG-MTMR2 S58A and
cultured as described in 'Experimental Procedures'. Cells were stimulated with 5 ng/ml
EGF for 10 minutes, lysed and analyzed by immunoblot analysis. B) Graphs represent
normalized quantitative immunoblot densitometry data of each indicated antibody to their
respective α-actin loading control. Data represents mean and SEM values from at least n
= 3 independent experiments, with ***P<0.001, **P<0.01 or *P<0.05.

178

This data was fortified upon observation of a significant decrease in MTMR2 Ser58
phosphorylation levels when cells were grown under low serum conditions, which had
not been stimulated with EGF, as compared to their 10% serum containing counterparts
[Fig. 6.3A,B]. Importantly, these cells also exhibited low pERK1/2 levels, thus activity,
all patterns that were also observed upon analysis of endogenous MTMR2 [Fig. 6.3A,C
and Fig. 6.4].

Moreover,

HEK293 cells expressing MTMR2 under low serum

conditions were pre-treated with or without the MAPK/ERK kinase (MEK) inhibitor
U0126, then subjected to short EGF stimulation and subsequently examined for the
effects on MTMR2 Ser58 phosphorylation [Fig. 6.3].

EGF stimulation transiently

activated ERK1/2 in cells that were void of MEK inhibition (- U0126), as detected by an
increase in pERK1/2 levels and of phospho-S6 kinase (pS6K) levels, a downstream
ERK1/2 substrate, in comparison to levels from those cells exposed to MEK inhibition (+
U0126) [Fig. 6.3A,C]. Under these same conditions, MTMR2 Ser58 phosphorylation
levels also increased ~2-fold compared to the samples treated with the MEK inhibitor
[Fig. 6.3A,B]. Importantly, this observed increase in Ser58 phosphorylation was strongly
attenuated upon pre-treatment of cells with the MEK inhibitor coinciding with decreased
ERK1/2 activity [Fig. 6.3]. These results, taken together with those of our in vitro kinase
assays, strongly implicate ERK1/2 as kinases capable of phosphorylating MTMR2 at
position Ser58.

ERK1/2 inhibition and knockdown targets MTMR2 to endosomal structures
For insight to the potential of ERK1/2 as not only a regulator of MTMR2 Ser58
phosphorylation, but also of MTMR2 endosomal localization, we performed similar
experiments in HeLa cells, and through immunofluorescence, examined them to identify
if attenuation of ERK1/2 and/or pERK1/2 levels would alter MTMR2 localization
patterns. MTMR2 commonly displays a predominantly diffuse cytoplasmic localization,
likely due to the high stoichiometry of Ser58 phosphorylation under typical cell culture
growth conditions of 10% serum-containing media [13-16].

Dephosphorylation of

MTMR2 Ser58 leads to its recruitment to Rab5- and PI(3)P-containing endosomes, as
indicated by the formation of a distinctly co-localized punctate distribution [14].
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Figure 6.3 - Inhibition of ERK1/2 activity decreases MTMR2 Ser58 phosphorylation.
A) HEK293 cells were transiently transfected with empty vector (UT) or with FLAGMTMR2, serum-starved (- serum) for 30 minutes, then treated with the MEK inhibitor
U0126 to inhibit ERK1/2 activation (where indicated). Following stimulation with 5
ng/ml EGF for 5 or 30 minutes at 37°C, cells were lysed, FLAG-immunoprecipitated (IP:
FLAG), then probed for phosphorylation of MTMR2 Ser58 by immunoblot (IB).
Immunoblots of all samples for FLAG was used to confirm equal transfections and
loading IP levels. Total ERK1/2 and actin lysate immunoblots served as loading
controls, while pERK1/2 immunoblots displayed U0126 efficacy and ERK1/2 activation
by EGF. B) MTMR2 Ser58 phosphorylation was quantified by densitometry using
ImageJ, normalized to FLAG IP levels and represented as fold change relative to serumstarved control without inhibitor. C) Changes in ERK1/2 phosphorylation (pERK1/2)
thus activation is represented as the relative change in pERK1/2 levels compared to total
ERK1/2 levels. All data represents mean and SD values from at least n = 3 independent
experiments, with ***P<0.001, **P<0.01 or *P<0.05.
180

Figure 6.4 - Endogenous MTMR2 Ser58 and ERK1/2 phosphorylation is influenced by
altering serum conditions. A) HEK 293 cells were cultured and processed as described
in 'Experimental Procedures', following either serum (+ 10% (v/v) serum; + serum) or
low serum (+ 0.5% (v/v) serum; - serum) treatment for ~ 12 h. Both lysate and
immunoprecipitates (IP) were subjected to immunoblot (IB) analysis using the indicated
antibodies. B) Graphs represent normalized quantitative densitometry data to the
indicated loading control (y-axis). Data represents mean and SD values from at least n =
3 independent experiments.

181

Consistent with the in vitro kinase assays, inhibitors to JNK and p38α did not alter the
localization pattern of MTMR2 as compared to untreated cells [Fig. 6.5A]. However,
when cells were treated with the MEK inhibitor U0126, MTMR2 dramatically relocalized to Rab5-rich endosomal structures, exhibiting a localization pattern analogous
to MTMR2 S58A [Fig. 6.5B,C].

Similarly, upon serum starvation conditions we

observed significant co-localization of MTMR2 with Rab5 positive endosomes [Fig.
6.6A], with this observation also being recapitulated at the endogenous level [Fig. 6.6B].
Moreover, analysis of MTMR2 localization in HeLa cells subjected to similar conditions
of siRNA-mediated ERK1/2 knockdown as those described above, we observed a similar
shift of MTMR2 localization to endosomal punctate structures [Fig. 6.7]. Collectively,
these results indicate that both direct and indirect attenuation of ERK1/2 signaling
promotes MTMR2 endosomal targeting presumably by influences accrued through
ERK1/2-mediated phosphorylation of MTMR2 Ser58.

Furthermore, our results

complement those of MTMR2 phospho-Ser58 immunoblot analyses performed under
similar conditions, and together with the in vitro kinase assays, begin establishing a
working model for the hypothesis that endosomal targeting of MTMR2 is mediated
through an ERK1/2 negative feedback mechanism.

Phosphomimetic mutagenesis of MTMR2 Ser58 alters solvent accessibility in regions
of the PH-GRAM domain
The data presented have provided a role for MAPK-mediated signaling in the potent
allosteric regulation of MTMR2 localization.

Reports of using hydrogen-deuterium

exchange mass spectrometry (H/DX MS) for structural protein analysis are continually
growing, with experiments using both point-mutations and bona fide phosphorylation
events being abundantly and continually reported in the literature [44,47,58-60]. To
begin investigation of structural mechanisms controlling MTMR2 phospho-dependent
sub-cellular localization, we employed H/DX MS to examine conformational protein
dynamics through alterations in protein solvent accessibility upon MTMR2
phosphorylation using our previously characterized phosphomimetic mutant MTMR2
S58E. From this approach, we have identified regions in the putative PIP-binding
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Figure 6.5 - Inhibition of the ERK1/2 pathway induces sub-cellular targeting of
MTMR2 to Rab5-positive endosomes. A-C) HeLa cells were transiently transfected with
FLAG-MTMR2 or FLAG-MTMR2 S58A and treated with the MEK inhibitor U0126
(ERK1/2) at 50 µM for 1 hour, SB203580 (p38) at 20 µM for 30 minutes and SP600125
(JNK) at 40 µM for 1 hour as indicated and described in 'Experimental Procedures'.
Cells were analyzed by immunofluorescence for either FLAG-MTMR2 (grayscale or red)
alone or with endogenous Rab5 (green). Merged images display regions of colocalization and are represented in expanded views. Images were collected using 40x oil
objectives; Scale bars: 15 μm.

183

Figure 6.6 - Serum starvation induces subcellular targeting of MTMR2 to Rab5positive endosomes. A) HeLa cells were transiently transfected with FLAG-MTMR2 and
analyzed by immunofluorescence microscopy following either serum (+ 10% (v/v)
serum; + serum) or low serum (+ 0.5% (v/v) serum; - serum) treatment as described in
'Experimental Procedures'. Cells were probed for FLAG-MTMR2 (red) and Rab5
(green). B) HeLa cells were treated as above and probed with endogenous MTMR2
(green) and Rab5 (red). Merged images display regions of co-localization and are
represented in expanded views. Images were collected using 40x oil objectives; Scale
bars: 15 μm.
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Figure 6.7 - Depletion of ERK1/2 expression by siRNA induces sub-cellular targeting
of MTMR2 to punctate regions. A) HeLa cells were transfected with control scramble
siRNA or ERK1/2 siRNA, followed by FLAG-MTMR2 and cultured as described in
'Experimental Procedures'. Cells were stimulated with 5 ng/ml EGF for 10 minutes then
analyzed by immunofluorescence analysis of FLAG-MTMR2 (green) and pERK1/2
(red). Images were collected using 40x oil objectives; Scale bars: 15 μm. B) Graphs
represent the total number of puncta between control scramble siRNA and ERK1/2
siRNA using automated counting in ImageJ. Data represents mean and SD values from
at least n = 3 independent experiments counting n = 10 cells per experiment, with
***P<0.001, **P<0.01 or *P<0.05.
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pleckstrin homology-glucosyltransferases, Rab-like GTPase activators and myotubularins
(PH-GRAM) domain which exhibit decreased solvent accessibility upon N-terminal
pseudo-phosphorylation [Fig. 6.8A,B]. Similarly, decreased accessibility was observed
within the phosphorylated region itself [Fig. 6.8C], suggesting that these regions may be
involved in co-coordinating the allosteric regulation of MTMR2 by phosphorylation.
Upon modeling this data onto the available crystal structure and the previous HDX MS
studies of MTMR2 [12], it was observed that the three dimensional folding of these
regional targets form a highly solvent accessible pocket of positive electrostatic potential
on the membrane proximal face of the enzyme [Fig. 6.9A,B] [12]. As many phosphate
and PIP binding modules utilize electrostatic interactions to partially stabilize and orient
the electronegative charge density of phosphorylated biomolecules, this phosphorylation
event could sequester MTMR2 from substrate/membrane association by preventing key
residues within the PIP binding domain accessibility to membrane phospholipid ligands.

Mutation of basic residues in the PH-GRAM domain of MTMR2 influence endosomal
localization and accessibility of the Ser58 phosphorylation site
From our H/DX MS data, we developed a targeted-structural framework for
mutagenic studies of candidate residues within the PH-GRAM domain potentially
involved in phosphate and/or endosomal interactions. Combining elements from the
crystal structure and from primary sequence analysis of our HDX MS data, we made
point mutations of Lys137 (K137A), Arg172 (R172A) and Arg173 (R173A) to alanine,
as well as the double mutants K137A/R172A and K137A/R173A. We first analyzed
these constructs (K137A/R172A MTMR2 and K137A/R172A MTMR2) for Ser58
phosphorylation and found that there was no significant change [Fig. 6.10A,C,D]. From
this, we began testing the hypothesis that these PH-GRAM domain mutants increase the
accessibility of phospho-Ser58.

Using co-immunoprecipitation experiments, we

examined the ability of our phospho-specific antibody to enrich for MTMR2, MTMR2
S58A, MTMR2 K137A/R172A and MTMR2 K137A/R172A. We reproducibly observed
that both mutants, K137A/R172A and K137A/R172A, exhibited increased enrichment as
compared to both MTMR2 and the negative control MTMR2 S58A [Fig. 6.10A,B].
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Figure 6.8 - Deuterium exchange of S58E MTMR2 suggests conformational changes
may occur in a basic cleft within the PH-GRAM domain. A,B) Purified bacterial
recombinant MTMR2-His6 and MTMR2 S58E-His6 was analyzed by HDX-MS as
described in 'Experimental Procedures'. Peptides of the PH-GRAM domain in MTMR2
S58E (red) showed significant alteration in their relative deuterium uptake compared to
wild-type (black). Highlighted is the signature motif KXn(K/R)XR characteristic of high
affinity PIP-binding PH domains (increased font size and underlined) as well as
neighbouring basic and hydrophobic amino acids (underlined). C) The mutated peptide
containing residue S58E also shows decreased uptake (red). The peptide shown has
Ser58 for clarity of the mutation site. Graphs represent calibrated average isotopic m/z
values from each individual MALDI-TOF MS spectra and are represented as a collective
average value. Primary sequence elucidation was determined by exact mass matching
and/or tandem MS using post-source decay as previously described and as in
'Experimental Procedures'.
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Figure 6.9 - Crystal structure of the lipid phosphatase MTMR2 shows residues of the
electropositive PH-GRAM domain regions undergoing changes in solvent accessibility
upon Ser58 phosphorylation. A) Crystal structure and B) surface electrostatic potential
map of MTMR2 shows the position of target basic peptides found on the membrane
proximal face (boxed) with respect to the locale of the active site cleft, both showing a
net positive charge, presumably for polyphosphorylated lipid interactions. Inset
highlights residues (Lys137, Arg172 and Arg173) responsible for the formation of this
basic region within the PH-GRAM domain. Crystal structure and electrostatic potential
map of MTMR2 from Begley et al., Proc. Nat. Acad. Sci., 103:4 (2006) 927-932.
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Figure 6.10 - Mutation of target basic residues in the PH-GRAM domain leads to
increased accessibility of phospho-Ser58. A) HEK293 cells were transiently transfected
with the indicated FLAG-MTMR2 variants of target PH-GRAM domain residues and
analyzed by co-immunoprecipitation (IP) using both α-FLAG and α-pSer58, and by
immunoblotting (IB) with α-FLAG, α-pSer58 and α-actin. B) FLAG-MTMR2 levels of
α-pSer58 IP samples were quantified by densitometry using ImageJ and normalized to
FLAG lysate levels. C) FLAG-MTMR2 pSer58 levels of α-FLAG IP samples were
quantified by densitometry using ImageJ and normalized to FLAG-MTMR2 levels from
α-FLAG IP samples. D) FLAG-MTMR2 lysate levels were quantified by densitometry
using ImageJ and normalized to actin lysate levels. All graphs represent normalized
quantitative immunoblot densitometry, with data representing the mean and SEM values
from at least n = 3 independent experiments.
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These observations suggest that endosomal localization may indeed depend on the
regulated competition between phosphate and PIP electrostatic interactions with this
basic region of the PH-GRAM domain. Furthermore, to test if Ser58 dephosphorylation
alone was sufficient in localizing MTMR2 to PI(3)P-rich endosomes, we mutated Ser58
to alanine on these constructs to form MTMR2 S58A/K137A/R172A and MTMR2
S58A/K137A/R173A and analyzed them using immunofluorescence. Comparing to both
MTMR2 and MTMR2 S58A, we observed that these mutants displayed the common
diffuse, cytosolic staining pattern similar to that of wild type [Fig. 6.11]. Moreover, they
did not cause mis-localization of the PI(3)P-binding marker, EGFP-2xFYVE, as is
observed for endosomal MTMR2 S58A, suggesting that MTMR2 endosomal localization
may require these basic residues for stabilization at the membrane [Fig. 6.11]. Overall,
coupling structural mass spectrometry approaches to traditional cell biology techniques
has provided mechanistic insight into how reversible phosphorylation so effectively
regulates MTMR2 endosomal targeting.
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Figure 6.11 - Phospho-dependent endosomal localization of MTMR2 requires basic
residues of the PH-GRAM domain. A) HeLa cells were transiently transfected with the
indicated FLAG-MTMR2 variants of target PH-GRAM domain residues along with the
endosomal PI(3)P marker EGFP-2xFYVE, and analyzed by immunofluorescence
microscopy as described in 'Experimental Procedures'. Cells were probed for FLAGMTMR2 (red) and EGFP (green). Merged images display regions of co-localization,
while images were collected using 40x oil objectives; Scale bars: 15 μm.
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6.4 - DISCUSSION

In recent years, it has become apparent that early endosomes are heterogeneous in
terms of both their protein and phosphatidylinositol lipid composition on the vesicular
surface [61,62]. This provides layers of functional diversity that likely contribute to the
regulated differentiation among endosomal cargo destinations, maturation rates, and/or
signaling through the coordinated recruitment of distinct effector proteins. Our discovery
that ERK1/2 regulates the phosphorylation of MTMR2 Ser58 is a compelling finding that
implicates MAPK signaling in the regulation of endosomal processing events through
direct influence on PI(3)P phosphatases. In this regard, we have shown by various means
that attenuation of ERK1/2 activity reduces MTMR2 phospho-Ser58 levels leading to
MTMR2 co-localization with Rab5/PI(3)P-rich early endosomes.

Here, MTMR2

mediates the depletion of PI(3)P, in turn, regulates receptor signaling duration through
increased growth factor stimulated ERK1/2 activation. Moreover, we have evidence that
phosphorylation of Ser58 results in decreased solvent accessibility in both the intrinsic
Ser58 phospho-region and the PH-GRAM domain of MTMR2, acting to potentially
shield a poly-basic region from stabilizing endosomal interactions. Similarly, mutations
within this basic region do not alter Ser58 phospho-levels, but do increase the
accessibility of phospho-Ser58, collectively suggesting a transient interaction may exist
between these two moieties. Although dephosphorylation of Ser58 targets MTMR2 to
endosomal structures and does not affect interaction with MTMR5 [14], these PH-GRAM
domain mutations prevent MTMR2 phospho-dependent endosomal localization, and thus,
the mis-localization of PI(3)P-binding proteins when combined with the constitutively
dephosphorylated variant MTMR2 S58A (MTMR2 S58A/K137A/R172A), further
suggesting a role for both Ser58 phosphorylation and the PH-GRAM domain of MTMR2
in endosomal docking events.
Extending the scope our findings, a recent phosphoproteomic study mapped Ser631 as
a phosphorylation site on MTMR2 [63]. Coincidently, as for Ser58, Ser631 also resides
immediately N-terminal to an adjacent proline residue typical of a proline-directed kinase
consensus sequence suggesting that a MAPK family member may also regulate this
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phosphorylation event. Thus in relation to Ser58, we were again interested in examining
the endosomal localization pattern of MTMR2 in response to different MAPK inhibitors,
alone or in combination. To this end, we have begun to characterize this secondary
phosphorylation site with respect to its functional role within the previously established
MAPK-mediated Ser58 phospho-dependent endosomal localization of MTMR2. To our
surprise, combined inhibition of MEK1/2 and JNK1 displayed a pronounced MTMR2
punctate pattern, however, these vesicles were completely void of the MEK1/2 inhibitorinduced, Rab5-rich, endosomal co-localization described above [Fig. 6.5B,C]. These
distinct MTMR2-rich endosomes were also noticeably enlarged when compared to their
Rab5-rich counterparts [37].
Recent evidence has defined a subpopulation of enlarged vesicles containing APPL1
as an early and transient endosomal subtype that resides downstream of clathrin-coated
pits en route to formation of PI(3)P-positive early endosomes.

In addition, PI(3)P

depletion has resulted in the reversion of isolated Rab5/PI(3)P-rich endosomes back into
their preceding APPL1 progenitors as well as their vesicular re-enlargement and
sustained EGF signaling [32], suggesting that under these dual MAPK inhibitory
conditions, MTMR2 may be localizing to APPL1-rich vesicles.

Thus, using co-

immunofluorescence, we found that MTMR2 strongly co-localized with APPL1 under
these MEK1/2 and JNK1 inhibitory conditions, whereas inhibition of the MEK1/2
pathway alone resulted in a punctate staining pattern devoid of APPL1 co-staining [37].
To complement this result, we found that the dephosphorylated mutant of MTMR2,
S58A/S631A, also co-localized with APPL1, but not with Rab5, suggesting that this
doubly dephosphorylated form of MTMR2 localizes to APPL1 endosomes that are Rab5negative. By contrast, the mutant form MTMR2 S58A/S631E was unable to co-localize
with APPL1, but could still target to Rab5-rich early endosomes. Moreover, regardless
of the phospho-status of Ser631, phosphorylation of Ser58 sequesters MTMR2 to the
cytoplasm away from endocytic structures, suggesting that Ser58 is the master regulator
controlling general endosomal targeting, while Ser631 is responsible for regulation of
shuttling between endosomal subtypes [37].
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Taken together, we have found that MAPK regulated phospho-isomers of MTMR2
localize to different endosomal subtypes, illustrating the important role of reversible posttranslational modifications (PTMs) in regulating and achieving early endosome
heterogeneity. In the case of MTMR2, our data strongly suggests that Ser58 regulates the
general endosomal binding capacity of MTMR2, as the phosphomimetic mutation (S58E)
sequestered MTMR2 in the cytoplasm regardless of the phosphorylation status of Ser631.
Meanwhile, upon Ser58 dephosphorylation, it is the phosphorylation of Ser631 that
seems to regulate early endosomal subtype destination; if phosphorylated, MTMR2 is
targeted to PI(3)P-rich Rab5-positive endosomes; if dephosphorylated, MTMR2 is
targeted to APPL1-positive endosomes. Understanding the structural mechanisms behind
this Ser58-based master regulation of MTMR2 localization, thus catalytic activity and
PI(3)P levels, would have deep implications in understanding how PTMs contribute to
the orchestration of cross-talk among membrane targeting, vesicular trafficking, and
regulation of signal transduction pathways.
Upon solving the crystal structure of MTMR2, it was observed that this enzyme
possessed an N-terminal pleckstrin homology (PH)-like domain fold within its suspected
glucosyltransferases, Rab-like GTPase activators and myotubularins (GRAM) domain
[17], which has since been coined a PH-GRAM domain [11]. Moreover, Begley et al.
suggested that of the ~180 suspected GRAM domain containing proteins, all of them
would likely adopt a similar fold [11,17]. The PH-GRAM domain of MTMR2 adapts a
classical PH domain fold, exhibiting a β-sandwich structure capped by an α-helix, with
loops connecting adjacent β-strands. Several other binding modules have been shown to
adapt a fold similar to that of PH domains despite having extreme variability in their
primary sequence, and while being one of the largest domain families in the proteome,
the distinct properties of PH domains in membrane association are yet to be clearly
defined [11,18].
Based on sequence homology, crystal structure and binding assays, it has been
discovered that a distinctly positioned β-loop within a group of high-affinity,
stereospecific PH domains lines a deep binding pocket containing the sequence motif
KXn(K/R)XR which functions in the interactions with phosphoinositide headgroups
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[18,64,65].

The side chains of basic residues form most of the phosphate-group

interactions, whereas other complementary residues from elsewhere within the domain
provide additional contacts to define the preferred inositol ring orientation and
phosphorylation pattern. Defined rules for predicting ligand preference on the basis of
sequence have been identified, suggesting that contributions from the intrinsic GRAM
domain may dictate the distinct phosphoinositide-binding affinities/specificities and
contribute to variations on the above themes [65,66]. Combination of our H/DX mass
spectrometry experiments with those of others, and the three-dimensional crystal
structure of MTMR2, we observed that mutation of Ser58 to glutamic acid resulted in
decreased solvent accessibility of both this pseudophospho-region itself, and a region
within the PH-GRAM domain [Fig. 6.8A,B]. Upon closer inspection, we identified that
this regional target of the PH-GRAM domain resides in the same loop as that described
above, and also possesses the signature motif along with flanking hydrophobic and basic
residues [Fig. 6.8A,B]. Moreover, this region lies on the membrane proximal face of the
enzyme, adjacent to the active site, closely resembling the electropositive charge density
observed within the active site cleft [Fig. 6.8C] [12]. This was compelling due to the fact
that this motif has been defined mostly among highly affinitive and specific PIP-binding
PH domains, whereas in MTMR2, localization to PIP-containing vesicles, namely
substrate containing endosomes, had been elusive for some time.
It is thought that nearly 80% of known PH domain-containing proteins likely do not
bind PIPs at all due to the lack of functional redundancy among these similarly folded
domains [67]. Additionally, many PIP-associating proteins require multivalent aviditybased interactions to stabilize transient membrane docking [18,20]. Previous studies
have shown that the coiled-coil domain of MTMR2 is capable of forming a parallel dimer
with itself and/or the inactive myotubularin, MTMR5, which in the case of the former,
would double the available PIP-binding PH-GRAM domains on the membrane proximal
face which are capable of stabilizing such an interaction [13,15]. Although the inactive
binding partner MTMR5 contains a much larger and more diverse domain arrangement,
and has been shown to affect the localization of MTMR2, whether it could contribute to
stabilizing membrane interactions is yet to be determined [15]. Homology modeling of
the electrostatic polarization of inactive members using MTMR2 as a template showed
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that the membrane proximal face of the inactive members analyzed (MTMR9 MTMR12) mostly had an electronegative charge density, suggesting that these binding
partners may not be involved in the membrane associations of their respective active
binding partners, but perhaps in regulating them [12].
As previously mentioned, MTMR2 seems to possess the sequence motif and structure
of high-affinity PIP-binding PH domains [18], but can only localize to vesicular
structures when Ser58 is dephosphorylated, which has been found to occur independently
of PI(3)P presence (unpublished data). Data has also been suggested that the PH-GRAM
domain alone is capable of associating with PIPs in vitro [13], however, in all of the
MTMR2 crystal structures to date, the catalytically inactive variant has been used, along
with the incorporation of artificial water soluble PI(3)P or PI(3,5)P2 substrate analogs,
which did not show any signs of PH-GRAM domain association [11,12]. Furthermore,
alignment of putative GRAM domain-containing proteins shows high degree of sequence
similarity among this basic motif found within the PH-GRAM domain of MTMR2, with
strong conservation of the targeted Lys and Arg residues from our studies [11,17]. From
these observations, it is not clear whether effects on these regions within the PH-GRAM
domain limit the binding affinity to PIPs or if a multivalent avidity-based mechanism
involving membrane and/or protein contacts is necessary to stabilize and/or destabilize
interactions, or if it is some combination of the two. Based on these possibilities, we
tested the effects of Ser58 phosphorylation and PH-GRAM domain residues on the ability
to sequester MTMR2 away from membrane docking, either directly or indirectly. The
position of Ser58 is ~30 amino acids upstream of the PH-GRAM domain, is quite flexible
and solvent accessible, but has not been resolved in any crystal structures to date [11,12].
We hypothesized that like some other PIP-binding proteins, including another lipid
phosphatase, phosphorylation may shield the accessibility of key residues within the PIPbinding domain from membrane association [68-70]. Upon mutation of the PH domain
loop motif residues, we found that phospho-Ser58 levels were unaltered, however, the
accessibility of this N-terminal phosphosite increased. Similarly, the same mutations on
the constitutively dephosphorylated variant prevented localization to PI(3)P-rich
vesicular structures and subsequent PI(3)P depletion, suggesting that regulation of
MTMR2 localization to substrate-rich membranes may be mediated through competitive
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phospho-dependent interactions between Ser58, endosomal PIPs, and residues within the
PH-GRAM domain. Ultimately, we have begun to uncover how this master regulator
potently regulates the sub-cellular localization of MTMR2, providing future insights to
studying the regulation of shuttling between Rab5 and APPL1 subtypes. It will be
interesting to test if mutations within the PH-GRAM domain effect the ability of duallydephosphorylated MTMR2 variants (MTMR2 S58A/S631A) to localize to PI(3)P-poor
APPL1 endosomes. This would determine if membrane associations between the two
endosomal subtypes are performed similarly or are completely unique, furthering the
understanding of phospho-dependent endosomal targeting of PI phosphatases and the
regulation of relative PI(3)P levels on each.
We are currently using chemical cross-linking in conjunction with targeted MS
applications to examine structural contact constraints between Ser58 and Lys residues
within the PH-GRAM domain. Preliminary data using precursor ion scanning MS has
provided a means for rapid detection of the targeted, low abundant cross-linked peptides
containing Ser58, thus allowing for a comprehensive future analysis of stable contacts of
this phospho-region. Alternatively, we have preliminary data suggesting that the PHGRAM domain alone is capable of endosomal interaction, however, still requires
dephosphorylation of Ser58, suggesting that homo/hetero-dimerization is not required for
stabilizing membrane associations. This suggests that regions within the C-terminus are
required for endosomal shuttling and stabilization at APPL1 containing vesicles, however
further evidence is required to rule out any APPL1 localization of these constructs.
There are numerous reports that have described APPL1 and APPL2 as Rab5 effector
molecules that co-localize on early endosomes [32,33,71]. The dissociation of APPL1
from early endosomes during the conversion of APPL1 endosomes into Rab5/EEA1 early
endosomes is mediated by the accumulation of PI(3)P, and in turn, the recruitment of
FYVE domain containing proteins including EEA1.

Therefore, the generation and

accumulation of PI(3)P is thought to function as the molecular switch that controls
maturation into the canonical early endosomes. It has also been shown that EEA1 and
APPL1 compete for a limited number of binding sites on Rab5-positive endosomes [32].
When PI(3)P is depleted, the binding of APPL1 to Rab5-positive endosomes is
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dramatically increased, whereas in contrast, attenuation of APPL1 association to
endosomes by PI(3)P generation allows for proficient stabilization of EEA1 binding to
Rab5 endosomes. This competitive scenario is thus mediated by both PI(3)P kinases and
phosphatases to ultimately regulate the signaling and maturation properties of early
endocytic events transitioning through these particular stages.

The direct ability to

allosterically control the activities of these families of enzymes provides a potent tier of
regulation to achieve proper response to a given stimulus. This effect further transitions
to downstream sorting machinery which utilize PI(3)P binding modules for activity. For
example, we recently identified a novel PI(3)P binding protein, receptor-mediated
endocytosis-8 (RME-8), involved in endosomal sorting decisions and retrograde transport
[19]. RME-8 association with early endosomes was dependent on PI(3)P levels, being
attenuated by MTMR2 lipid phosphatase activity, exemplifying the importance of
phosphatidylinositol levels among a diversity of endosomal activities.
It is also important to note that in all cases it was observed that MTMR2/APPL1positive endosomes (either MTMR2 S58A/S631A or stimulated equivalents) were
reproducibly found enlarged when compared to APPL-positive endosomes alone.
Surprisingly,

when

catalytic

activity

of

MTMR2

was

impaired

(MTMR2

S58A/C417S/S631A), vesicle size did not change, remaining comparable to sole APPL1
containing endosomes [37]. One possibility is that MTMR2/APPL1 endosomes are a
distinct endosomal subtype that function as an initial platform for downstream signaling
events regulated in a PI(3)P-dependent fashion. However, a more likely explanation is
that these MTMR2/APPL1 endosomes represent a proximal endosomal stage that
precedes Rab5/APPL1 early endosome formation, potentially as a means to spatially and
temporally control PI(3)P levels which, in part, regulates the linked signaling events.
Supporting our and others findings with respect to these endosomal maturation and
signaling capabilities, a similar, but prolonged increase in ERK1/2 activation during EGF
stimulation was also observed upon expression of the aforementioned MTMR2
S58A/S631A variant as compared to that observed for MTMR2 S58A alone [37]. Since
the formation of enlarged MTMR2/APPL1 endosomes is dependent on MTMR2 catalytic
competency, these combined findings support the hypothesis that MTMR2/APPL1
endosomes may act to control PI(3)P accumulation rates, to in turn, regulate intrinsic
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endosomal signaling events. In this regard, MTMR2-mediated PI(3)P depletion may lead
to halting or retardation of endosomal maturation, a phenotype which others have shown
to result in endosomal enlargement and continued receptor signaling [72-74].
Further testing of this hypothesis will be needed, as our current results do not directly
demonstrate PI(3)P depletion on APPL1-positive endosomes. Nonetheless, our findings
are reminiscent of an elegant study by De Camilli and colleagues who used a chimeric
MTM1 inducible system to deplete PI(3)P from EEA1/Rab5 vesicles causing reversion
back into APPL1-positive endosomes. Importantly in this study, these PI(3)P depleted
APPL1 endosomes were also enlarged and displayed increased growth factor signaling,
with the enlargement also being dependent on the catalytic activity of MTM1 [32].
However, in the inaugural studies using this chimeric MTM1 inducible system, Larijani
and colleagues concluded that PI(3)P depletion resulted in endosomal tubulation rather
than enlargement [75].

Both of these studies however, clearly demonstrated that

depletion of PI(3)P on early endosome compartments acutely compromises endosome
maturation. Analogous to the inducible chimeric MTM1 system, our results highlight
how controlling the PI(3)P phosphatase activity of MTMR2 allosterically via reversible
phosphorylation serves as a potent mechanism to regulate the residency time of MTMR2
on these various early endosomal subtypes.

The importance of these finding is

highlighted by the fact that MTM1 and the homologous MTMR1 also possess potential
phosphorylation sites within similar N-terminal and C-terminal regions. It stands to
reason that this may then be a common mode for the controlled subcellular targeting of
other MTM family members through similar reversible phosphorylation-mediated
regulatory mechanisms.
Nevertheless, we have uncovered a potential negative feedback mechanism that may
have involvement in both the transient and/or sustained activation of ERK1/2 signal
transduction events.

A long standing dogma is that MAPK signaling duration can

dynamically influence cellular fate [76], whereby sustained ERK activation is thought to
illicit different biological outcomes compared to transient ERK activation. For example,
differentiation of PC12 cells into sympathetic-like neurons requires sustained ERK
activation, whereas transient ERK activation induces PC12 cell proliferation [77,78]. As
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is seen in PC12 cells, in most cell types, sustained ERK activation induces differentiation.
However, in Schwann cells, sustained ERK activation triggers de-differentiation in
response to a variety of environmental cues including neuronal injury [79,80]. Schwann
cell de-differentiation into a progenitor cell-like stage is critical for axonal re-growth and
is highlighted by extensive demyelination [80]. Moreover, Schwann cell demyelination
is one of the main hallmarks of CMT diseases, including those devoid in proper MTMR2
functions. Since phosphorylation of MTMR2 at position Ser58 by ERK1/2 results in
allosteric inactivation through cytoplasmic sequestration of MTMR2 away from its
PI(3)P-rich endosomal substrates, it will be important to investigate if sustained ERK1/2
mediated phosphorylation of MTMR2 plays a role in the pathophysiology of CMT
disease(s).
From these collective observations, our working model is that dephosphorylation of
MTMR2 increases accessibility of key residues within PH-GRAM which leads to its
stabilized localization to Rab5/PI(3)P-rich endosomes, resulting in PI(3)P depletion, mislocalization of PI(3)P-binding proteins, and ERK1/2 activation. This resultant ERK1/2
activation may then lead to Ser58 phosphorylation, destabilizing MTMR2-endosomal
interactions through competitive shielding of the PH-GRAM domain, and thus
completing a functional negative feedback mechanism to remove MTMR2 from
substrate-rich early endosomes.

This may, in part, be critical for achieving proper

homeostatic endosomal signaling and maturation rates, acting to halt or slow maturation
events to allow for increased receptor-signaling responses from these PI(3)P depleted
endosomes until an appropriate threshold is met, triggering ERK1/2-mediated attenuation
of the stimulus through Ser58 phosphorylation.
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CHAPTER 7 - GENERAL CONCLUSIONS, OUTLOOK AND FUTURE WORK

7.1 - Regulation of Biological Redox Switches:

Novel Labeling and Enrichment

Strategies for Monitoring Protein Thiol S-Modifications Using Mass Spectrometry
Research Significance
Cellular oxidants are often considered unfavourable by-products of aerobic
respiration, but increasing evidence has highlighted their roles as second messenger
molecules in normal signal transduction. Reactive oxygen and nitrogen species provide a
tier of transient and reversible post-translational regulation over 'redox switch or sensor'
proteins whose activities depend on cysteine thiols. Multiple redox-based S-modification
of target proteins exist, occurring rapidly and specifically with susceptible thiols, and it is
these characteristics that often hinder isolation, detection, identification and
quantification. However, it is also these collective characteristics which highlight the
importance of the continued development of methods and reagents for use in their study.
In collaborative methods pioneered by our and Dr. Bulent Mutus' lab (University of
Windsor), we have used a variety of novel labeling and enrichment strategies allowing
for quantitative and/or qualitative identification of protein thiol redox status using mass
spectrometry (MS).
Using chemically assisted fragmentation (CAF) technology, we developed a novel,
MS-based chemical derivatization method to identify inter-peptidyl disulfide bonding of
the tyrosine phosphatase human YVH1. This was one of the first accounts that protein
tyrosine phosphatase (PTP) oxidation is not limited to the active site thiol, but capable of
modifying other intrinsic low pKa thiols which serve to buffer inactivating oxidative
stress conditions and preserve catalytic activity. In a separate study, isotope coded
affinity tag (ICAT) technology and thiol labeling was used by Kozarova et al., on the
oxidoreductase protein disulfide isomerase (PDI) to show some of the first evidence for
quantitative analysis of thiol redox status using MS.
In a following proof of concept study, we used these redox regulated proteins as
models for a novel approach which combined both thiol isolation and enrichment steps.
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Our method exploited the near covalent interaction of gold nanoparticles (AuNPs) with
protein thiols providing a simple, single or multiple-step enrichment method of Smodified peptides for subsequent MS analysis of the specific site and type of Smodification(s). These manuscripts have since fostered an invited article on methods for
studying redox regulation of PTPs and an invited review of current methods for
identifying protein S-glutathionylation and S-nitrosylation sites.
Our latest approaches have focused on reversible, low pH labeling of thiols for their
enrichment and analysis using MS.

We have used Mercury-Immobilized Affinity

Chromatography (Hg-IMAC) to specifically isolate reversibly oxidized thiol-containing
peptides for subsequent MS analysis.

In a similar approach, based on the scheme

proposed by Nielson et al., we have began development of a ITC-CAD-based chemical
library of low pH thiol labeling reagents in which unique functionality can be built on the
designed platform of reagents. Combined with this discovery, the designed reagents act
as molecular reporter ions within the MS, having future applications in quantitative MS
of a diverse array of biological thiols.
Practical Application Significance
Identification of cross-linked species by MS is often hindered by their low abundance,
increased size, and the resulting mixture of data arising from two (or more) peptides
which are covalently linked. Based on the studies above, differential CAF labeling
technology and molecular reporter ions enables one to locate and dramatically improve
identification and de novo sequencing of labeled and di- or higher order peptides using
MS. These characteristics could have profound utility in studying structural protein
interaction networks with biochemical cross-linking reagents by improving data
acquisition and simplifying interpretation. Moreover, the CAD-based reagent platform
can be tailored to impart multiple chemical functionalities, and thus, will serve as a
multifaceted MS-labeling agent. Similar to that of the ICAT methodology, both CAF,
CAD and AuNP methodologies can be readily applied to high-throughput proteomicbased MS approaches.

Our CAD and nanoparticle-based approaches are further

highlighted by their inexpensive synthesis, ability to interact with a variety of S-modified
protein thiols, ease of harvesting by centrifugation (for AuNPs), and elution by thiol
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exchange. Most notably, the AuNP enrichment strategy has been recently cited by
multiple review articles published in journals such as Cancer Letters, Analytical and
Bioanalytical Chemistry, Antioxidants and Redox Signaling, and Proteomics.

This

exhibits the broad range of future applications this framework may support for end-users
among diverse areas of study.

7.2 - Differential Phosphorylation of the Phosphoinositide-3-phosphatase MTMR2
Regulates its association with Early Endosome Subtypes - Journal of Cell Science
Research Significance
Early endosome maturation rates are dependent on their membrane complement of the
phospholipid phosphatidylinositol-3-phosphate (PI(3)P), one substrate of the lipid
phosphatase myotubularin related protein 2 (MTMR2). Recently we have shown that
phosphorylation of MTMR2 on Ser58 is responsible for its cytoplasmic sequestration. A
deficient variant, MTMR2 S58A, targets MTMR2 to Rab5-positive endosomes resulting
in PI(3)P depletion, mislocalization of PI(3)P binding proteins, and an increase in
endosomal signaling [1,2].

Notably was a significant increase in activation of the

mitogen activated protein kinase (MAPK), extracellular receptor kinase 1/2 (ERK1/2)
[1].
Using in vitro kinase assays, cellular MAPK inhibitors, siRNA and an in-house
generated phosphospecific-Ser58 antibody, we have provided evidence that ERK1/2 are
kinases responsible for phosphorylating MTMR2 at position Ser58.

This strongly

suggests that the endosomal targeting of MTMR2 may be regulated through an ERK1/2mediated negative feedback mechanism.

We have further shown evidence that

phosphorylation of MTMR2 allosterically regulates its sub-cellular localization through
effects mediated by the PH-GRAM domain. In addition, we provided evidence that
MTMR2 is dynamically regulated by multiple MAPKs resulting in differential
localization to and among endosomal subtypes; phospho-status of Ser58 regulates general
endosomal localization, while the phospho-status of Ser631 mediates endosomal shuttling
between Rab5 and APPL1 subtypes. Taken together, this illustrates an important role for
MAPK-mediated phosphorylation in regulating and achieving early endosomal
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heterogeneity and thus aspects of receptor signaling and vesicular trafficking through
direct influences on PI(3)P phosphatases.

Practical Application Significance
Phospho-specific antibodies offer an economic and safe alternative to radioactive [32P]
labeling experiments while still providing adequate sensitivity and specificity for
analyzing unique phosphorylation events. Based on the above findings, the ability to
monitor phosphorylation of MTMR2 Ser58 would reflect levels of the pseudo-inactive
state of MTMR2 towards endosomal PI(3)P. This would in turn provide an indirect
measure of endosomal PI(3)P levels, and insight to both the binding events and
maturation rates of vesicular trafficking under the tested condition. Since loss of function
mutations in the mtmr2 gene result in Charcot-Marie Tooth disease 4B1, this reagent may
find clinical use in discovering functional pathophysiologic roles of MTMR2. This is
supported by strong evidence that differential ERK1/2 activity is essential for Schwann
cell differentiation and myelination, a main process disrupted by CMT4B1.
Monitoring`phosphorylation of MTMR2 Ser58 may not only represent a proximal
ERK1/2 substrate, but serve as a diagnostic marker for transient upstream ERK1/2
activation events, both in normal and disease models. These notions highlight the future
applicability of the designed reagent to those studying among diverse fields ranging from
vesicular trafficking to cellular signaling to pathophysiology.
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APPENDICES
APPENDIX A - CHAPTER 5
Experimental parameters for reverse phase ultra performance liquid chromatography
and mass spectrometry applications
Samples were injected onto a 180 µm x 20 mm x 5 µm Symmetry® C18 reverse phase
nanoACQUITY UPLC trapping column then resolved on a 100 µm x 100 mm x 1.7 µm
BEH®130 C18 reverse phase nanoACQUITY UPLC analytical column as described in
the experimental parameters [Appendix A1].

Timed-ion chromatograms and mass

spectra were acquired on a Waters Quattro-micro® nanoESI triple-quadrupole MS.
Instrument settings varied based on MS tune requirements for each mode and are
described in the experimental parameters [Appendix A2-4]. For targeted approaches
(MS/MS and PIS), tune settings were determined empirically by continuous directinjection of molecule(s) of interest using the microESI source interfaced onto the above
triple-quadrupole MS and found to be similar to those used in LC/MS/MS and LC/PIS
experiments. Noted differences were a reduction in Cone voltage to ~ 26 V, and increase
in collision energy to ~ 31 - 33.
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APPENDIX B - CHAPTER 6
Production, isolation, purification and characterization of avian α-pSer58 MTMR2
and α-MTMR2 polyclonal antibodies
To construct the pSer58 MTMR2 antigen, we used the Basic Local Allignment Search
Tool to perform multiple searches across the human proteome to limit the sequence
similarity between the target peptide epitope and other endogenous proteins.

Once

determined, we checked both the predicted antigenicity and hydrophobicity, and found no
limitations on either. From this, we placed an N-terminal cysteine on the peptide and
amidated the C-terminus to mask the negative charge.

The target peptide was

synthesized (NEO BioScience), resuspended in conjugation buffer (100 mM NaPO4, 150
mM NaCl, 5 mM EDTA, pH 7.3), reduced with immobilized TCEP (Pierce
Biotechnology) and conjugated to maleimide-activated Keyhole Limpet Hemocyanin
(Pierce Biotechnology) through the engineered thiol terminal.

Reduction by tris(2-

carboxyethyl) phosphine hydrochloride (TCEP-HCl) was monitored by matrix-assisted
laser desorption ionization mass spectrometry (MALDI-TOF MS) and 5,5-dithio-bis(2nitrobenzoic acid) (DTNB)-based assays. The formulated carrier was then used for
immunization of Gallus gallus (Amicus Biotech Inc.).

Purified polyclonal chicken

immunoglobulin Y (IgY) was isolated by the water dilution method as described below
and characterized for efficacy against the target epitope by immunoblot analysis. As
observed, only purified bacterial recombinant MTMR2 was readily detected, niether
recombinant hYVH1, transiently over-expressed MTMR2 in HEK 293 cells nor
endogenous MTMR2 were detected to a significant amount. This highlighted that αMTMR2 IgY could specifically recognize MTMR2, but in a non-phospho-specific
manner, thus required affinity purification to isolate the phospho-specific antibodies
[Appendix B1].
Chicken α-pSer58 MTMR2 IgY antibodies were isolated sequentially by subtractive
affinity chromatography against non-phophosphorylated and phosphorylated peptide
epitopes immobilized on iodoacetamide-activated agarose (Pierce Biotechnology)
conjugated similarly to that described above [Appendix B2]. Antibodies were first eluted
off the column using 175 mM glycine pH 2.5 being immediately neutralized with 1 M
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Tris-HCl pH 8, however, it was determined by enzyme-linked immunosorbant assays that
during the course of elution, IgY, not IgG-HRP secondary, loses nearly 50% of its
binding activity under these conditions, while addition of a stabilizer, sorbitol, improved
this to 75%. Using 50 mM diethylamine, no significant loss of binding activity was
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observed, thus this eluant was continued throughout subsequent affinity purification of
avian IgY antibodies [Appendix B3,4].
Antibody specificity was tested against both MTMR2 peptide and protein epitopes by
standard dot and immunoblot procedures.

Briefly, peptides or FLAG-MTMR2

immunoprecipitates (as described in Chapter 6 'Experimental Procedures') were
resuspended in 50 mM Tris-HCl pH 9.3, 1 mM MgCl2, 0.1 mM ZnCl2 and treated with or
without 2.5 U of calf intestinal alkaline phosphatase (Promega) for 4–6 hours at 25 °C
shaking, then spotted on nitrocellulose (peptide dot blot analysis) or prepared for
immunoblotting. Alkaline phosphatase activity was monitored using MALDI-TOF MS
[Appendix B6]. Membranes were probed with chicken anti-pSer58 MTMR2 IgY at
1:1000 (0.7 µg/µl stock) in 2.5% BSA TBST, washed, then probed with donkey antichicken IgY-HRP conjugate at 1:3000 (Gallus Immunotech) in 2% BSA/TBST for
subsequent chemiliuminescent imaging [Appendix B5,6].
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APPENDIX C - CHAPTER 6
Mathematical matrix calculating peptide masses upon hydrolysis at every possible
combination of peptide bond(s).
Using Microsoft Excel 'IF' functions, three consecutive formulae were constructed to
convert primary amino acid sequences (one-letter code) into their respective residue
masses. Summation of these formula align the masses of each residue within the protein
of interest. Transposition of the primary amino acid sequences (one-letter code) and their
calculated respective masses down the left column sets up the starting amino acid (n) for
a given peptide of interest. A given mass is located within the matrix using the 'find'
function, whereby the horizontal axis denotes the amino-terminal peptide residue (n),
while the vertical axis denotes the carboxyl-terminal peptide residue (x), giving the
corresponding theoretical peptide. Detailed descriptions of the mathematical formulae
are outlined in the matrix [Appendix C1].
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APPENDIX D - CHAPTER 6
Isolation, purification and characterization of avian polyclonal antibodies
Prior to immunization, ~ 6 eggs were collected as 'pre-immune' comparative controls.
After immunization, eggs were collected and processed similarly to the water-dilution
method described by Akita and Nakai, Journal of food science, 57, (1992) 629-634
[Appendix D1]. Briefly, after letting eggs settle, they were cracked open to separate the
vitellus (yolk; IgY) from the albumen (egg white; IgA and IgM). Yolk sacs are rinsed
with water, then with 5% glacial acetic acid directly over collected albumen to remove
any residual traces left on the sac. Vitellus is then drained into a large secondary vessel
by puncturing the sac, ensuring not to rip or drop the membrane into the vessel. The
collected vitellus is diluted 1:10 (~ 135 mL/yolk) in slightly acidified water (with acetic
acid) and gently mixed by magnetic stir bar, with the pH being adjusted to ~ 5.1.
Solution is poured equally into oak-ridge centrifuge tubes, tubes are balanced, then left
still overnight at 4 °C. The egg albumin is treated similarly, being diluted 1:4 (~ 35
mL/egg) in slightly acidified water, gently mixed as above, with the pH being adjusted to
≤ 5. Solution was partitioned and let stand overnight as above.
The soluble fraction of egg albumen is filtered through coarse filter paper to separate
the soluble immunoglobulin A (IgA) containing fraction from the insoluble
immunoglobulin M (IgM) containing fraction. Insoluble IgM can be stored as is at 4 °C
for extended time periods, or can be resolubilized by neutralizing the system. The
soluble IgA fraction (WSF IgA) is gently stirred at 4 °C, slowly being brought to 40%
ammonium sulfate (AMS). Once reached, sample is stirred for ~ 1 h, then let stand
overnight at 4 °C. The samples containing the diluted vitellus are spun at 6000 x g for 20
min at 4 °C to separate the lipids and lipoproteins from the soluble immunoglobulin Y
(IgY). The soluble supernatant is collected (WSF IgY), then treated similarly to that of
soluble IgA, being brought to 40% AMS and let stand overnight.
Insoluble Ig pellets are centrifuged at 6000 x g for 20 min at 4 °C, washed 2 - 3x with
cold 100% AMS, collected and stored at 4 °C in 100% AMS until use. At time of use,
pellet is resuspended, an aliquot taken which is centrifuged to collect pellet. The 100%
AMS storage solution is removed, antibodies are resuspended in sterile phosphate
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buffered saline and dialyzed against≥ 10 volumes of PBS 2 - 3x until AMS is removed
as determined by a BaSO4 turbidity assay (detection limit ~ 10 - 20 µM). Antibodies
(AMS ppt IgY or IgA) are empirically tested for efficacy among immunological assays of
interest and compared to pre-immune antibody controls.
To characterize the purification, samples were resolved by 10% SDS-PAGE and
visualized by coomassie stain or by immunoblot analysis against the target
immunoglobulins using the appropriate horserasdish peroxidase conjugated secondary
[Appendix D2]. As observed, this two step purification method is capable of achieving
near 80 - 90% purity of target immunoglobulins, with yields of ~ 100 mg total IgY/yolk
and 15 mg total IgY/egg. Membranes were blocked with 5% skim milk in tris-buffered
saline/0.1% Tween-20, then probed with donkey anti-chicken IgY-HRP conjugate at
1:3000 or donkey anti-chicken IgA-HRP conjugate (Gallus Immunotech) in 2.5% skim
milk/TBST for subsequent chemiliuminescent imaging.
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APPENDIX E
Production, isolation, purification and characterization of avian α-hYVH1 polyclonal
antibodies
Recombinant bacterial human YVH1 was purified by affinity chromatography then
anion exchange chromatography to produce a high purity antigen for immunization. A 1
mL EconoPac High Q Cartridge (Bio-Rad) was equilibrated with degassed, 0.2 µm
filtered mobile phase A of 25 mM Tris-HCl pH 8 and mobile phase B of 25 mM TrisHCl, 1 M NaCl pH 8 as per manufacturer instructions using a Bio-Logic Low Pressure
Liquid Chromatography (LPLC; Bio-Rad) system monitoring λAbs @ 280 nm and
conductivity (mS/cm). After zeroing absorbance, sample was injected directly on the
column at 500 µL/min using an off-line syringe pump luer-fitted to the column inlet. The
system flow was then re-connected and the column equilibrated at 1 mL/min with mobile
phase A until near baseline absorbance was achieved. Samples were eluted using a linear
gradient of 0 - 100% mobile phase B over 60 min at 1 mL/min and collected in 1 mL
fractions [Appendix E1]. Fractions were resolved using 12% SDS-PAGE and purity was
determined by silver staining [Appendix E1]. Target fractions 1 thru 5 were pooled,
concentrated using an Amicon centrifugal concentration device, and compared directly to
an equal amount of starting material (prior to anion exchange as per Bradford assay) by
12% SDS-PAGE analysis as above [Appendix E2]. This highly purified protein was
tested for phosphatase activity using the artificial substrate analog DiFMUP, and for
identity using in-gel trypsin digestion as described [Appendix E3,4]. The confirmed
antigen of interest was used as an immunogen for the immunization of Gallus gallus
(Amicus Biotech).
Target antibodies were purified as described [Appendix D] and IgY was tested for
efficacy in the detection of hYVH1 by immunoblot (IB) and immunoprecipitation (IP)
analysis. As observed, both transiently over-expressed hYVH1 in HEK 293 cells and
purified bacterial recombinant hYVH1 were readily detected, however, endogenous
hYVH1 was not detected to a significant amount [Appendix B1]. This highlighted that αhYVH1 IgY required affinity purification.
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Chicken α-hYVH1 IgY antibodies were isolated by affinity chromatography against
purified bacterial recombinant hYVH1 immobilized on iodoacetamide-activated agarose
conjugated similarly to that described above [Appendix B]. Target antibodies were again
tested for efficacy in the detection of hYVH1 by immunoblot (IB) and
immunoprecipitation (IP) analysis. As observed, affinity purified α-hYVH1 IgY was
able to detect endogenous protein levels in both HeLa and HEK293 cells as directed
compared to α-hYVH1 IgG.

Moreover, this antibody was able to effectively IP

endogenous hYVH1 from the cell lines, as detected by both α-hYVH1 IgY and IgG.
Affinity purification, immunoprecipitation and immunoblotting conditions are currently
being optimized to reduce the non-specific interactions. To note, thick bands in the αhYVH1 IgY IP and α-hYVH1 IgY IB blots is the heavy chain of IgY (~ 65 kDa).
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